Dialkoxyalkenyl alkoxymethyl ether compound and method for producing terminally conjugated alkadienal compound using the same

Dialkoxyalkenyl alkoxymethyl ether compounds are used to synthesize terminally conjugated alkadienal compounds with high selectivity and yield, addressing industrial synthesis challenges by eliminating hazardous materials and reducing costs.

JP7583697B2Active Publication Date: 2024-11-14SHIN ETSU CHEMICAL CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2021161127
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-10-02
Filing Date
2021-09-30
Publication Date
2024-11-14
Estimated Expiration
2041-09-30

AI Technical Summary

Technical Problem

Existing methods for synthesizing terminally conjugated alkadienal compounds, such as (9E)-9,11-dodecadienal and (9Z)-9,11-dodecadienal, face challenges including the use of carcinogenic solvents, expensive reagents, low yield, poor geometric selectivity, and environmental hazards, making them unsuitable for industrial application.

Method used

The use of dialkoxyalkenyl alkoxymethyl ether compounds as intermediates allows for the production of terminally conjugated alkadienal compounds with high geometric selectivity and good yield through a series of controlled reactions, avoiding hazardous substances and expensive reagents.

Benefits of technology

This method enables the efficient production of both E and Z forms of terminally conjugated alkadienal compounds, overcoming industrial limitations by providing a safer, more cost-effective, and environmentally friendly synthesis process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007583697000001
    Figure 0007583697000001
  • Figure 0007583697000002
    Figure 0007583697000002
  • Figure 0007583697000003
    Figure 0007583697000003
Patent Text Reader

Abstract

To provide a method capable of manufacturing a terminal conjugated alkadienal compound with high yield and high geometric selectivity.SOLUTION: The present invention provides a manufacturing method of a dialkoxy alkenyl=alkoxy methyl=ether compound represented by the following general formula (1): R1CH2OCH2OCH2CH2CH=CH(CH2)aCH(OR2)(OR3) (1) (in the formula, R1 represents hydrogen atom, n-alkyl group of 1 to 9 carbons or phenyl group, R2 and R3 each represent independently monovalent hydrocarbon group of 1 to 15 carbons, or R2 and R3 are mutually bonded to represent divalent hydrocarbon of 2 to 10 carbons as R2-R3, and a represents an integer of 1 to 15) and a terminal conjugated alkadienal compound represented by the following general formula (5): CH2=CHCH=CH(CH2)aCHO (5)(in the formula, a is as defined above).SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a dialkoxyalkenyl alkoxymethyl ether compound and a method for producing a terminally conjugated alkadienal compound using the same. [Background technology]

[0002] Nettle caterpillar ( Setothosea asigna and Setora Nitens ) are serious pests of oil palm in Southeast Asia, including Indonesia and Malaysia. The damage caused by these pests to palm leaves significantly reduces the yield of oil palm, and is therefore a major problem in plantations. In addition, from the standpoint of reducing the environmental load and managing the health of plantation workers, there are limitations on the insecticides that can be used, making effective control difficult. In recent years, biological control methods have been attracting attention, and one promising method is the use of sex pheromone substances.

[0003] Setothosea asigna It has been reported that the sex pheromone of is a mixture of (9E)-9-dodecenal and (9E)-9,11-dodecadienal, which is a terminally conjugated alkadienal compound (Non-Patent Document 1 below). Setora Nitens It has been reported that the sex pheromone of this insect is a mixture of (9Z)-9-dodecenal and (9Z)-9,11-dodecadienal, which is a terminally conjugated alkadienal compound (Non-Patent Document 2 below).

[0004] Setothosea asignaAs a method for synthesizing (9E)-9,11-dodecadienal, which is the sex pheromone of the insect, for example, a method has been reported in which (9E)-9,11-dodecadienol is synthesized by alkylation of 3-sulfolene, a desulfurization reaction, and deprotection of THP, and the hydroxyl groups of the synthesized (9E)-9,11-dodecadienol are then oxidized with pyridinium chlorochromate (PCC) (Non-Patent Document 1 listed below).

[0005] Also, Setora Nitens As a method for synthesizing (9Z)-9,11-dodecadienal, which is the sex pheromone substance of the insect, a method has been reported in which a reaction mixture containing (9E)-9,11-dodecadienol synthesized by the method described in Non-Patent Document 1 and a small amount of (9Z)-9,11-dodecadienol is subjected to a Diels-Alder reaction with tetracyanoethylene (TCNE), and a reaction product is obtained by selectively reacting only the E isomer in the reaction, and the (9Z)-9,11-dodecadienol is isolated from the reaction product, and the hydroxyl group of the isolated (9Z)-9,11-dodecadienol is oxidized with pyridinium chlorochromate (PCC) (Non-Patent Document 2 below). [Prior art documents] [Non-patent literature]

[0006] [Non-Patent Document 1] Gerhard Gries et al.,1997,J.Chem.Ecol.,23(9):2187-2196. [Non-Patent Document 2] Gerhard Gries et al.,2000,J.Chem.Ecol.,26(8):1983-1990. [Non-Patent Document 3] Matthew S. Siderhurst et al.,2007,Entomologia Experimentalis et Applica,125:63-69. Summary of the Invention [Problem to be solved by the invention]

[0007] However, in both of the production methods reported in Non-Patent Documents 1 and 2, alkylation of 3-sulfolene is used as the key reaction. This reaction uses a large amount of hexamethylphosphoric triamide, a carcinogenic substance, as a solvent, and also uses an expensive reagent such as lithium (bistrimethylsilyl)amide (LHMDS). Furthermore, the reaction needs to be carried out at a low temperature, which requires special production equipment, making it industrially unfavorable. In the production method for obtaining (9E)-9,11-dodecadienal described in Non-Patent Document 1, about 4% of a geometric isomer (Z form) is produced as a by-product in the synthesis of terminal conjugated dienes by a desulfurization reaction, and therefore poor geometric selectivity is also an issue (Non-Patent Document 3). In addition, the production methods reported in Non-Patent Documents 1 and 2 use reactions that have a large environmental impact, such as a desulfurization reaction that generates sulfur dioxide and a PCC oxidation reaction using chromium. Furthermore, the oxidation reaction often involves a risk of explosion, making it difficult to carry out on an industrial scale. Furthermore, the method for synthesizing (9Z)-9,11-dodecadienal reported in Non-Patent Document 2 uses tetracyanoethylene (TCNE), which generates highly toxic hydrogen cyanide when decomposed, making industrial use difficult. In addition, the yield is extremely low because only a small amount of (9Z)-9,11-dodecadienol is obtained from (9E)-9,11-dodecadienol, and the (9E)-9,11-dodecadienol that has undergone the Diels-Alder reaction with TCNE cannot be recovered and becomes waste, making the method inefficient and unsuitable for industrial use as a method for synthesizing the Z isomer.

[0008] The present invention has been made in consideration of the above circumstances, and an object of the present invention is to provide a method for producing a terminally conjugated alkadienal compound with good yield and high geometric selectivity. [Means for solving the problem]

[0009] The present inventors have conducted intensive research to solve the above problems, and have found that dialkoxyalkenyl alkoxymethyl ether compounds are useful intermediates in the production of terminally conjugated alkadienal compounds.Then, by utilizing the reaction-dependent property of the dialkoxyalkenyl alkoxymethyl ether compound that can be selectively produced with E-selectivity or Z-selectivity, the geometry of the double bond inside the terminally conjugated alkadienal compound can be highly selectively constructed, and the terminally conjugated alkadienal compound can be produced with high yield and high geometric selectivity from the dialkoxyalkenyl alkoxymethyl ether compound, which is a common intermediate, and have thus achieved the present invention.

[0010] According to one embodiment of the present invention, a compound represented by the following general formula (1): R 1 CH 2 OCH 2 OCH 2 CH 2 CH=CH(CH 2 ) a CH(OR 2 )(OR 3 ) (1) (In the formula, R 1 represents a hydrogen atom, an n-alkyl group having 1 to 9 carbon atoms, or a phenyl group; R 2 and R 3 are each independently a monovalent hydrocarbon group having 1 to 15 carbon atoms, or R 2 and R 3 are combined together to form R 2 -R 3 represents a divalent hydrocarbon group having 2 to 10 carbon atoms, and a represents an integer of 1 to 15. The dialkoxyalkenyl alkoxymethyl ether compound represented by the following general formula (2): HOCH 2 CH 2 CH=CH(CH 2 ) a CH(OR 4 )(OR 5 ) (2) (In the formula, R 4 and R 5are each independently a monovalent hydrocarbon group having 1 to 15 carbon atoms, or R 4 and R 5 are combined together to form R 4 -R 5 represents a divalent hydrocarbon group having 2 to 10 carbon atoms, and a is as defined above. obtaining a dialkoxy-3-alkene-1-ol compound represented by The dialkoxy-3-alkene-1-ol compound (2) is halogenated to obtain a compound represented by the following general formula (3): XCH 2 CH 2 CH=CH(CH 2 ) a CH(OR 4 )(OR 5 ) (3) (wherein X represents a halogen atom, and R 4 , R 5 and a is as defined above. obtaining a 1-halodialkoxy-3-alkene compound represented by the formula: The 1-halodialkoxy-3-alkene compound (3) is subjected to an elimination reaction in the presence of a base to obtain a compound represented by the following general formula (4): CH 2 =CHCH=CH(CH 2 ) a CH(OR 4 )(OR 5 ) (4) (In the formula, R 4 , R 5 and a is as defined above. obtaining a dialkoxy-1,3-alkadiene compound represented by the formula: The dialkoxy-1,3-alkadiene compound (4) is hydrolyzed to obtain a compound represented by the following general formula (5): CH 2 =CHCH=CH(CH 2 ) a CHOS (5) (In the formula, a is as defined above.) obtaining a terminally conjugated alkadienal compound represented by The present invention provides a method for producing a terminally conjugated alkadienal compound (5), comprising at least

[0011] According to another aspect of the present invention, a compound represented by the following general formula (1): R 1 CH 2 OCH 2 OCH 2 CH 2 CH=CH(CH 2 ) a CH(OR 2 )(OR 3 ) (1) (In the formula, R 1 represents a hydrogen atom, an n-alkyl group having 1 to 9 carbon atoms, or a phenyl group; R 2 and R 3 are each independently a monovalent hydrocarbon group having 1 to 15 carbon atoms, or R 2 and R 3 are combined together to form R 2 -R 3 represents a divalent hydrocarbon group having 2 to 10 carbon atoms, and a represents an integer of 1 to 15. The dialkoxyalkenyl alkoxymethyl ether compound is represented by the following formula: Effect of the Invention

[0012] According to the present invention, it is possible to produce a terminally conjugated alkadienal compound (5) in a high yield and with high geometric selectivity without using an oxidation reaction. In addition, it is possible to efficiently produce the E- or Z-type terminally conjugated alkadienal compound (5) using the dialkoxyalkenyl alkoxymethyl ether compound (1) as a common intermediate. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0013] <Dialkoxyalkenyl alkoxymethyl ether compounds> First, the dialkoxyalkenyl alkoxymethyl ether compound represented by the following general formula (1) will be described. R 1 CH 2 OCH2 OCH 2 CH 2 CH=CH(CH 2 ) a CH(OR 2 )(OR 3 ) (1) R 1 represents a hydrogen atom, an n-alkyl group having 1 to 9 carbon atoms, preferably 1 to 5 carbon atoms, and more preferably 1 to 2 carbon atoms, or a phenyl group.

[0014] R 1 Examples of the n-alkyl group include linear saturated hydrocarbon groups such as methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, and n-nonyl groups.

[0015] R 2 and R 3 each independently represents a monovalent hydrocarbon group having 1 to 15 carbon atoms, preferably 1 to 10 carbon atoms, and more preferably 1 to 4 carbon atoms, or R 2 and R 3 are combined together to form R 2 -R 3 represents a divalent hydrocarbon group having 2 to 10 carbon atoms, preferably 2 to 4 carbon atoms.

[0016] R 2 and R 3 Examples of the monovalent hydrocarbon group include linear saturated hydrocarbon groups such as methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, and n-dodecyl; branched saturated hydrocarbon groups such as isopropyl, 2-isobutyl, and 2-methylbutyl; linear unsaturated hydrocarbon groups such as 2-propenyl; branched unsaturated hydrocarbon groups such as 2-methyl-2-propenyl; and cyclic saturated hydrocarbon groups such as cyclopropyl, and may be hydrocarbon groups that are isomers of these. In addition, some of the hydrogen atoms of these hydrocarbon groups may be substituted with methyl or ethyl groups. From the viewpoint of handling, preferred monovalent hydrocarbon groups are a methyl group, an ethyl group, an n-propyl group, and an n-butyl group.

[0017] Examples of the divalent hydrocarbon group include linear saturated hydrocarbon groups such as ethylene, 1,3-propylene, and 1,4-butylene groups; branched saturated hydrocarbon groups such as 1,2-propylene, 2,2-dimethyl-1,3-propylene, 1,2-butylene, 1,3-butylene, 2,3-butylene, and 2,3-dimethyl-2,3-butylene groups; linear unsaturated hydrocarbon groups such as 1-vinylethylene groups; branched unsaturated hydrocarbon groups such as 2-methylene-1,3-propylene groups; and cyclic hydrocarbon groups such as 1,2-cyclopropylene and 1,2-cyclobutylene groups, and may be hydrocarbon groups that are isomers of these groups. In addition, some of the hydrogen atoms of these hydrocarbon groups may be substituted with methyl groups, ethyl groups, etc. In consideration of the reactivity in deprotection, ease of purification, and ease of availability, the divalent hydrocarbon group is preferably a lower hydrocarbon group (preferably having 2 to 4 carbon atoms) which is highly reactive and from which by-products generated by deprotection can be easily removed by washing with water or concentration. Taking these into consideration, particularly preferred examples of the divalent hydrocarbon group include an ethylene group, a 1,3-propylene group, a 1,2-propylene group, a 1,2-butylene group, a 1,3-butylene group, and a 2,3-dimethyl-2,3-butylene group.

[0018] a represents an integer of 1 to 15, and from the viewpoint of producing a lepidopteran pest pheromone, preferably an integer of 3 to 13, more preferably an integer of 5 to 11. When a is 7, the dialkoxyalkenyl alkoxymethyl ether compound (1) is a dialkoxydodecenyl alkoxymethyl ether compound (1:a=7), and the dialkoxydodecenyl alkoxymethyl ether compound (1:a=7) is Setothosea asigna (9E)-9,11-dodecadienal, the sex pheromone of Setora Nitens This compound is useful for producing (9Z)-9,11-dodecadienal, the sex pheromone of the insect.

[0019] Specific examples of the dialkoxyalkenyl alkoxymethyl ether compound (1) include the following compounds: dialkoxyhexenyl methoxymethyl ether compounds such as dimethoxyhexenyl methoxymethyl ether, diethoxyhexenyl methoxymethyl ether, dipropoxyhexenyl methoxymethyl ether, dibutoxyhexenyl methoxymethyl ether, dipentyloxyhexenyl methoxymethyl ether, dihexyloxyhexenyl methoxymethyl ether, diheptyloxyhexenyl methoxymethyl ether, dioctyloxyhexenyl methoxymethyl ether, dinonyloxyhexenyl methoxymethyl ether and didecyloxyhexenyl methoxymethyl ether; dialkoxyheptenyl methoxymethyl ether compounds such as dimethoxyheptenyl methoxymethyl ether, diethoxyheptenyl methoxymethyl ether, dipropoxyheptenyl methoxymethyl ether, dibutoxyheptenyl methoxymethyl ether, dipentyloxyheptenyl methoxymethyl ether, dihexyloxyheptenyl methoxymethyl ether, diheptyloxyheptenyl methoxymethyl ether, dioctyloxyheptenyl methoxymethyl ether, dinonyloxyheptenyl methoxymethyl ether and didecyloxyheptenyl methoxymethyl ether; dialkoxyheptenyl ethoxymethyl ether compounds such as dimethoxyheptenyl ethoxymethyl ether, diethoxyheptenyl ethoxymethyl ether, dipropoxyheptenyl ethoxymethyl ether, dibutoxyheptenyl ethoxymethyl ether, dipentyloxyheptenyl ethoxymethyl ether, dihexyloxyheptenyl ethoxymethyl ether, diheptyloxyheptenyl ethoxymethyl ether, dioctyloxyheptenyl ethoxymethyl ether, dinonyloxyheptenyl ethoxymethyl ether and didecyloxyheptenyl ethoxymethyl ether; dialkoxyheptenyl propoxymethyl ether compounds such as dimethoxyheptenyl propoxymethyl ether, diethoxyheptenyl propoxymethyl ether, dipropoxyheptenyl propoxymethyl ether, dibutoxyheptenyl propoxymethyl ether, dipentyloxyheptenyl propoxymethyl ether, dihexyloxyheptenyl propoxymethyl ether, diheptyloxyheptenyl propoxymethyl ether, dioctyloxyheptenyl propoxymethyl ether, dinonyloxyheptenyl propoxymethyl ether and didecyloxyheptenyl propoxymethyl ether; dialkoxyheptenyl butoxymethyl ether compounds such as dimethoxyheptenyl butoxymethyl ether, diethoxyheptenyl butoxymethyl ether, dipropoxyheptenyl butoxymethyl ether, dibutoxyheptenyl butoxymethyl ether, dipentyloxyheptenyl butoxymethyl ether, dihexyloxyheptenyl butoxymethyl ether, diheptyloxyheptenyl butoxymethyl ether, dioctyloxyheptenyl butoxymethyl ether, dinonyloxyheptenyl butoxymethyl ether and didecyloxyheptenyl butoxymethyl ether; dialkoxyheptenyl pentyloxymethyl ether compounds such as dimethoxyheptenyl pentyloxymethyl ether, diethoxyheptenyl pentyloxymethyl ether, dipropoxyheptenyl pentyloxymethyl ether, dibutoxyheptenyl pentyloxymethyl ether, dipentyloxyheptenyl pentyloxymethyl ether, dihexyloxyheptenyl pentyloxymethyl ether, diheptyloxyheptenyl pentyloxymethyl ether, dioctyloxyheptenyl pentyloxymethyl ether, dinonyloxyheptenyl pentyloxymethyl ether and didecyloxyheptenyl pentyloxymethyl ether; dialkoxyheptenyl hexyloxymethyl ether compounds such as dimethoxyheptenyl hexyloxymethyl ether, diethoxyheptenyl hexyloxymethyl ether, dipropoxyheptenyl hexyloxymethyl ether, dibutoxyheptenyl hexyloxymethyl ether, dipentyloxyheptenyl hexyloxymethyl ether, dihexyloxyheptenyl hexyloxymethyl ether, diheptyloxyheptenyl hexyloxymethyl ether, dioctyloxyheptenyl hexyloxymethyl ether, dinonyloxyheptenyl hexyloxymethyl ether and didecyloxyheptenyl hexyloxymethyl ether; dialkoxyheptenyl=heptyloxymethyl=ether compounds such as dimethoxyheptenyl=heptyloxymethyl=ether, diethoxyheptenyl=heptyloxymethyl=ether, dipropoxyheptenyl=heptyloxymethyl=ether, dibutoxyheptenyl=heptyloxymethyl=ether, dipentyloxyheptenyl=heptyloxymethyl=ether, dihexyloxyheptenyl=heptyloxymethyl=ether, diheptyloxyheptenyl=heptyloxymethyl=ether, dioctyloxyheptenyl=heptyloxymethyl=ether, dinonyloxyheptenyl=heptyloxymethyl=ether and didecyloxyheptenyl=heptyloxymethyl=ether; dialkoxyheptenyl octyloxymethyl ether compounds such as dimethoxyheptenyl octyloxymethyl ether, diethoxyheptenyl octyloxymethyl ether, dipropoxyheptenyl octyloxymethyl ether, dibutoxyheptenyl octyloxymethyl ether, dipentyloxyheptenyl octyloxymethyl ether, dihexyloxyheptenyl octyloxymethyl ether, diheptyloxyheptenyl octyloxymethyl ether, dioctyloxyheptenyl octyloxymethyl ether, dinonyloxyheptenyl octyloxymethyl ether and didecyloxyheptenyl octyloxymethyl ether; dialkoxyheptenyl nonyloxymethyl ether compounds such as dimethoxyheptenyl nonyloxymethyl ether, diethoxyheptenyl nonyloxymethyl ether, dipropoxyheptenyl nonyloxymethyl ether, dibutoxyheptenyl nonyloxymethyl ether, dipentyloxyheptenyl nonyloxymethyl ether, dihexyloxyheptenyl nonyloxymethyl ether, diheptyloxyheptenyl nonyloxymethyl ether, dioctyloxyheptenyl nonyloxymethyl ether, dinonyloxyheptenyl nonyloxymethyl ether and didecyloxyheptenyl nonyloxymethyl ether; dialkoxyheptenyl decyloxymethyl ether compounds such as dimethoxyheptenyl decyloxymethyl ether, diethoxyheptenyl decyloxymethyl ether, dipropoxyheptenyl decyloxymethyl ether, dibutoxyheptenyl decyloxymethyl ether, dipentyloxyheptenyl decyloxymethyl ether, dihexyloxyheptenyl decyloxymethyl ether, diheptyloxyheptenyl decyloxymethyl ether, dioctyloxyheptenyl decyloxymethyl ether, dinonyloxyheptenyl decyloxymethyl ether and didecyloxyheptenyl decyloxymethyl ether; dialkoxyheptenyl benzyloxymethyl ether compounds such as dimethoxyheptenyl benzyloxymethyl ether, diethoxyheptenyl benzyloxymethyl ether, dipropoxyheptenyl benzyloxymethyl ether, dibutoxyheptenyl benzyloxymethyl ether, dipentyloxyheptenyl benzyloxymethyl ether, dihexyloxyheptenyl benzyloxymethyl ether, diheptyloxyheptenyl benzyloxymethyl ether, dioctyloxyheptenyl benzyloxymethyl ether, dinonyloxyheptenyl benzyloxymethyl ether and didecyloxyheptenyl benzyloxymethyl ether; dialkoxyoctenyl alkoxymethyl ether compounds such as dimethoxyoctenyl methoxymethyl ether, diethoxyoctenyl methoxymethyl ether, dipropoxyoctenyl methoxymethyl ether, dibutoxyoctenyl methoxymethyl ether, dipentyloxyoctenyl methoxymethyl ether, dihexyloxyoctenyl methoxymethyl ether, diheptyloxyoctenyl methoxymethyl ether, dioctyloxyoctenyl methoxymethyl ether, dinonyloxyoctenyl methoxymethyl ether and didecyloxyoctenyl methoxymethyl ether; dialkoxynonenyl alkoxymethyl ether compounds such as dimethoxynonenyl methoxymethyl ether, diethoxynonenyl methoxymethyl ether, dipropoxynonenyl methoxymethyl ether, dibutoxynonenyl methoxymethyl ether, dipentyloxynonenyl methoxymethyl ether, dihexyloxynonenyl methoxymethyl ether, diheptyloxynonenyl methoxymethyl ether, dioctyloxynonenyl methoxymethyl ether, dinonyloxynonenyl methoxymethyl ether and didecyloxynonenyl methoxymethyl ether; dialkoxydecenyl alkoxymethyl ether compounds such as dimethoxydecenyl methoxymethyl ether, diethoxydecenyl methoxymethyl ether, dipropoxydecenyl methoxymethyl ether, dibutoxydecenyl methoxymethyl ether, dipentyloxydecenyl methoxymethyl ether, dihexyloxydecenyl methoxymethyl ether, diheptyloxydecenyl methoxymethyl ether, dioctyloxydecenyl methoxymethyl ether, dinonyloxydecenyl methoxymethyl ether and didecyloxydecenyl methoxymethyl ether; dialkoxyundecenyl alkoxymethyl ether compounds such as dimethoxyundecenyl methoxymethyl ether, diethoxyundecenyl methoxymethyl ether, dipropoxyundecenyl methoxymethyl ether, dibutoxyundecenyl methoxymethyl ether, dipentyloxyundecenyl methoxymethyl ether, dihexyloxyundecenyl methoxymethyl ether, diheptyloxyundecenyl methoxymethyl ether, dioctyloxyundecenyl methoxymethyl ether, dinonyloxyundecenyl methoxymethyl ether and didecyloxyundecenyl methoxymethyl ether; dialkoxydodecenyl methoxymethyl ether compounds such as dimethoxydodecenyl methoxymethyl ether, diethoxydodecenyl methoxymethyl ether, dipropoxydodecenyl methoxymethyl ether, dibutoxydodecenyl methoxymethyl ether, dipentyloxydodecenyl methoxymethyl ether, dihexyloxydodecenyl methoxymethyl ether, diheptyloxydodecenyl methoxymethyl ether, dioctyloxydodecenyl methoxymethyl ether, dinonyloxydodecenyl methoxymethyl ether and didecyloxydodecenyl methoxymethyl ether; dialkoxydodecenyl ethoxymethyl ether compounds such as dimethoxydodecenyl ethoxymethyl ether, diethoxydodecenyl ethoxymethyl ether, dipropoxydodecenyl ethoxymethyl ether, dibutoxydodecenyl ethoxymethyl ether, dipentyloxydodecenyl ethoxymethyl ether, dihexyloxydodecenyl ethoxymethyl ether, diheptyloxydodecenyl ethoxymethyl ether, dioctyloxydodecenyl ethoxymethyl ether, dinonyloxydodecenyl ethoxymethyl ether and didecyloxydodecenyl ethoxymethyl ether; dialkoxydodecenyl propoxymethyl ether compounds such as dimethoxydodecenyl propoxymethyl ether, diethoxydodecenyl propoxymethyl ether, dipropoxydodecenyl propoxymethyl ether, dibutoxydodecenyl propoxymethyl ether, dipentyloxydodecenyl propoxymethyl ether, dihexyloxydodecenyl propoxymethyl ether, diheptyloxydodecenyl propoxymethyl ether, dioctyloxydodecenyl propoxymethyl ether, dinonyloxydodecenyl propoxymethyl ether and didecyloxydodecenyl propoxymethyl ether; dialkoxydodecenyl butoxymethyl ether compounds such as dimethoxydodecenyl butoxymethyl ether, diethoxydodecenyl butoxymethyl ether, dipropoxydodecenyl butoxymethyl ether, dibutoxydodecenyl butoxymethyl ether, dipentyloxydodecenyl butoxymethyl ether, dihexyloxydodecenyl butoxymethyl ether, diheptyloxydodecenyl butoxymethyl ether, dioctyloxydodecenyl butoxymethyl ether, dinonyloxydodecenyl butoxymethyl ether and didecyloxydodecenyl butoxymethyl ether; dialkoxydodecenyl pentyloxymethyl ether compounds such as dimethoxydodecenyl pentyloxymethyl ether, diethoxydodecenyl pentyloxymethyl ether, dipropoxydodecenyl pentyloxymethyl ether, dibutoxydodecenyl pentyloxymethyl ether, dipentyloxydodecenyl pentyloxymethyl ether, dihexyloxydodecenyl pentyloxymethyl ether, diheptyloxydodecenyl pentyloxymethyl ether, dioctyloxydodecenyl pentyloxymethyl ether, dinonyloxydodecenyl pentyloxymethyl ether and didecyloxydodecenyl pentyloxymethyl ether; dialkoxydodecenyl hexyloxymethyl ether compounds such as dimethoxydodecenyl hexyloxymethyl ether, diethoxydodecenyl hexyloxymethyl ether, dipropoxydodecenyl hexyloxymethyl ether, dibutoxydodecenyl hexyloxymethyl ether, dipentyloxydodecenyl hexyloxymethyl ether, dihexyloxydodecenyl hexyloxymethyl ether, diheptyloxydodecenyl hexyloxymethyl ether, dioctyloxydodecenyl hexyloxymethyl ether, dinonyloxydodecenyl hexyloxymethyl ether and didecyloxydodecenyl hexyloxymethyl ether; dialkoxydodecenyl=heptyloxymethyl=ether compounds such as dimethoxydodecenyl=heptyloxymethyl=ether, diethoxydodecenyl=heptyloxymethyl=ether, dipropoxydodecenyl=heptyloxymethyl=ether, dibutoxydodecenyl=heptyloxymethyl=ether, dipentyloxydodecenyl=heptyloxymethyl=ether, dihexyloxydodecenyl=heptyloxymethyl=ether, diheptyloxydodecenyl=heptyloxymethyl=ether, dioctyloxydodecenyl=heptyloxymethyl=ether, dinonyloxydodecenyl=heptyloxymethyl=ether and didecyloxydodecenyl=heptyloxymethyl=ether; dialkoxydodecenyl octyloxymethyl ether compounds such as dimethoxydodecenyl octyloxymethyl ether, diethoxydodecenyl octyloxymethyl ether, dipropoxydodecenyl octyloxymethyl ether, dibutoxydodecenyl octyloxymethyl ether, dipentyloxydodecenyl octyloxymethyl ether, dihexyloxydodecenyl octyloxymethyl ether, diheptyloxydodecenyl octyloxymethyl ether, dioctyloxydodecenyl octyloxymethyl ether, dinonyloxydodecenyl octyloxymethyl ether and didecyloxydodecenyl octyloxymethyl ether; dialkoxydodecenyl nonyloxymethyl ether compounds such as dimethoxydodecenyl nonyloxymethyl ether, diethoxydodecenyl nonyloxymethyl ether, dipropoxydodecenyl nonyloxymethyl ether, dibutoxydodecenyl nonyloxymethyl ether, dipentyloxydodecenyl nonyloxymethyl ether, dihexyloxydodecenyl nonyloxymethyl ether, diheptyloxydodecenyl nonyloxymethyl ether, dioctyloxydodecenyl nonyloxymethyl ether, dinonyloxydodecenyl nonyloxymethyl ether and didecyloxydodecenyl nonyloxymethyl ether; dialkoxydodecenyl decyloxymethyl ether compounds such as dimethoxydodecenyl decyloxymethyl ether, diethoxydodecenyl decyloxymethyl ether, dipropoxydodecenyl decyloxymethyl ether, dibutoxydodecenyl decyloxymethyl ether, dipentyloxydodecenyl decyloxymethyl ether, dihexyloxydodecenyl decyloxymethyl ether, diheptyloxydodecenyl decyloxymethyl ether, dioctyloxydodecenyl decyloxymethyl ether, dinonyloxydodecenyl decyloxymethyl ether and didecyloxydodecenyl decyloxymethyl ether; dialkoxydodecenyl benzyloxymethyl ether compounds such as dimethoxydodecenyl benzyloxymethyl ether, diethoxydodecenyl benzyloxymethyl ether, dipropoxydodecenyl benzyloxymethyl ether, dibutoxydodecenyl benzyloxymethyl ether, dipentyloxydodecenyl benzyloxymethyl ether, dihexyloxydodecenyl benzyloxymethyl ether, diheptyloxydodecenyl benzyloxymethyl ether, dioctyloxydodecenyl benzyloxymethyl ether, dinonyloxydodecenyl benzyloxymethyl ether and didecyloxydodecenyl benzyloxymethyl ether; dialkoxytridecenyl alkoxymethyl ether compounds such as dimethoxytridecenyl methoxymethyl ether, diethoxytridecenyl methoxymethyl ether, dipropoxytridecenyl methoxymethyl ether, dibutoxytridecenyl methoxymethyl ether, dipentyloxytridecenyl methoxymethyl ether, dihexyloxytridecenyl methoxymethyl ether, diheptyloxytridecenyl methoxymethyl ether, dioctyloxytridecenyl methoxymethyl ether, dinonyloxytridecenyl methoxymethyl ether and didecyloxytridecenyl methoxymethyl ether; dialkoxytetradecenyl methoxymethyl ether compounds such as dimethoxytetradecenyl methoxymethyl ether, diethoxytetradecenyl methoxymethyl ether, dipropoxytetradecenyl methoxymethyl ether, dibutoxytetradecenyl methoxymethyl ether, dipentyloxytetradecenyl methoxymethyl ether, dihexyloxytetradecenyl methoxymethyl ether, diheptyloxytetradecenyl methoxymethyl ether, dioctyloxytetradecenyl methoxymethyl ether, dinonyloxytetradecenyl methoxymethyl ether and didecyloxytetradecenyl methoxymethyl ether; dialkoxytetradecenyl ethoxymethyl ether compounds such as dimethoxytetradecenyl ethoxymethyl ether, diethoxytetradecenyl ethoxymethyl ether, dipropoxytetradecenyl ethoxymethyl ether, dibutoxytetradecenyl ethoxymethyl ether, dipentyloxytetradecenyl ethoxymethyl ether, dihexyloxytetradecenyl ethoxymethyl ether, diheptyloxytetradecenyl ethoxymethyl ether, dioctyloxytetradecenyl ethoxymethyl ether, dinonyloxytetradecenyl ethoxymethyl ether and didecyloxytetradecenyl ethoxymethyl ether; dialkoxytetradecenyl propoxymethyl ether compounds such as dimethoxytetradecenyl propoxymethyl ether, diethoxytetradecenyl propoxymethyl ether, dipropoxytetradecenyl propoxymethyl ether, dibutoxytetradecenyl propoxymethyl ether, dipentyloxytetradecenyl propoxymethyl ether, dihexyloxytetradecenyl propoxymethyl ether, diheptyloxytetradecenyl propoxymethyl ether, dioctyloxytetradecenyl propoxymethyl ether, dinonyloxytetradecenyl propoxymethyl ether and didecyloxytetradecenyl propoxymethyl ether; dialkoxytetradecenyl butoxymethyl ether compounds such as dimethoxytetradecenyl butoxymethyl ether, diethoxytetradecenyl butoxymethyl ether, dipropoxytetradecenyl butoxymethyl ether, dibutoxytetradecenyl butoxymethyl ether, dipentyloxytetradecenyl butoxymethyl ether, dihexyloxytetradecenyl butoxymethyl ether, diheptyloxytetradecenyl butoxymethyl ether, dioctyloxytetradecenyl butoxymethyl ether, dinonyloxytetradecenyl butoxymethyl ether and didecyloxytetradecenyl butoxymethyl ether; dialkoxytetradecenyl pentyloxymethyl ether compounds such as dimethoxytetradecenyl pentyloxymethyl ether, diethoxytetradecenyl pentyloxymethyl ether, dipropoxytetradecenyl pentyloxymethyl ether, dibutoxytetradecenyl pentyloxymethyl ether, dipentyloxytetradecenyl pentyloxymethyl ether, dihexyloxytetradecenyl pentyloxymethyl ether, diheptyloxytetradecenyl pentyloxymethyl ether, dioctyloxytetradecenyl pentyloxymethyl ether, dinonyloxytetradecenyl pentyloxymethyl ether and didecyloxytetradecenyl pentyloxymethyl ether; dialkoxytetradecenyl hexyloxymethyl ether compounds such as dimethoxytetradecenyl hexyloxymethyl ether, diethoxytetradecenyl hexyloxymethyl ether, dipropoxytetradecenyl hexyloxymethyl ether, dibutoxytetradecenyl hexyloxymethyl ether, dipentyloxytetradecenyl hexyloxymethyl ether, dihexyloxytetradecenyl hexyloxymethyl ether, diheptyloxytetradecenyl hexyloxymethyl ether, dioctyloxytetradecenyl hexyloxymethyl ether, dinonyloxytetradecenyl hexyloxymethyl ether and didecyloxytetradecenyl hexyloxymethyl ether; dialkoxytetradecenyl heptyloxymethyl ether compounds such as dimethoxytetradecenyl heptyloxymethyl ether, diethoxytetradecenyl heptyloxymethyl ether, dipropoxytetradecenyl heptyloxymethyl ether, dibutoxytetradecenyl heptyloxymethyl ether, dipentyloxytetradecenyl heptyloxymethyl ether, dihexyloxytetradecenyl heptyloxymethyl ether, diheptyloxytetradecenyl heptyloxymethyl ether, dioctyloxytetradecenyl heptyloxymethyl ether, dinonyloxytetradecenyl heptyloxymethyl ether and didecyloxytetradecenyl heptyloxymethyl ether; dialkoxytetradecenyl octyloxymethyl ether compounds such as dimethoxytetradecenyl octyloxymethyl ether, diethoxytetradecenyl octyloxymethyl ether, dipropoxytetradecenyl octyloxymethyl ether, dibutoxytetradecenyl octyloxymethyl ether, dipentyloxytetradecenyl octyloxymethyl ether, dihexyloxytetradecenyl octyloxymethyl ether, diheptyloxytetradecenyl octyloxymethyl ether, dioctyloxytetradecenyl octyloxymethyl ether, dinonyloxytetradecenyl octyloxymethyl ether and didecyloxytetradecenyl octyloxymethyl ether; dialkoxytetradecenyl nonyloxymethyl ether compounds such as dimethoxytetradecenyl nonyloxymethyl ether, diethoxytetradecenyl nonyloxymethyl ether, dipropoxytetradecenyl nonyloxymethyl ether, dibutoxytetradecenyl nonyloxymethyl ether, dipentyloxytetradecenyl nonyloxymethyl ether, dihexyloxytetradecenyl nonyloxymethyl ether, diheptyloxytetradecenyl nonyloxymethyl ether, dioctyloxytetradecenyl nonyloxymethyl ether, dinonyloxytetradecenyl nonyloxymethyl ether and didecyloxytetradecenyl nonyloxymethyl ether; dialkoxytetradecenyl decyloxymethyl ether compounds such as dimethoxytetradecenyl decyloxymethyl ether, diethoxytetradecenyl decyloxymethyl ether, dipropoxytetradecenyl decyloxymethyl ether, dibutoxytetradecenyl decyloxymethyl ether, dipentyloxytetradecenyl decyloxymethyl ether, dihexyloxytetradecenyl decyloxymethyl ether, diheptyloxytetradecenyl decyloxymethyl ether, dioctyloxytetradecenyl decyloxymethyl ether, dinonyloxytetradecenyl decyloxymethyl ether and didecyloxytetradecenyl decyloxymethyl ether; dialkoxytetradecenyl benzyloxymethyl ether compounds such as dimethoxytetradecenyl benzyloxymethyl ether, diethoxytetradecenyl benzyloxymethyl ether, dipropoxytetradecenyl benzyloxymethyl ether, dibutoxytetradecenyl benzyloxymethyl ether, dipentyloxytetradecenyl benzyloxymethyl ether, dihexyloxytetradecenyl benzyloxymethyl ether, diheptyloxytetradecenyl benzyloxymethyl ether, dioctyloxytetradecenyl benzyloxymethyl ether, dinonyloxytetradecenyl benzyloxymethyl ether and didecyloxytetradecenyl benzyloxymethyl ether; dialkoxypentadecenyl methoxymethyl ether compounds such as dimethoxypentadecenyl methoxymethyl ether, diethoxypentadecenyl methoxymethyl ether, dipropoxypentadecenyl methoxymethyl ether, dibutoxypentadecenyl methoxymethyl ether, dipentyloxypentadecenyl methoxymethyl ether, dihexyloxypentadecenyl methoxymethyl ether, diheptyloxypentadecenyl methoxymethyl ether, dioctyloxypentadecenyl methoxymethyl ether, dinonyloxypentadecenyl methoxymethyl ether and didecyloxypentadecenyl methoxymethyl ether; dialkoxyhexadecenyl methoxymethyl ether compounds such as dimethoxyhexadecenyl methoxymethyl ether, diethoxyhexadecenyl methoxymethyl ether, dipropoxyhexadecenyl methoxymethyl ether, dibutoxyhexadecenyl methoxymethyl ether, dipentyloxyhexadecenyl methoxymethyl ether, dihexyloxyhexadecenyl methoxymethyl ether, diheptyloxyhexadecenyl methoxymethyl ether, dioctyloxyhexadecenyl methoxymethyl ether, dinonyloxyhexadecenyl methoxymethyl ether and didecyloxyhexadecenyl methoxymethyl ether; Dialkoxyheptadecenyl methoxymethyl ether compounds such as dimethoxyheptadecenyl methoxymethyl ether, diethoxyheptadecenyl methoxymethyl ether, dipropoxyheptadecenyl methoxymethyl ether, dibutoxyheptadecenyl methoxymethyl ether, dipentyloxyheptadecenyl methoxymethyl ether, dihexyloxyheptadecenyl methoxymethyl ether, diheptyloxyheptadecenyl methoxymethyl ether, dioctyloxyheptadecenyl methoxymethyl ether, dinonyloxyheptadecenyl methoxymethyl ether and didecyloxyheptadecenyl methoxymethyl ether; and Dialkoxyoctadecenyl methoxymethyl ether compounds such as dimethoxyoctadecenyl methoxymethyl ether, diethoxyoctadecenyl methoxymethyl ether, dipropoxyoctadecenyl methoxymethyl ether, dibutoxyoctadecenyl methoxymethyl ether, dipentyloxyoctadecenyl methoxymethyl ether, dihexyloxyoctadecenyl methoxymethyl ether, diheptyloxyoctadecenyl methoxymethyl ether, dioctyloxyoctadecenyl methoxymethyl ether, dinonyloxyoctadecenyl methoxymethyl ether and didecyloxyoctadecenyl methoxymethyl ether. Among these dialkoxyalkenyl alkoxymethyl ether compounds (1), Setothosea asigna (9E)-9,11-dodecadienal, the sex pheromone of Setora Nitens From the viewpoint of producing (9Z)-9,11-dodecadienal, which is the sex pheromone of the insect, dialkoxydodecenyl alkoxymethyl ether compound (a=7) is preferred.

[0020] The dialkoxyalkenyl alkoxymethyl ether compound (1) can be synthesized by various synthesis methods shown below, depending on the number of a in general formula (1). Note that in the following explanation of the synthesis methods, the explanation of each compound is not limited to the case where the compound is produced according to the specific synthesis method shown below, but also includes the case where the compound is produced according to a method other than the synthesis method.

[0021] When the above-mentioned a is 2 and 5 to 15, the dialkoxyalkenyl alkoxymethyl ether compound (1) can be synthesized, for example, according to a reaction scheme including five steps 1 to 3, 6 and 7 (when a=2) shown in the following reaction scheme, or seven steps 1 to 7 (when a=5 to 15) shown in the following reaction scheme. [ka]

[0022] First, an alkoxymethyl 3-butynyl ether compound represented by the general formula (7) is reacted with a base, and then with ethylene oxide to increase the carbon number, thereby obtaining a 6-hydroxy-3-hexynyl alkoxymethyl ether compound represented by the general formula (8) (first step). The carbon-carbon triple bond of the obtained 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8) is reduced to obtain a 6-hydroxy-3-hexenyl alkoxymethyl ether compound represented by the general formula (9) (second step). The hydroxyl group of the obtained 6-hydroxy-3-hexenyl alkoxymethyl ether compound (9) is halogenated to obtain a 6-halo-3-hexenyl alkoxymethyl ether compound represented by the general formula (10-a) (third step). The obtained 6-halo-3-hexenyl alkoxymethyl ether compound (10-a) is reacted with magnesium or an organolithium reagent in a solvent to obtain a 6-(alkoxymethoxy)-3-hexenyl nucleophile (11-a) represented by general formula (11-a) (fourth step). The obtained 6-(alkoxymethoxy)-3-hexenyl nucleophile (11-a) is subjected to a coupling reaction with a dihaloalkane represented by general formula (12) to obtain a haloalkenyl alkoxymethyl ether compound represented by general formula (10) with a different carbon number (fifth step). The obtained haloalkenyl alkoxymethyl ether compound (10) is reacted with magnesium or an organolithium reagent in a solvent to obtain an (alkoxymethoxy)-3-alkenyl nucleophile represented by general formula (11) (sixth step). The (alkoxymethoxy)-3-alkenyl nucleophilic reagent (11) thus obtained is subjected to a nucleophilic substitution reaction with an orthoformate compound represented by general formula (13) to be acetalized, thereby obtaining a dialkoxyalkenyl alkoxymethyl ether compound (1) (seventh step). In addition, when a in the above general formula (1) is 2, there is no need to change the number of carbon atoms in the above fifth step. Therefore, the dialkoxyalkenyl alkoxymethyl ether compound (1: a = 2) can be synthesized by directly proceeding from the fourth step to the seventh step. The above synthesis method for the dialkoxyalkenyl alkoxymethyl ether compound (1) will be described in more detail below.

[0023] The alkoxymethyl 3-butynyl ether compound (7) shown in the above reaction scheme will be explained below. R in the above general formula (7) 1 is as defined in general formula (1) above.

[0024] Specific examples of the alkoxymethyl 3-butynyl ether compound (7) include methoxymethyl 3-butynyl ether, ethoxymethyl 3-butynyl ether, propoxymethyl 3-butynyl ether, butoxymethyl 3-butynyl ether, pentyloxymethyl 3-butynyl ether, hexyloxymethyl 3-butynyl ether, heptyloxymethyl 3-butynyl ether, octyloxymethyl 3-butynyl ether, nonyloxymethyl 3-butynyl ether, decyloxymethyl 3-butynyl ether, and benzyloxymethyl 3-butynyl ether.

[0025] Examples of the base used in the carbon-increasing reaction in which the alkoxymethyl 3-butynyl ether compound (7) is reacted with a base and then with ethylene oxide include organometallic reagents such as n-butyllithium, tert-butyllithium, methylmagnesium chloride, methylmagnesium bromide, sodium acetylide, and potassium acetylide; and metal hydride reagents such as sodium hydride and potassium hydride. From the viewpoint of reactivity, however, organometallic reagents are preferred. The amount of the base used is preferably 1.0 to 5.0 mol, more preferably 1.0 to 2.0 mol, per 1 mol of the alkoxymethyl 3-butynyl ether compound (7), from the viewpoint of reactivity. The amount of ethylene oxide used is preferably 1.0 to 10.0 mol, more preferably 1.0 to 3.0 mol, per mol of the alkoxymethyl 3-butynyl ether compound (7), from the viewpoint of reactivity.

[0026] In the carbon-increasing reaction, a solvent may be used as necessary. Examples of the solvent include common solvents, such as ethers such as diethyl ether, dibutyl ether, 4-methyltetrahydropyran, tetrahydrofuran (THF), cyclopentyl methyl ether, and 1,4-dioxane; hydrocarbons such as hexane, heptane, benzene, toluene, xylene, and cumene; chlorine-based solvents such as trichloroethylene, dichloromethane, and chloroform; aprotic polar solvents such as dimethyl sulfoxide, γ-butyrolactone (GBL), N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, and hexamethylphosphoric triamide; and nitriles such as acetonitrile and propionitrile. From the viewpoint of reactivity, ethers such as diethyl ether, tetrahydrofuran, and 4-methyltetrahydropyran are preferred. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used is preferably 50 to 3000 g, more preferably 100 to 1200 g, per 1 mol of the alkoxymethyl 3-butynyl ether compound (7) from the viewpoint of reactivity.

[0027] The 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8) shown in the above reaction scheme will be explained below. R in the above general formula (8) 1 is as defined in general formula (1) above.

[0028] Specific examples of the 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8) include 6-hydroxy-3-hexynyl methoxymethyl ether, 6-hydroxy-3-hexynyl ethoxymethyl ether, 6-hydroxy-3-hexynyl propoxymethyl ether, 6-hydroxy-3-hexynyl butoxymethyl ether, 6-hydroxy-3-hexynyl pentoxymethyl ether, 6-hydroxy-3-hexynyl hexyloxymethyl ether, 6-hydroxy-3-hexynyl heptyloxymethyl ether, 6-hydroxy-3-hexynyl octyloxymethyl ether, 6-hydroxy-3-hexynyl nonyloxymethyl ether, 6-hydroxy-3-hexynyl decyloxymethyl ether, and 6-hydroxy-3-hexynyl benzyloxymethyl ether.

[0029] Examples of the reduction reaction for synthesizing the 6-hydroxy-3-hexenyl alkoxymethyl ether compound (9) include (i) catalytic hydrogenation, (ii) reduction using a zinc compound in an alcohol solvent, (iii) hydroboration using dialkylborane followed by reduction by protonation, (iv) reduction using potassium hydroxide and N,N-dimethylformamide (DMF) in the presence of a palladium catalyst such as palladium acetate, (v) hydrosilylation to obtain vinylsilane, followed by reduction by desilylation, (vi) hydroalumination, and (vii) Birch reduction. From the viewpoints of selectivity and productivity, the above (i) catalytic reduction, (ii) reduction using zinc, (iii) hydroboration followed by reduction by protonation, and (vi) hydroalumination are preferred. When the carbon-carbon double bond of the 6-hydroxy-3-hexenyl alkoxymethyl ether compound (9) is to be synthesized Z-selectively, the above catalytic reduction reaction (i) is more preferred, and when the carbon-carbon double bond of the 6-hydroxy-3-hexenyl alkoxymethyl ether compound (9) is to be synthesized E-selectively, the above hydroalumination reaction (vi) is more preferred.

[0030] (i) Catalytic reduction reaction The catalytic reduction reaction is carried out by adding hydrogen gas in the presence of a metal catalyst. Examples of metal catalysts used in the catalytic reduction reaction include nickel catalysts such as Lindlar catalyst and P-2 nickel boride catalyst (Thomas J. Caggiano et al. Encyclopedia of Reagents for Organic Synthesis: 3694-3699.) (hereinafter also referred to as "P-2Ni catalyst"), as well as palladium catalysts such as palladium on carbon and Pd-PEI in which palladium on carbon is poisoned with polyethyleneimine polymer (PEI). From the viewpoint of economy, however, Lindlar catalyst and nickel catalyst are preferred. The amount of the metal catalyst used varies depending on the catalyst used, but from the viewpoint of reactivity, when the catalyst is a solid such as Lindlar catalyst, the amount is preferably 0.01 to 50 g per 1 mol of the 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8). In addition, the P-2Ni catalyst is preferably used in an amount of 0.001 to 0.50 mol calculated as a nickel compound per 1 mol of the 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8). The solid catalyst may be used by dispersing it in a solvent.

[0031] When the activity of the metal catalyst is high, a catalyst poison may be used as necessary. Examples of the catalyst poison include amine compounds such as pyridine, quinoline, and ethylenediamine; phosphorus compounds such as triphenylphosphine, tritolylphosphine, and triethyl phosphite; and sulfur compounds such as benzenethiol, diphenyl sulfide, dimethyl sulfide, and dimethyl sulfoxide. The amount of the catalyst poison used varies greatly depending on the catalyst poison used, but from the viewpoints of reaction rate and geometric selectivity, it is preferably 0.0001 to 10.0 g per 1 mol of the 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8).

[0032] Examples of the solvent used in the catalytic reduction reaction include hydrocarbons such as hexane, heptane, benzene, toluene, xylene, and cumene; nitriles such as acetonitrile and propionitrile; esters such as methyl acetate, ethyl acetate, n-propyl acetate, and n-butyl acetate; and alcohols such as methanol, ethanol, propanol, butanol, pentanol, hexanol, 2-propanol, 2-butanol, and cyclohexanol. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used.

[0033] When a Lindlar catalyst is used, the solvent is preferably a hydrocarbon such as hexane, heptane, toluene, xylene, etc. from the viewpoint of reactivity. When a nickel catalyst is used, the solvent is preferably an alcohol such as methanol, ethanol, propanol, butanol, 2-propanol, etc. from the viewpoint of reactivity. When a palladium catalyst such as palladium on carbon is used, the solvent is preferably an ester such as methyl acetate, ethyl acetate, etc. from the viewpoint of reactivity. The amount of the solvent used varies depending on the catalyst and / or solvent used, but from the viewpoint of reactivity, it is preferably 0 to 1000 g per 1 mol of the 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8).

[0034] The reaction temperature of the catalytic reduction reaction varies depending on the type of catalyst and / or solvent used, but is preferably 0 to 160°C, more preferably 20 to 100°C, from the viewpoint of geometric selectivity. The reaction time of the catalytic reduction reaction is preferably 1 to 100 hours from the viewpoint of yield.

[0035] (ii) Reduction reaction using zinc compounds in alcohol solvents The reduction reaction is carried out with a zinc compound in an alcohol solvent. The number of carbon atoms in the alcohol used as the solvent is preferably 1 to 10, more preferably 1 to 5. Examples of the alcohol used as the solvent include linear alcohol compounds such as methanol, ethanol, propanol, butanol, pentanol, hexanol, heptanol, octanol, nonanol, and decanol; branched alcohol compounds such as 2-propanol and 2-butanol; and cyclic alcohol compounds such as cyclohexanol. From the viewpoint of reactivity, however, alcohol compounds having 1 to 5 carbon atoms such as methanol, ethanol, propanol, butanol, pentanol, and 2-propanol are preferred. The amount of the alcohol used is preferably 46 to 1000 g per 1 mol of the 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8) from the viewpoint of reactivity. The zinc compound refers to metallic zinc or activated zinc, which will be described later. The amount of the zinc compound used is preferably 1.0 to 1000 mol, more preferably 1.0 to 200 mol, per 1 mol of the 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8) from the viewpoint of reactivity.

[0036] The reduction reaction may take a long time due to the low reactivity of zinc, so an activator for activating zinc may be added as necessary, or a previously prepared activated zinc compound may be used. The activating agent includes 1,2-dibromoethane, cuprous chloride, cuprous bromide, cuprous iodide, lithium bromide, iodine, chlorotrimethylsilane, and the like. The activator may be used alone or, if necessary, in combination with two or more kinds. The amount of the activator used is preferably 0.01 to 10.0 mol per 1 mol of the 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8) from the viewpoint of reactivity. Activated zinc can be prepared, for example, by treating metallic zinc with an acid such as hydrochloric acid, or by reducing zinc chloride with metallic lithium in tetrahydrofuran, or by reacting metallic zinc with 1,2-dibromoethane and lithium dibromocuprate in tetrahydrofuran.

[0037] The reaction temperature for the reduction reaction varies depending on the solvent used, but is preferably 20 to 120° C. from the viewpoint of reactivity. The reaction time of the reduction reaction is preferably 1 to 150 hours from the viewpoint of completion of the reaction.

[0038] (iii) Hydroboration with dialkylboranes followed by reduction by protonation In the reduction reaction, hydroboration is first carried out using a dialkylborane in a solvent. The dialkylborane used in the hydroboration preferably has 4 to 18 carbon atoms, and more preferably 6 to 12 carbon atoms. Examples of the dialkylborane include dicyclohexylborane, diisoamylborane, disiamylborane, 9-borabicyclo[3.3.1]nonane (9-BBN), diisopinocampheylborane, catecholborane, and pinacolborane. From the viewpoint of reactivity, dicyclohexylborane and diisoamylborane are preferred. The amount of the dialkylborane used is preferably 1.0 to 4.0 mol per 1 mol of the 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8) from the viewpoint of reactivity.

[0039] Examples of the solvent used in the hydroboration include ethers such as tetrahydrofuran, diethyl ether, dibutyl ether, 4-methyltetrahydropyran, cyclopentyl methyl ether, 1,4-dioxane, and diethylene glycol dimethyl ether; and hydrocarbons such as hexane, heptane, benzene, toluene, xylene, and cumene. From the viewpoint of reactivity, ethers such as tetrahydrofuran, 4-methyltetrahydropyran, and diethylene glycol dimethyl ether are more preferred. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used is preferably 100 to 3,000 g per 1 mol of the 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8) from the viewpoint of reactivity.

[0040] The reaction temperature for the hydroboration is preferably −20° C. to 50° C. from the viewpoint of geometric selectivity. The reaction time for the hydroboration varies depending on the reaction temperature and / or the scale of the reaction, but is preferably 1 to 100 hours from the viewpoint of reactivity.

[0041] In the reduction reaction, hydroboration is followed by protonation using an acid in a solvent. Examples of acids used in the protonation following hydroboration include carboxylic acids such as acetic acid, propionic acid, butyric acid, pentanoic acid, pivalic acid, heptanoic acid, trifluoroacetic acid, chloroacetic acid, formic acid, and oxalic acid; sulfonic acids such as p-toluenesulfonic acid; and mineral acids such as sulfuric acid, hydrochloric acid, nitric acid, and phosphoric acid. From the viewpoint of reactivity, carboxylic acids such as acetic acid and propionic acid are preferred. The amount of the acid used is preferably 2.0 to 20.0 mol per 1 mol of the 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8) from the viewpoint of reactivity. The solvent and the amount thereof used for the protonation are the same as those used for the hydroboration since the protonation is carried out in the same reaction system subsequent to the hydroboration.

[0042] The reaction temperature for the protonation varies depending on the reagent used, but is preferably 0° C. to 150° C. from the viewpoint of reaction rate. The reaction time for the protonation varies depending on the reaction temperature and / or the scale of the reaction, but is preferably 1 to 70 hours from the viewpoint of reactivity.

[0043] (iv) Reduction reaction using potassium hydroxide and N,N-dimethylformamide (DMF) in the presence of a palladium catalyst such as palladium acetate The reduction reaction is carried out using potassium hydroxide and N,N-dimethylformamide (DMF) in the presence of a palladium catalyst such as palladium acetate, preferably at 100 to 180° C. for 6 to 100 hours.

[0044] (v) Hydrosilylation to give vinylsilanes, followed by reduction to desilylate The hydrosilylation is carried out using metal catalysts such as Wilkinson's and Trost's catalysts and trialkylsilanes. The amount of the metal catalyst used is preferably 0.0001 to 4.0 mol, more preferably 0.001 to 1.0 mol, per 1 mol of the 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8), from the viewpoint of reactivity. The hydrosilylation is preferably carried out at 5 to 100° C. for 1 to 100 hours. The desilylation after the hydrosilylation is preferably carried out using at least one of an acid such as sulfuric acid or hydrochloric acid, hydrogen iodide, acetyl chloride, titanium tetrachloride, and iodine at 5° C. to 80° C. for 1 to 100 hours.

[0045] (vi) Hydroalumination The hydroalumination is carried out with lithium aluminum hydride. The amount of lithium aluminum hydride used is preferably 0.25 to 4.0 mol, more preferably 0.35 to 2.0 mol, per mol of the 6-hydroxy-3-hexynyl alkoxymethyl ether compound (8), from the viewpoint of reactivity. Examples of the solvent used in the hydroaluminization include ethers such as diethyl ether, dibutyl ether, 4-methyltetrahydropyran, tetrahydrofuran (THF), cyclopentyl methyl ether, 1,4-dioxane, and diethylene glycol dimethyl ether; and hydrocarbons such as hexane, heptane, benzene, toluene, xylene, and cumene. From the viewpoint of reactivity, however, ethers such as tetrahydrofuran, 4-methyltetrahydropyran, and diethylene glycol dimethyl ether are preferred. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The hydroaluminization is preferably carried out at 20 to 180° C. for 1 to 100 hours.

[0046] (vii) Birch reduction The Birch reduction is carried out with metals in amines or alcohols. Such metals include alkali metals such as potassium, sodium and lithium; and alkaline earth metals such as calcium and magnesium. The amines include ammonia and lower amines such as methylamine, ethylamine and propylamine. The alcohol includes methanol, ethanol, 2-methylpropanol, and the like. The Birch reduction is preferably carried out at −78 to 20° C. for 1 to 100 hours. By selecting the reduction conditions, the geometry of the carbon-carbon double bond of the 6-hydroxy-3-hexenyl alkoxymethyl ether compound (9) can be made E- or Z-selective.

[0047] The 6-hydroxy-3-hexenyl alkoxymethyl ether compound (9) shown in the above reaction scheme will be described below. R in the above general formula (9) 1 is as defined in general formula (1) above.

[0048] Specific examples of the 6-hydroxy-3-hexenyl alkoxymethyl ether compound (9) include 6-hydroxy-3-hexenyl methoxymethyl ether, 6-hydroxy-3-hexenyl ethoxymethyl ether, 6-hydroxy-3-hexenyl propoxymethyl ether, 6-hydroxy-3-hexenyl butoxymethyl ether, 6-hydroxy-3-hexenyl pentoxymethyl ether, 6-hydroxy-3-hexenyl hexyloxymethyl ether, 6-hydroxy-3-hexenyl heptyloxymethyl ether, 6-hydroxy-3-hexenyl octyloxymethyl ether, 6-hydroxy-3-hexenyl nonyloxymethyl ether, 6-hydroxy-3-hexenyl decyloxymethyl ether, and 6-hydroxy-3-hexenyl benzyloxymethyl ether.

[0049] The halogenation reaction for synthesizing the 6-halo-3-hexenyl alkoxymethyl ether compound (10-a) can be carried out, for example, by a method in which a hydroxyl group is tosylated using a p-toluenesulfonyl halide compound, and then halogenated using a lithium halide compound, or a method in which direct halogenation is carried out using a halogenating agent. Examples of the halogenating agent include halogens such as chlorine, bromine, and iodine; hydrogen halide compounds such as hydrogen chloride, hydrogen bromide, and hydrogen iodide; methanesulfonyl halide compounds such as methanesulfonyl chloride, methanesulfonyl bromide, and methanesulfonyl iodide; benzenesulfonyl halide compounds such as benzenesulfonyl chloride, benzenesulfonyl bromide, and benzenesulfonyl iodide; p-toluenesulfonyl halide compounds such as p-toluenesulfonyl chloride, p-toluenesulfonyl bromide, and p-toluenesulfonyl iodide; phosphorus halide compounds such as phosphorus trichloride, phosphorus pentachloride, and phosphorus tribromide; carbon tetrahalide compounds such as carbon tetrachloride, carbon tetrabromide, and carbon tetraiodide; tetramethylsilyl chloride, tetramethylsilyl bromide, tetramethylsilyl iodide, triethylsilyl chloride, and the like. Examples of the alkylsilyl halide compounds include alkylsilyl halide compounds such as oxalyl chloride, oxalyl bromide, triethylsilyl iodide, triisopropylsilyl chloride, triisopropylsilyl bromide, triisopropylsilyl iodide, tert-butyldimethylsilyl chloride, tert-butyldimethylsilyl bromide, and tert-butyldimethylsilyl iodide; oxalyl halide compounds such as oxalyl chloride, oxalyl bromide, and oxalyl iodide; and N-halosuccinimide compounds such as N-chlorosuccinimide, N-bromosuccinimide, and N-iodosuccinimide. From the viewpoint of suppressing side reactions, however, preferred are methanesulfonyl halide compounds, benzenesulfonyl halide compounds, and p-toluenesulfonyl halide compounds, with methanesulfonyl halide compounds being particularly preferred. The halogenating agent may be used alone or in combination of two or more as required. The halogenating agent may be a commercially available product. The amount of the halogenating agent used is preferably 0.8 to 5.0 mol, more preferably 1.0 to 2.5 mol, per mol of the 6-hydroxy-3-hexenyl alkoxymethyl ether compound (9).

[0050] In the halogenation reaction, a base may be used, if necessary. Examples of the base include hydroxides such as sodium hydroxide, potassium hydroxide, calcium hydroxide, and magnesium hydroxide; carbonates such as sodium carbonate, potassium carbonate, calcium carbonate, and magnesium carbonate; amines such as triethylamine, N,N-diisopropylethylamine, piperidine, pyrrolidine, pyridine, lutidine, 4-dimethylaminopyridine, N,N-dimethylaniline, N,N-diethylaniline, and 1,8-diazabicyclo[5.4.0]-7-undecene (DBU); and phosphines such as tributylphosphine, triphenylphosphine, and tritolylphosphine. When a methanesulfonyl halide compound, a benzenesulfonyl halide compound, a p-toluenesulfonyl halide compound or the like is used as the halogenating agent, it is preferable to use an amine as the base, and it is more preferable to use a pyridine such as pyridine, lutidine or 4-dimethylaminopyridine. The base may be used alone or in combination with two or more kinds, if necessary. In addition, commercially available bases may be used. The amount of the base used is preferably 0 to 8.0 mol, more preferably 0 to 3.0 mol, per mol of the 6-hydroxy-3-hexenyl alkoxymethyl ether compound (9), from the viewpoints of yield and economic efficiency.

[0051] In the halogenation reaction, a metal salt may be added, if necessary. Examples of the metal salt include lithium salts such as lithium chloride, lithium bromide, and lithium iodide; sodium salts such as sodium chloride, sodium bromide, and sodium iodide; potassium salts such as potassium chloride, potassium bromide, and potassium iodide; calcium salts such as calcium chloride, calcium bromide, and calcium iodide; and magnesium salts such as magnesium chloride, magnesium bromide, and magnesium iodide. The metal salt may be used alone or in combination with two or more kinds, if necessary. In addition, commercially available metal salts may be used. The amount of the metal salt used is preferably 0 to 30.0 mol, more preferably 0 to 5.0 mol, per mol of the 6-hydroxy-3-hexenyl alkoxymethyl ether compound (9), from the viewpoint of reactivity. By adding the metal salt, the halide concentration in the reaction system can be increased, thereby increasing the reactivity. However, taking into account economic and / or environmental considerations, it is preferable to carry out the reaction without using a metal salt.

[0052] The halogenation reaction may be carried out in the presence of a solvent, if necessary. Examples of the solvent include general solvents, such as ethers such as diethyl ether, dibutyl ether, 4-methyltetrahydropyran, tetrahydrofuran (THF), cyclopentyl methyl ether, and 1,4-dioxane; hydrocarbons such as hexane, heptane, benzene, toluene, xylene, and cumene; chlorine-based solvents such as trichloroethylene, dichloromethane, and chloroform; dimethyl sulfoxide, γ-butyrolactone (GBL), N-methylpyrrolidone (NMP), N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMF), and the like. Examples of suitable solvents include aprotic polar solvents such as N-dimethylformamide (DMAC) and hexamethylphosphoric triamide (HMPA); nitriles such as acetonitrile and propionitrile; and esters such as methyl acetate, ethyl acetate, n-propyl acetate, and n-butyl acetate. From the viewpoint of reactivity, however, 4-methyltetrahydropyran, dichloromethane, chloroform, γ-butyrolactone, N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, and acetonitrile are preferred, and from the viewpoint of safety, γ-butyrolactone and acetonitrile are particularly preferred. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used in the halogenation reaction is preferably 0 to 3000 g, more preferably 0 to 800 g, based on 1 mol of the 6-hydroxy-3-hexenyl alkoxymethyl ether compound (9). Since the use of the solvent reduces the amount of the charged material and decreases the productivity, the reaction may be carried out without using the above-mentioned solvent, or may be carried out using a base as a solvent.

[0053] The reaction temperature in the halogenation reaction varies depending on the halogenating agent used, but is preferably 5 to 180° C. from the viewpoint of reactivity. The reaction time in the halogenation reaction varies depending on the halogenating agent used and / or the reaction scale, but is preferably 0.5 to 100 hours from the viewpoint of reactivity.

[0054] The 6-halo-3-hexenyl alkoxymethyl ether compound (10-a) shown in the above reaction scheme will be described below. R in the above general formula (10-a) 1 is as defined in general formula (1) above.

[0055] Specific examples of the 6-halo-3-hexenyl alkoxymethyl ether compound (10-a) include 6-halo-3-hexenyl methoxymethyl ether, 6-halo-3-hexenyl ethoxymethyl ether, 6-halo-3-hexenyl propoxymethyl ether, 6-halo-3-hexenyl butoxymethyl ether, 6-halo-3-hexenyl pentoxymethyl ether, 6-halo-3-hexenyl hexyloxymethyl ether, 6-halo-3-hexenyl heptyloxymethyl ether, 6-halo-3-hexenyl octyloxymethyl ether, 6-halo-3-hexenyl nonyloxymethyl ether, 6-halo-3-hexenyl decyloxymethyl ether, and 6-halo-3-hexenyl benzyloxymethyl ether.

[0056] The 6-halo-3-hexenyl alkoxymethyl ether compound (10-a) is reacted with, for example, magnesium or an organolithium reagent in a solvent to obtain a 6-(alkoxymethoxy)-3-hexenyl nucleophile (11-a), and the resulting 6-(alkoxymethoxy)-3-hexenyl nucleophile (11-a) is then subjected to a coupling reaction with a dihaloalkane (12) to adjust the carbon number of the haloalkenyl alkoxymethyl ether compound (10). The adjustment of the carbon number by the coupling reaction is carried out when a in the general formula (1) of the final target dialkoxyalkenyl alkoxymethyl ether compound (1) is 5 to 15.

[0057] As one method for synthesizing the 6-(alkoxymethoxy)-3-hexenyl nucleophilic reagent (11-a), for example, as shown in the chemical reaction formula below, a 6-halo-3-hexenyl alkoxymethyl ether compound (10-a) is reacted with magnesium in a solvent to obtain a 6-(alkoxymethoxy)-3-hexenyl nucleophilic reagent (11-a:M) as a Grignard reagent. 1 =MgZ 1 ) can be mentioned (hereinafter also referred to as "magnesium-mediated conversion reaction"). [ka]

[0058] The amount of magnesium used in the conversion reaction with magnesium is preferably 1.0 to 2.0 gram atoms per mol of the 6-halo-3-hexenyl alkoxymethyl ether compound (10-a) from the viewpoint of completing the reaction. Examples of the solvent used in the conversion reaction with magnesium include ethers such as tetrahydrofuran, diethyl ether, and 4-methyltetrahydropyran; and hydrocarbons such as toluene, xylene, and hexane. From the viewpoint of the reaction rate of producing a Grignard reagent, ethers such as tetrahydrofuran, diethyl ether, and 4-methyltetrahydropyran are preferred, and tetrahydrofuran is more preferred. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used is preferably 50 to 5000 g, more preferably 100 g to 3000 g, per 1 mol of the 6-halo-3-hexenyl alkoxymethyl ether compound (10-a) from the viewpoint of reactivity.

[0059] The reaction temperature in the conversion reaction with magnesium varies depending on the solvent used, but is preferably 0 to 120° C. from the viewpoint of reactivity. The reaction time in the conversion reaction with magnesium varies depending on the solvent used and / or the reaction scale, but is preferably 0.5 to 100 hours from the viewpoint of reactivity.

[0060] As another method for synthesizing the 6-(alkoxymethoxy)-3-hexenyl nucleophilic reagent (11-a), for example, as shown in the chemical reaction formula below, a 6-halo-3-hexenyl alkoxymethyl ether compound (10-a) is reacted with an organolithium reagent in a solvent to give a 6-(alkoxymethoxy)-3-hexenyl lithium compound (11-a:M 1 =Li) can be mentioned (hereinafter, also referred to as "conversion reaction using an organolithium reagent"). [ka]

[0061] Examples of the organolithium reagent include linear organolithium reagents such as methyllithium, ethyllithium, n-propyllithium, n-butyllithium, and n-pentyllithium; and branched organolithium reagents such as sec-butyllithium and tert-butyllithium. From the viewpoint of availability, however, methyllithium, n-butyllithium, sec-butyllithium, and tert-butyllithium are preferred. The amount of the organolithium reagent used is preferably 1.0 to 4.0 mol, more preferably 1.0 to 2.0 mol, per 1 mol of the 6-halo-3-hexenyl alkoxymethyl ether compound (10-a), from the viewpoint of reactivity. Solvents used in the conversion reaction with an organolithium reagent include ethers such as tetrahydrofuran, diethyl ether, and 4-methyltetrahydropyran; and hydrocarbons such as toluene, xylene, and hexane. The preferred solvent varies depending on the organolithium reagent used, but generally, tetrahydrofuran, diethyl ether, toluene, and hexane are preferred from the viewpoint of reactivity. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used is preferably 50 to 5000 g, more preferably 100 to 3000 g, per 1 mol of the 6-halo-3-hexenyl alkoxymethyl ether compound (10-a) from the viewpoint of reactivity.

[0062] The reaction temperature in the conversion reaction with an organolithium reagent varies depending on the solvent used, but is preferably −78 to 25° C. from the viewpoint of reactivity. The reaction time in the conversion reaction with an organolithium reagent varies depending on the solvent used and / or the reaction scale, but is preferably 0.5 to 100 hours from the viewpoint of reactivity.

[0063] The 6-(alkoxymethoxy)-3-hexenyl nucleophile (11-a) depicted in the above reaction scheme is described below. R in general formula (11-a) 1 is as defined in general formula (1) above. M 1 Li or MgZ 1 and Z 1 represents a halogen atom or a 6-(alkoxymethoxy)-3-hexenyl group. 1 Examples of the aryl group include a chlorine atom, a bromine atom, and an iodine atom. Examples of the 6-(alkoxymethoxy)-3-hexenyl nucleophile (11-a) include a (3E)-6-(alkoxymethoxy)-3-hexenyl nucleophile represented by the following general formula (11-aE), a (3Z)-6-(alkoxymethoxy)-3-hexenyl nucleophile represented by the following general formula (11-aZ), and a mixture thereof. [ka]

[0064] Specific examples of the (3E)-6-(alkoxymethoxy)-3-hexenyl nucleophile (11-aE) include the following compounds: (3E)-6-(alkoxymethoxy)-3-hexenyllithium compounds such as (3E)-6-(methoxymethoxy)-3-hexenyllithium, (3E)-6-(ethoxymethoxy)-3-hexenyllithium, (3E)-6-(propoxymethoxy)-3-hexenyllithium, (3E)-6-(butoxymethoxy)-3-hexenyllithium, (3E)-6-(pentyloxymethoxy)-3-hexenyllithium, (3E)-6-(hexyloxymethoxy)-3-hexenyllithium, (3E)-6-(heptyloxymethoxy)-3-hexenyllithium, (3E)-6-(octyloxymethoxy)-3-hexenyllithium, (3E)-6-(nonyloxymethoxy)-3-hexenyllithium and (3E)-6-(decyloxymethoxy)-3-hexenyllithium; (3E)-6-(methoxymethoxy)-3-hexenylmagnesium chloride, (3E)-6-(ethoxymethoxy)-3-hexenylmagnesium chloride, (3E)-6-(propoxymethoxy)-3-hexenylmagnesium chloride, (3E)-6-(butoxymethoxy)-3-hexenylmagnesium chloride, (3E)-6-(pentyloxymethoxy)-3-hexenylmagnesium chloride, (3E)-6-(hexyloxymethoxy)-3-hexenyl (3E)-6-(alkoxymethoxy)-3-hexenylmagnesium chloride compounds such as (3E)-6-(heptyloxymethoxy)-3-hexenylmagnesium chloride, (3E)-6-(octyloxymethoxy)-3-hexenylmagnesium chloride, (3E)-6-(nonyloxymethoxy)-3-hexenylmagnesium chloride and (3E)-6-(decyloxymethoxy)-3-hexenylmagnesium chloride; (3E)-6-(methoxymethoxy)-3-hexenylmagnesium bromide, (3E)-6-(ethoxymethoxy)-3-hexenylmagnesium bromide, (3E)-6-(propoxymethoxy)-3-hexenylmagnesium bromide, (3E)-6-(butoxymethoxy)-3-hexenylmagnesium bromide, (3E)-6-(pentyloxymethoxy)-3-hexenylmagnesium bromide, (3E)-6-(hexyloxymethoxy)-3-hexenyl Magnesium bromide, (3E)-6-(heptyloxymethoxy)-3-hexenylmagnesium bromide, (3E)-6-(octyloxymethoxy)-3-hexenylmagnesium bromide, (3E)-6-(nonyloxymethoxy)-3-hexenylmagnesium bromide and (3E)-6-(decyloxymethoxy)-3-hexenylmagnesium bromide compounds such as magnesium bromide, (3E)-6-(alkoxymethoxy)-3-hexenylmagnesium bromide, (3E)-6-(heptyloxymethoxy)-3-hexenylmagnesium bromide, (3E)-6-(octyloxymethoxy)-3-hexenylmagnesium bromide, (3E)-6-(nonyloxymethoxy)-3-hexenylmagnesium bromide and (3E)-6-(decyloxymethoxy)-3-hexenylmagnesium bromide; and (3E)-6-(methoxymethoxy)-3-hexenylmagnesium iodide, (3E)-6-(ethoxymethoxy)-3-hexenylmagnesium iodide, (3E)-6-(propoxymethoxy)-3-hexenylmagnesium iodide, (3E)-6-(butoxymethoxy)-3-hexenylmagnesium iodide, (3E)-6-(pentyloxymethoxy)-3-hexenylmagnesium iodide, (3E)-6-(hexyloxymethoxy)-3-hexenyl (3E)-6-(alkoxymethoxy)-3-hexenylmagnesium iodide compounds such as (3E)-6-(heptyloxymethoxy)-3-hexenylmagnesium iodide, (3E)-6-(octyloxymethoxy)-3-hexenylmagnesium iodide, (3E)-6-(nonyloxymethoxy)-3-hexenylmagnesium iodide and (3E)-6-(decyloxymethoxy)-3-hexenylmagnesium iodide. Among these compounds, from the viewpoint of easy availability, (3E)-6-(alkoxymethoxy)-3-hexenylmagnesium halide compounds such as (3E)-6-(alkoxymethoxy)-3-hexenylmagnesium chloride compounds are preferred.

[0065] Specific examples of the (3Z)-6-(alkoxymethoxy)-3-hexenyl nucleophile (11-aZ) include the following compounds: (3Z)-6-(alkoxymethoxy)-3-hexenyllithium compounds such as (3Z)-6-(methoxymethoxy)-3-hexenyllithium, (3Z)-6-(ethoxymethoxy)-3-hexenyllithium, (3Z)-6-(propoxymethoxy)-3-hexenyllithium, (3Z)-6-(butoxymethoxy)-3-hexenyllithium, (3Z)-6-(pentyloxymethoxy)-3-hexenyllithium, (3Z)-6-(hexyloxymethoxy)-3-hexenyllithium, (3Z)-6-(heptyloxymethoxy)-3-hexenyllithium, (3Z)-6-(octyloxymethoxy)-3-hexenyllithium, (3Z)-6-(nonyloxymethoxy)-3-hexenyllithium and (3Z)-6-(decyloxymethoxy)-3-hexenyllithium; (3Z)-6-(methoxymethoxy)-3-hexenylmagnesium chloride, (3Z)-6-(ethoxymethoxy)-3-hexenylmagnesium chloride, (3Z)-6-(propoxymethoxy)-3-hexenylmagnesium chloride, (3Z)-6-(butoxymethoxy)-3-hexenylmagnesium chloride, (3Z)-6-(pentyloxymethoxy)-3-hexenylmagnesium chloride, (3Z)-6-(hexyloxymethoxy)-3-hexenyl (3Z)-6-(alkoxymethoxy)-3-hexenylmagnesium chloride compounds such as (3Z)-6-(heptyloxymethoxy)-3-hexenylmagnesium chloride, (3Z)-6-(octyloxymethoxy)-3-hexenylmagnesium chloride, (3Z)-6-(nonyloxymethoxy)-3-hexenylmagnesium chloride and (3Z)-6-(decyloxymethoxy)-3-hexenylmagnesium chloride; (3Z)-6-(methoxymethoxy)-3-hexenylmagnesium bromide, (3Z)-6-(ethoxymethoxy)-3-hexenylmagnesium bromide, (3Z)-6-(propoxymethoxy)-3-hexenylmagnesium bromide, (3Z)-6-(butoxymethoxy)-3-hexenylmagnesium bromide, (3Z)-6-(pentyloxymethoxy)-3-hexenylmagnesium bromide, (3Z)-6-(hexyloxymethoxy)-3-hexenyl Magnesium bromide, (3Z)-6-(heptyloxymethoxy)-3-hexenylmagnesium bromide, (3Z)-6-(octyloxymethoxy)-3-hexenylmagnesium bromide, (3Z)-6-(nonyloxymethoxy)-3-hexenylmagnesium bromide and (3Z)-6-(decyloxymethoxy)-3-hexenylmagnesium bromide compounds such as (3Z)-6-(alkoxymethoxy)-3-hexenylmagnesium bromide; and (3Z)-6-(methoxymethoxy)-3-hexenylmagnesium iodide, (3Z)-6-(ethoxymethoxy)-3-hexenylmagnesium iodide, (3Z)-6-(propoxymethoxy)-3-hexenylmagnesium iodide, (3Z)-6-(butoxymethoxy)-3-hexenylmagnesium iodide, (3Z)-6-(pentyloxymethoxy)-3-hexenylmagnesium iodide, (3Z)-6-(hexyloxymethoxy)-3-hexenylmagnesium iodide

[0036] (3Z)-6-(alkoxymethoxy)-3-hexenylmagnesium iodide compounds such as (3Z)-6-(heptyloxymethoxy)-3-hexenylmagnesium iodide, (3Z)-6-(octyloxymethoxy)-3-hexenylmagnesium iodide, (3Z)-6-(nonyloxymethoxy)-3-hexenylmagnesium iodide and (3Z)-6-(decyloxymethoxy)-3-hexenylmagnesium iodide. Among these compounds, from the viewpoint of easy availability, (3Z)-6-(alkoxymethoxy)-3-hexenylmagnesium halide compounds such as (3Z)-6-(alkoxymethoxy)-3-hexenylmagnesium chloride compounds are preferred.

[0066] The 6-(alkoxymethoxy)-3-hexenyl nucleophile (11-a) may be used alone or in combination of two or more kinds, if necessary. The 6-(alkoxymethoxy)-3-hexenyl nucleophile (11-a) can be either commercially available or independently synthesized.

[0067] The dihaloalkane (12) depicted in the above reaction scheme is described below. X in the above general formula (12) 3 and X 4 each independently represents a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom or an iodine atom. In the above general formula (12), b represents an integer of 3 to 13, and preferably 3 to 9. By selecting the carbon number, i.e., b, of the dihaloalkane (12) used, it is possible to produce a haloalkenyl alkoxymethyl ether compound (10) having a desired carbon number. The amount of the dihaloalkane (12) used is preferably 0.7 to 5.0 mol, more preferably 0.7 to 2.5 mol, per mol of the 6-halo-3-hexenyl alkoxymethyl ether compound (10-a), from the viewpoint of reactivity.

[0068] Specific examples of the dihaloalkane compound (12) include the following compounds: 1,3-dihalopropane compounds (b=3) such as 1,3-dichloropropane, 1,3-dibromopropane, 1,3-diiodopropane, 1-bromo-3-chloropropane, 1-chloro-3-iodopropane and 1-bromo-3-iodopropane; 1,4-dihalobutane compounds (b=4) such as 1,4-dichlorobutane, 1,4-dibromobutane, 1,4-diiodobutane, 1-bromo-4-chlorobutane, 1-chloro-4-iodobutane and 1-bromo-4-iodobutane; 1,5-dihalopentane compounds (b=5) such as 1,5-dichloropentane, 1,5-dibromopentane, 1,5-diiodopentane, 1-bromo-5-chloropentane, 1-chloro-5-iodopentane and 1-bromo-5-iodopentane; 1,6-dihalohexane compounds (b=6) such as 1,6-dichlorohexane, 1,6-dibromohexane, 1,6-diiodohexane, 1-bromo-6-chlorohexane, 1-chloro-6-iodohexane and 1-bromo-6-iodohexane; 1,7-dihaloheptane compounds (b=7) such as 1,7-dichloroheptane, 1,7-dibromoheptane, 1,7-diiodoheptane, 1-bromo-7-chloroheptane, 1-chloro-7-iodoheptane and 1-bromo-7-iodoheptane; 1,8-dihalooctane compounds (b=8) such as 1,8-dichlorooctane, 1,8-dibromooctane, 1,8-diiodooctane, 1-bromo-8-chlorooctane, 1-chloro-8-iodooctane and 1-bromo-8-iodooctane; 1,9-dihalononane compounds (b=9) such as 1,9-dichlorononane, 1,9-dibromononane, 1,9-diiodononane, 1-bromo-9-chlorononane, 1-chloro-9-iodononane and 1-bromo-9-iodononane; 1,10-dihalodecane compounds (b=10) such as 1,10-dichlorodecane, 1,10-dibromodecane, 1,10-diiododecane, 1-bromo-10-chlorodecane, 1-chloro-10-iododecane and 1-bromo-10-iododecane; 1,11-dihaloundecane compounds (b=11) such as 1,11-dichloroundecane, 1,11-dibromoundecane, 1,11-diiodoundecane, 1-bromo-11-chloroundecane, 1-chloro-11-iodoundecane and 1-bromo-11-iodoundecane; 1,12-dihalododecane compounds (b=12), such as 1,12-dichlorododecane, 1,12-dibromododecane, 1,12-diiodododecane, 1-bromo-12-chlorododecane, 1-chloro-12-iodododecane and 1-bromo-12-iodododecane; and 1,13-Dihalotridecane compounds (b=13) such as 1,13-dichlorotridecane, 1,13-dibromotridecane, 1,13-diiodotridecane, 1-bromo-13-chlorotridecane, 1-chloro-13-iodotridecane and 1-bromo-13-iodotridecane. The dihaloalkane compound (12) may be used alone or in combination of two or more as required. The dihaloalkane compound (12) may also be a compound that is independently synthesized.

[0069] In the coupling reaction, a solvent may be used as necessary. Examples of the solvent include common solvents, such as ethers such as diethyl ether, dibutyl ether, 4-methyltetrahydropyran, tetrahydrofuran (THF), cyclopentyl methyl ether and 1,4-dioxane; hydrocarbons such as hexane, heptane, benzene, toluene, xylene and cumene; chlorine-based solvents such as trichloroethylene, dichloromethane and chloroform; aprotic polar solvents such as dimethyl sulfoxide, γ-butyrolactone (GBL), N-methylpyrrolidone (NMP), N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAC) and hexamethylphosphoric triamide (HMPA); and nitriles such as acetonitrile and propionitrile, but from the viewpoint of reactivity, toluene, tetrahydrofuran, 4-methyltetrahydropyran and acetonitrile are preferred, and tetrahydrofuran is more preferred. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used is preferably 30 to 5000 g, more preferably 50 to 3000 g, per 1 mol of the 6-halo-3-hexenyl alkoxymethyl ether compound (10-a) from the viewpoint of reactivity.

[0070] In the coupling reaction, a catalyst may be used as necessary. Examples of the catalyst include monovalent copper halides such as cuprous chloride, cuprous bromide, and cuprous iodide, and divalent copper halides such as cupric chloride, cupric bromide, and cupric iodide; iron compounds such as iron chloride (II), iron chloride (III), iron bromide (II), iron bromide (III), iron iodide (II), iron iodide (III), and iron acetylacetonate (III); silver compounds such as silver chloride, silver nitrate, and silver acetate; and titanium compounds such as titanium tetrachloride, titanium tetrabromide, titanium (IV) methoxide, titanium (IV) ethoxide, titanium (IV) isopropoxide, and titanium (IV) oxide. palladium(II) compounds such as dichlorobis(triphenylphosphine)palladium and dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium; and nickel compounds such as nickel chloride, dichloro[1,2-bis(diphenylphosphino)ethane]nickel(II) and dichlorobis(triphenylphosphine)nickel(II). The 6-(alkoxymethoxy)-3-hexenyl nucleophile (11-a) is a Grignard reagent, i.e., 6-(alkoxymethoxy)-3-hexenyl magnesium halide compound (11-a:M 1 =MgZ 1 ), from the viewpoint of reactivity and / or economy, a copper compound is preferred, and a copper halide such as cuprous chloride, cuprous bromide, or cuprous iodide is more preferred. The catalyst may be used alone or in combination with two or more kinds, if necessary. In addition, commercially available catalysts may be used. The amount of the catalyst used is preferably 0.0003 to 0.300 mol, more preferably 0.003 to 0.100 mol, per 1 mol of the 6-halo-3-hexenyl alkoxymethyl ether compound (10-a), from the viewpoints of reaction rate and post-treatment.

[0071] When a catalyst is used in the coupling reaction, a cocatalyst may be used as necessary. Examples of the cocatalyst include trialkyl phosphite compounds having 3 to 9 carbon atoms, such as triethyl phosphite; and arylphosphine compounds having 18 to 44 carbon atoms, such as triphenylphosphine, tritolylphosphine, and 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (BINAP). From the viewpoint of reactivity, trialkyl phosphite is preferred, and triethyl phosphite is particularly preferred. The co-catalyst may be one type or, if necessary, two or more types. In addition, the co-catalyst may be a commercially available product. The amount of the cocatalyst used is preferably 0.0001 to 1.00 mol, more preferably 0.001 to 0.300 mol, relative to 1 mol of the 6-halo-3-hexenyl alkoxymethyl ether compound (10-a). When an organolithium reagent is used in the coupling reaction, the reaction rate may be improved by adding N,N,N',N'-tetramethylethylenediamine (TMEDA), hexamethylphosphoric triamide (HMPA), N,N'-dimethylpropyleneurea (DMPU), or the like, as necessary.

[0072] When a catalyst is used in the coupling reaction, a lithium halide may be added as necessary. Examples of the lithium halide include lithium chloride, lithium bromide, and lithium iodide, and from the viewpoint of reactivity, lithium chloride is preferred. The amount of lithium halide used in the coupling reaction is preferably 0.0001 to 1.00 mol, more preferably 0.001 to 0.300 mol, per 1 mol of the 6-halo-3-hexenyl alkoxymethyl ether compound (10-a), from the viewpoint of reactivity.

[0073] The reaction temperature in the coupling reaction varies depending on the 6-(alkoxymethoxy)-3-hexenyl nucleophilic reagent (11-a) used, but is preferably −78 to 80° C., more preferably −25 to 40° C., from the viewpoint of reactivity. The reaction time in the coupling reaction varies depending on the solvent used and / or the reaction scale, but is preferably 0.5 to 100 hours from the viewpoint of reactivity.

[0074] The haloalkenyl alkoxymethyl ether compound (10) shown in the above reaction scheme is explained below. R in the above general formula (10) 1 and X 4 is as defined in general formula (1) above.

[0075] Specific examples of the haloalkenyl alkoxymethyl ether compound (10) include the following compounds: 7-halo-3-heptenyl alkoxymethyl ether compounds (a=3) such as 7-chloro-3-heptenyl methoxymethyl ether, 7-chloro-3-heptenyl ethoxymethyl ether, 7-bromo-3-heptenyl methoxymethyl ether, 7-bromo-3-heptenyl ethoxymethyl ether, 7-iodo-3-heptenyl methoxymethyl ether and 7-iodo-3-heptenyl ethoxymethyl ether; 8-halo-3-octenyl alkoxymethyl ether compounds (a=4) such as 8-chloro-3-octenyl methoxymethyl ether, 8-chloro-3-octenyl ethoxymethyl ether, 8-bromo-3-octenyl methoxymethyl ether, 8-bromo-3-octenyl ethoxymethyl ether, 8-iodo-3-octenyl methoxymethyl ether and 8-iodo-3-octenyl ethoxymethyl ether; 9-halo-3-nonanyl alkoxymethyl ether compounds (a=5) such as 9-chloro-3-nonanyl methoxymethyl ether, 9-chloro-3-nonanyl ethoxymethyl ether, 9-bromo-3-nonanyl methoxymethyl ether, 9-bromo-3-nonanyl ethoxymethyl ether, 9-iodo-3-nonanyl methoxymethyl ether and 9-iodo-3-nonanyl ethoxymethyl ether; 10-chloro-3-decenyl methoxymethyl ether, 10-chloro-3-decenyl ethoxymethyl ether, 10-chloro-3-decenyl propoxymethyl ether, 10-chloro-3-decenyl butoxymethyl ether, 10-chloro-3-decenyl pentyloxymethyl ether, 10-chloro-3-decenyl hexyloxymethyl ether, 10-chloro-3-decenyl heptyloxymethyl ether, 10-chloro-3-decenyl octyloxymethyl ether, 10-chloro-3-decenyl nonyloxymethyl ether 10-bromo-3-decenyl ethoxymethyl ether, 10-bromo-3-decenyl decyloxymethyl ether, 10-chloro-3-decenyl benzyloxymethyl ether, 10-bromo-3-decenyl methoxymethyl ether, 10-bromo-3-decenyl ethoxymethyl ether, 10-bromo-3-decenyl propoxymethyl ether, 10-bromo-3-decenyl butoxymethyl ether, 10-bromo-3-decenyl pentyloxymethyl ether, 10-bromo-3-decenyl hex ...methoxymethyl ether, 10-bromo-3-decenyl ethoxymethyl ether, 10-bromo-3-decenyl propoxymethyl ether, 10-bromo-3-decenyl butoxymethyl ether, 10-bromo-3-decenyl pentyloxymethyl ether, 10-bromo-3-decenyl hexyloxymethyl ether, 10-bromo-3 -decenyl heptyloxymethyl ether, 10-bromo-3-decenyl octyloxymethyl ether, 10-bromo-3-decenyl nonyloxymethyl ether, 10-bromo-3-decenyl decyloxymethyl ether, 10-bromo-3-decenyl benzyloxymethyl ether, 10-iodo-3-decenyl methoxymethyl ether, 10-iodo-3-decenyl ethoxymethyl ether, 10-iodo-3-decenyl propoxymethyl ether, 10-iodo-3-decenyl butoxymethyl ether 10-halo-3-decenyl alkoxymethyl ether compounds (a=6) such as 10-iodo-3-decenyl pentyloxymethyl ether, 10-iodo-3-decenyl hexyloxymethyl ether, 10-iodo-3-decenyl heptyloxymethyl ether, 10-iodo-3-decenyl octyloxymethyl ether, 10-iodo-3-decenyl nonyloxymethyl ether, 10-iodo-3-decenyl decyloxymethyl ether and 10-iodo-3-decenyl benzyloxymethyl ether; 11-halo-3-undecenyl alkoxymethyl ether compounds (a=7) such as 11-chloro-3-undecenyl methoxymethyl ether, 11-chloro-3-undecenyl ethoxymethyl ether, 11-bromo-3-undecenyl methoxymethyl ether, 11-bromo-3-undecenyl ethoxymethyl ether, 11-iodo-3-undecenyl methoxymethyl ether and 11-iodo-3-undecenyl ethoxymethyl ether; 12-chloro-3-dodecenyl methoxymethyl ether, 12-chloro-3-dodecenyl ethoxymethyl ether, 12-chloro-3-dodecenyl propoxymethyl ether, 12-chloro-3-dodecenyl butoxymethyl ether, 12-chloro-3-dodecenyl pentyloxymethyl ether, 12-chloro-3-dodecenyl hexyloxymethyl ether, 12-chloro-3-dodecenyl heptyloxymethyl ether, 12-chloro-3-dodecenyl octyloxymethyl ether, 1 2-Chloro-3-dodecenyl nonyloxymethyl ether, 12-Chloro-3-dodecenyl decyloxymethyl ether, 12-Chloro-3-dodecenyl benzyloxymethyl ether, 12-Bromo-3-dodecenyl methoxymethyl ether, 12-Bromo-3-dodecenyl ethoxymethyl ether, 12-Bromo-3-dodecenyl propoxymethyl ether, 12-Bromo-3-dodecenyl butoxymethyl ether, 12-Bromo-3-dodecenyl pentyl ... methoxymethyl ether, 12-Bromo-3-dodecenyl ethoxymethyl ether, 12-Bromo-3-dodecenyl propoxymethyl ether, 12-Bromo-3-dodecenyl butoxymethyl ether, 12-Bromo-3-dodecenyl pentyloxymethyl ether, 12-Bromo-3-dodecenyl pentyloxymethyl ether, 12-bromo-3-dodecenyl hexyloxymethyl ether, 12-bromo-3-dodecenyl heptyloxymethyl ether, 12-bromo-3-dodecenyl octyloxymethyl ether, 12-bromo-3-dodecenyl nonyloxymethyl ether, 12-bromo-3-dodecenyl decyloxymethyl ether, 12-bromo-3-dodecenyl benzyloxymethyl ether, 12-iodo-3-dodecenyl methoxymethyl ether, 12-iodo-3-dodecenyl ethoxymethyl ether, 12 -iodo-3-dodecenyl propoxymethyl ether, 12-iodo-3-dodecenyl butoxymethyl ether, 12-iodo-3-dodecenyl pentyloxymethyl ether, 12-iodo-3-dodecenyl hexyloxymethyl ether, 12-iodo-3-dodecenyl heptyloxymethyl ether, 12-iodo-3-dodecenyl octyloxymethyl ether, 12-iodo-3-dodecenyl nonyloxymethyl ether, 12-iodo-3-dodecenyl decyloxymethyl ether,12-halo-3-dodecenyl alkoxymethyl ether compounds (a=8), such as 12-iodo-3-dodecenyl benzyloxymethyl ether; 13-halo-3-tridecenyl alkoxymethyl ether compounds (a=9) such as 13-chloro-3-tridecenyl methoxymethyl ether, 13-chloro-3-tridecenyl ethoxymethyl ether, 13-bromo-3-tridecenyl methoxymethyl ether, 13-bromo-3-tridecenyl ethoxymethyl ether, 13-iodo-3-tridecenyl methoxymethyl ether and 13-iodo-3-tridecenyl ethoxymethyl ether; 14-halo-3-tetradecenyl alkoxymethyl ether compounds (a=10) such as 14-chloro-3-tetradecenyl methoxymethyl ether, 14-chloro-3-tetradecenyl ethoxymethyl ether, 14-bromo-3-tetradecenyl methoxymethyl ether, 14-bromo-3-tetradecenyl ethoxymethyl ether, 14-iodo-3-tetradecenyl methoxymethyl ether, and 14-iodo-3-tetradecenyl ethoxymethyl ether; 15-halo-3-pentadecenyl alkoxymethyl ether compounds (a=11) such as 15-chloro-3-pentadecenyl methoxymethyl ether, 15-chloro-3-pentadecenyl ethoxymethyl ether, 15-bromo-3-pentadecenyl methoxymethyl ether, 15-bromo-3-pentadecenyl ethoxymethyl ether, 15-iodo-3-pentadecenyl methoxymethyl ether and 15-iodo-3-pentadecenyl ethoxymethyl ether; 16-halo-3-hexadecenyl alkoxymethyl ether compounds (a=12) such as 16-chloro-3-hexadecenyl methoxymethyl ether, 16-chloro-3-hexadecenyl ethoxymethyl ether, 16-bromo-3-hexadecenyl methoxymethyl ether, 16-bromo-3-hexadecenyl ethoxymethyl ether, 16-iodo-3-hexadecenyl methoxymethyl ether and 16-iodo-3-hexadecenyl ethoxymethyl ether; 17-halo-3-heptadecenyl alkoxymethyl ether compounds (a=13) such as 17-chloro-3-heptadecenyl methoxymethyl ether, 17-chloro-3-heptadecenyl ethoxymethyl ether, 17-bromo-3-heptadecenyl methoxymethyl ether, 17-bromo-3-heptadecenyl ethoxymethyl ether, 17-iodo-3-heptadecenyl methoxymethyl ether and 17-iodo-3-heptadecenyl ethoxymethyl ether; and 18-Halo-3-octadecenyl alkoxymethyl ether compounds (a=14) such as 18-chloro-3-octadecenyl methoxymethyl ether, 18-chloro-3-octadecenyl ethoxymethyl ether, 18-bromo-3-octadecenyl methoxymethyl ether, 18-bromo-3-octadecenyl ethoxymethyl ether, 18-iodo-3-octadecenyl methoxymethyl ether and 18-iodo-3-octadecenyl ethoxymethyl ether.

[0076] As one method for synthesizing the (alkoxymethoxy)-3-alkenyl magnesium halide compound (11), for example, as shown in the following chemical reaction formula, a halo-3-alkenyl alkoxymethyl ether compound (10) is reacted with magnesium in a solvent to obtain an (alkoxymethoxy)-3-alkenyl magnesium halide compound (11:M) as a Grignard reagent. 2 =MgZ 2 ) can be obtained. [ka]

[0077] In this method, the amount of magnesium used, the solvent and the amount of the solvent used, as well as the reaction temperature and reaction time are the same as those described in the above conversion reaction by magnesium.

[0078] As another method for synthesizing the (alkoxymethoxy)-3-alkenyl nucleophilic reagent (11), for example, a halo-3-alkenyl alkoxymethyl ether compound (10) is reacted with an organolithium reagent in a solvent to give an (alkoxymethoxy)-3-alkenyllithium compound (11:M), as shown in the following chemical reaction scheme: 2 Here are some ways to obtain the formula:

[0079] [ka]

[0080] In this method, the amount of organolithium reagent used, the solvent and the amount of said solvent used, as well as the reaction temperature and reaction time are the same as the amount of magnesium used, the solvent and the amount of said solvent used, as well as the reaction temperature and reaction time described in the above conversion reaction using an organolithium reagent.

[0081] The (alkoxymethoxy)-3-alkenyl nucleophile (11) depicted in the above reaction scheme is described below. R in the above general formula (11) 1 is as defined in general formula (1) above. M 2 Li or MgZ 2 and Z 2 represents a halogen atom or an (alkoxymethoxy)-3-alkenyl group. 2 Examples of the aryl group include a chlorine atom, a bromine atom, and an iodine atom. Examples of the (alkoxymethoxy)-3-alkenyl nucleophilic reagent (11) include a (3E)-(alkoxymethoxy)-3-alkenyl nucleophilic reagent represented by the following general formula (11-E), a (3Z)-(alkoxymethoxy)-3-alkenyl nucleophilic reagent represented by the following general formula (11-Z), and a mixture thereof. [ka]

[0082] Specific examples of the (3E)-(alkoxymethoxy)-3-alkenyl nucleophile (11-E) include the following compounds: (3E)-(alkoxymethoxy)-3-alkenyllithium compounds such as (3E)-(methoxymethoxy)-3-alkenyllithium, (3E)-(ethoxymethoxy)-3-alkenyllithium, (3E)-(propoxymethoxy)-3-alkenyllithium, (3E)-(butoxymethoxy)-3-alkenyllithium, (3E)-(pentyloxymethoxy)-3-alkenyllithium, (3E)-(hexyloxymethoxy)-3-alkenyllithium, (3E)-(heptyloxymethoxy)-3-alkenyllithium, (3E)-(octyloxymethoxy)-3-alkenyllithium, (3E)-(nonyloxymethoxy)-3-alkenyllithium and (3E)-(decyloxymethoxy)-3-alkenyllithium; (3E)-(methoxymethoxy)-3-alkenylmagnesium chloride, (3E)-(ethoxymethoxy)-3-alkenylmagnesium chloride, (3E)-(propoxymethoxy)-3-alkenylmagnesium chloride, (3E)-(butoxymethoxy)-3-alkenylmagnesium chloride, (3E)-(pentyloxymethoxy)-3-alkenylmagnesium chloride, (3E)-(hexyloxymethoxy)-3-alkenyl (3E)-(alkoxymethoxy)-3-alkenylmagnesium chloride compounds such as (3E)-(heptyloxymethoxy)-3-alkenylmagnesium chloride, (3E)-(octyloxymethoxy)-3-alkenylmagnesium chloride, (3E)-(nonyloxymethoxy)-3-alkenylmagnesium chloride and (3E)-(decyloxymethoxy)-3-alkenylmagnesium chloride; (3E)-(methoxymethoxy)-3-alkenylmagnesium bromide, (3E)-(ethoxymethoxy)-3-alkenylmagnesium bromide, (3E)-(propoxymethoxy)-3-alkenylmagnesium bromide, (3E)-(butoxymethoxy)-3-alkenylmagnesium bromide, (3E)-(pentyloxymethoxy)-3-alkenylmagnesium bromide, (3E)-(hexyloxymethoxy)-3-alkenylmagnesium bromide (3E)-(alkoxymethoxy)-3-alkenylmagnesium bromide compounds such as magnesium bromide, (3E)-(heptyloxymethoxy)-3-alkenylmagnesium bromide, (3E)-(octyloxymethoxy)-3-alkenylmagnesium bromide, (3E)-(nonyloxymethoxy)-3-alkenylmagnesium bromide and (3E)-(decyloxymethoxy)-3-alkenylmagnesium bromide; and (3E)-(methoxymethoxy)-3-alkenylmagnesium iodide, (3E)-(ethoxymethoxy)-3-alkenylmagnesium iodide, (3E)-(propoxymethoxy)-3-alkenylmagnesium iodide, (3E)-(butoxymethoxy)-3-alkenylmagnesium iodide, (3E)-(pentyloxymethoxy)-3-alkenylmagnesium iodide, (3E)-(hexyloxymethoxy)-3-alkenyl (3E)-(alkoxymethoxy)-3-alkenylmagnesium iodide compounds such as (3E)-(heptyloxymethoxy)-3-alkenylmagnesium iodide, (3E)-(octyloxymethoxy)-3-alkenylmagnesium iodide, (3E)-(nonyloxymethoxy)-3-alkenylmagnesium iodide and (3E)-(decyloxymethoxy)-3-alkenylmagnesium iodide. Among these compounds, from the viewpoint of easy availability, (3E)-(alkoxymethoxy)-3-alkenylmagnesium halide compounds such as (3E)-(alkoxymethoxy)-3-alkenylmagnesium chloride compounds are preferred.

[0083] Specific examples of the (3Z)-(alkoxymethoxy)-3-alkenyl nucleophile (11-Z) include the following compounds: (3Z)-(alkoxymethoxy)-3-alkenyllithium compounds such as 3Z-(methoxymethoxy)-3-alkenyllithium, (3Z)-(ethoxymethoxy)-3-alkenyllithium, (3Z)-(propoxymethoxy)-3-alkenyllithium, (3Z)-(butoxymethoxy)-3-alkenyllithium, (3Z)-(pentyloxymethoxy)-3-alkenyllithium, (3Z)-(hexyloxymethoxy)-3-alkenyllithium, (3Z)-(heptyloxymethoxy)-3-alkenyllithium, (3Z)-(octyloxymethoxy)-3-alkenyllithium, (3Z)-(nonyloxymethoxy)-3-alkenyllithium and (3Z)-(decyloxymethoxy)-3-alkenyllithium; (3Z)-(methoxymethoxy)-3-alkenylmagnesium chloride, (3Z)-(ethoxymethoxy)-3-alkenylmagnesium chloride, (3Z)-(propoxymethoxy)-3-alkenylmagnesium chloride, (3Z)-(butoxymethoxy)-3-alkenylmagnesium chloride, (3Z)-(pentyloxymethoxy)-3-alkenylmagnesium chloride, (3Z)-(hexyloxymethoxy)-3-alkenyl (3Z)-(alkoxymethoxy)-3-alkenylmagnesium chloride compounds such as (3Z)-(heptyloxymethoxy)-3-alkenylmagnesium chloride, (3Z)-(octyloxymethoxy)-3-alkenylmagnesium chloride, (3Z)-(nonyloxymethoxy)-3-alkenylmagnesium chloride and (3Z)-(decyloxymethoxy)-3-alkenylmagnesium chloride; (3Z)-(Methoxymethoxy)-3-alkenylmagnesium bromide, (3Z)-(ethoxymethoxy)-3-alkenylmagnesium bromide, (3Z)-(propoxymethoxy)-3-alkenylmagnesium bromide, (3Z)-(butoxymethoxy)-3-alkenylmagnesium bromide, (3Z)-(pentyloxymethoxy)-3-alkenylmagnesium bromide, (3Z)-(hexyloxymethoxy)-3-alkenylmagnesium bromide (3Z)-(alkoxymethoxy)-3-alkenylmagnesium bromide compounds such as (3Z)-(heptyloxymethoxy)-3-alkenylmagnesium bromide, (3Z)-(octyloxymethoxy)-3-alkenylmagnesium bromide, (3Z)-(nonyloxymethoxy)-3-alkenylmagnesium bromide and (3Z)-(decyloxymethoxy)-3-alkenylmagnesium bromide; and (3Z)-(Methoxymethoxy)-3-alkenylmagnesium iodide, (3Z)-(ethoxymethoxy)-3-alkenylmagnesium iodide, (3Z)-(propoxymethoxy)-3-alkenylmagnesium iodide, (3Z)-(butoxymethoxy)-3-alkenylmagnesium iodide, (3Z)-(pentyloxymethoxy)-3-alkenylmagnesium iodide, (3Z)-(hexyloxymethoxy)-3-alkenyl (3Z)-(alkoxymethoxy)-3-alkenylmagnesium iodide compounds such as (3Z)-(heptyloxymethoxy)-3-alkenylmagnesium iodide, (3Z)-(octyloxymethoxy)-3-alkenylmagnesium iodide, (3Z)-(nonyloxymethoxy)-3-alkenylmagnesium iodide and (3Z)-(decyloxymethoxy)-3-alkenylmagnesium iodide. Among these compounds, from the viewpoint of easy availability, (3Z)-(alkoxymethoxy)-3-alkenylmagnesium halide compounds such as (3Z)-(alkoxymethoxy)-3-alkenylmagnesium chloride compounds are preferred.

[0084] The (alkoxymethoxy)-3-alkenyl nucleophilic reagent (11) may be used alone or in combination, if necessary. In addition, the (alkoxymethoxy)-3-alkenyl nucleophile (11) may be commercially available or may be independently synthesized.

[0085] The orthoformate compound (13) shown in the above reaction scheme is explained below. The orthoformate compound (13) is represented by the following general formula (13). HC(OR 7 ) 3 (13) Three R in orthoformate compound (13) 7 represent alkyl groups, which may be the same or different, having 1 to 6 carbon atoms, preferably 1 to 3 carbon atoms. Examples of the alkyl group having 1 to 6 carbon atoms include linear alkyl groups such as a methyl group, an ethyl group, an n-propyl group, an n-butyl group, an n-pentyl group, and an n-hexyl group; and branched alkyl groups such as an isopropyl group and an isobutyl group. Examples of the orthoformate compound (13) include methyl orthoformate, ethyl orthoformate, propyl orthoformate, butyl orthoformate, pentyl orthoformate, and hexyl orthoformate. From the viewpoint of availability, methyl orthoformate and ethyl orthoformate are preferred. The orthoformate compound (13) may be used alone or in combination with two or more compounds as required. The orthoformate compound (13) may be a commercially available compound.

[0086] Examples of the solvent used in the nucleophilic substitution reaction include hydrocarbons such as toluene, xylene, and hexane; and ethers such as tetrahydrofuran, 4-methyltetrahydropyran, and diethyl ether. From the viewpoint of reactivity, tetrahydrofuran, toluene, and 4-methyltetrahydropyran are preferred. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. When the (alkoxymethoxy)-3-alkenyl nucleophile (11) is diluted with a solvent or when a solvent is used in preparing the (alkoxymethoxy)-3-alkenyl nucleophile (11), the solvent may be the same as or different from the solvent used in the nucleophilic substitution reaction. In addition, when the solvent is different, it may be replaced with a solvent that increases the reactivity of the nucleophilic substitution reaction. For example, in the case where tetrahydrofuran is used as a solvent in preparing the (alkoxymethoxy)-3-alkenyl nucleophile (11) and toluene is selected as a solvent for use in the nucleophilic substitution reaction, the (alkoxymethoxy)-3-alkenyl nucleophile (11) containing tetrahydrofuran may be added to a reactor containing an orthoformate compound and toluene, and the tetrahydrofuran may be distilled off during the process of increasing the reaction temperature, thereby replacing the solvent in the reaction system with toluene. From the viewpoint of reactivity, the amount of the solvent used is preferably 100 to 6,000 g per 1 mol of the orthoformate compound (13).

[0087] The reaction temperature in the nucleophilic substitution reaction is preferably 75 to 130° C. from the viewpoints of smoothly progressing the reaction and preventing evaporation of the solvent. The reaction time in the nucleophilic substitution reaction varies depending on the solvent used and / or the reaction scale, but is preferably 1 to 100 hours.

[0088] When the above a is 1, the dialkoxyalkenyl alkoxymethyl ether compound (1), i.e., the dialkoxypentenyl alkoxymethyl ether compound (1; a=1), can be synthesized, for example, according to a reaction scheme including the following three steps. [ka]

[0089] First, the hydroxyl group of a 5-hydroxy-3-pentenyl alkoxymethyl ether compound represented by the general formula (14) is halogenated to obtain a 5-halo-3-pentenyl alkoxymethyl ether compound represented by the general formula (10) (first step). The obtained 5-halo-3-pentenyl alkoxymethyl ether compound (10) is reacted with, for example, a magnesium or organolithium reagent in a solvent to obtain a 5-(alkoxymethoxy)-3-pentenyl nucleophile (11) represented by the general formula (11) (second step). The obtained 5-(alkoxymethoxy)-3-pentenyl nucleophile (11) is subjected to a nucleophilic substitution reaction with an orthoformate compound represented by the general formula (13) to acetalize, thereby obtaining a dialkoxypentenyl alkoxymethyl ether compound (1) (third step).

[0090] When the above a is 3 or 4, the dialkoxyalkenyl alkoxymethyl ether compound (1) can be synthesized, for example, according to the following reaction scheme including the following four steps. [ka]

[0091] First, an alkoxymethyl 3-butynyl ether compound represented by the general formula (7) is reacted with a base, and then a coupling reaction is carried out with a dihaloalkane represented by the general formula (12) to obtain a halo-3-alkynyl alkoxymethyl ether compound represented by the general formula (15) (first step). The carbon-carbon triple bond of the obtained halo-3-alkynyl alkoxymethyl ether compound (15) is reduced to obtain a halo-3-alkenyl alkoxymethyl ether compound represented by the general formula (10) (second step). The obtained halo-3-alkenyl alkoxymethyl ether compound (10) is reacted with, for example, magnesium or an organolithium reagent in a solvent to obtain an (alkoxymethoxy)-3-alkenyl nucleophilic reagent (11) represented by the general formula (11) (third step). The (alkoxymethoxy)-3-alkenyl nucleophilic reagent (11) obtained is subjected to a nucleophilic substitution reaction with an orthoformate compound represented by general formula (13) to be acetalized, thereby obtaining a dialkoxyalkenyl alkoxymethyl ether compound (1) (fourth step).

[0092] <Production of dialkoxy-3-alkene-1-ol compound (2) by dealkoxymethylation reaction> The dialkoxy-3-alkene-1-ol compound (2) can be produced by dealkoxymethylating the dialkoxyalkenyl alkoxymethyl ether compound (1) described above, as shown in the following chemical reaction formula.

[0093] [ka]

[0094] In the above dealkoxymethylation reaction, the dialkoxyalkenyl alkoxymethyl ether compound (1) may be used alone or, if necessary, in combination of two or more kinds. For example, (3E)-12,12-dialkoxy-3-dodecenyl methoxymethyl ether compound (1:R 1=H; a=7) and (3Z)-12,12-dialkoxy-3-dodecenyl methoxymethyl ether compound (1:R 1 =H; a=7) can be used to obtain a mixture of a (3E)-12,12-dialkoxy-3-dodecen-1-ol compound (2: a=7) and a (3Z)-12,12-dialkoxy-3-dodecen-1-ol compound (2: a=7). The dealkoxymethylation reaction is 1 The optimum conditions vary depending on the type. For example, R 1 When R is a phenyl group, dealkoxymethylation can be achieved by Birch reduction using sodium in liquid ammonia, while R 1 When is an n-alkyl group, such as a methyl group, or a hydrogen atom, dealkoxymethylation can be carried out using an acid or alcohol compound (6).

[0095] Examples of the acid include inorganic acids such as hydrochloric acid and hydrobromic acid; sulfonic acids such as p-toluenesulfonic acid and benzenesulfonic acid; organic acids such as trifluoroacetic acid, acetic acid, formic acid and oxalic acid; and Lewis acids such as iodotrimethylsilane and titanium tetrachloride. From the viewpoint of suppressing side reactions, p-toluenesulfonic acid, benzenesulfonic acid and hydrochloric acid are preferred, and p-toluenesulfonic acid is particularly preferred. The acid may be used alone or in combination with two or more acids as required. In addition, commercially available acids may be used. The amount of the acid used is preferably 0.0001 to 10.0 mol, more preferably 0.001 to 1.0 mol, per mol of the dialkoxyalkenyl alkoxymethyl ether compound (1).

[0096] The alcohol compound (6) is represented by the following general formula (6). R 6 OH (6) R 6 represents a monovalent hydrocarbon having 1 to 15 carbon atoms, and preferably having 1 to 6 carbon atoms from the viewpoint of cost or availability. The monovalent hydrocarbon group is R2 and R 3 is the same as the monovalent hydrocarbon group. Examples of the alcohol compound (6) include linear alcohols such as methanol, ethanol, n-propanol, n-butanol, n-pentanol, n-hexanol, n-heptanol, n-octanol, n-nonanol, n-decanol, n-undecanol, n-dodecanol, n-tridecanol, n-tetradecanol, and n-pentadecanol; branched alcohols such as isopropanol and 2-butanol; and diols such as ethylene glycol, propylene glycol, 2-methyl-1,3-propanediol, 2,2-dimethyl-1,3-propanediol, 1,2-dimethyl-1,3-propanediol, 1,3-dimethyl-1,3-propanediol, and 2-methyl-1,4-butanediol. From the viewpoint of reactivity, methanol and ethanol are preferred, and methanol is particularly preferred.

[0097] Under acidic conditions, in addition to the desired dealkoxymethylation, a transacetalization reaction occurs simultaneously. 2 and R 3 and R 6 R in OH(6) 6 is the same, the alkoxy group of the acetal does not change, so R 6 R 2 and R 3 is the same as R 6 It is preferred to use OH(6). Also, R 6 R 2 and R 3 Different from R 6 The R in the dialkoxyalkenyl alkoxymethyl ether compound (1) was prepared by intentionally using OH (6) to carry out an acetal exchange reaction. 2 and R 3 , R 2 and R 3 At least one of R is different 4 and R 5 In this case, R 4, R 5 , or R 4 and R 5 (i.e., R 4 =R 5 ) corresponding to R 6 R with 6 It is preferable to use OH(6). Thus, the R 2 and R 3 R 4 and R 5 By substituting each of these, it is possible to adjust the boiling point of the dialkoxy-3-alkene-1-ol compound (2) and the stability of the acetal. The alcohol compound (6) may be used alone or in combination of two or more, if necessary. Moreover, the alcohol compound (6) used may be a commercially available product. The amount of the alcohol compound (6) used is preferably 1 to 1000 mol, more preferably 3 to 100 mol, per mol of the dialkoxyalkenyl alkoxymethyl ether compound (1) from the viewpoint of reactivity.

[0098] In the dealkoxymethylation reaction, a solvent other than the alcohol compound (6) may be used, if necessary. Examples of the solvent include common solvents, such as ethers such as diethyl ether, dibutyl ether, 4-methyltetrahydropyran, tetrahydrofuran (THF), cyclopentyl methyl ether, and 1,4-dioxane; hydrocarbons such as hexane, heptane, benzene, toluene, xylene, and cumene; chlorine-based solvents such as trichloroethylene, dichloromethane, and chloroform; aprotic polar solvents such as dimethyl sulfoxide, γ-butyrolactone (GBL), N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, and hexamethylphosphoric triamide; nitriles such as acetonitrile and propionitrile; and esters such as methyl acetate, ethyl acetate, n-propyl acetate, and n-butyl acetate. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used in the dealkoxymethylation reaction is preferably 0 to 2000 g, more preferably 0 to 500 g, per mol of the dialkoxyalkenyl alkoxymethyl ether compound (1). The use of such a solvent reduces the amount of the reaction mixture charged, resulting in a decrease in productivity. Therefore, the reaction may be carried out without using any of the above solvents.

[0099] The reaction temperature in the dealkoxymethylation reaction varies depending on the dialkoxyalkenyl alkoxymethyl ether compound (1) used, but is preferably 5 to 180° C. from the viewpoint of reactivity. The reaction time in the dealkoxymethylation reaction varies depending on the dialkoxyalkenyl alkoxymethyl ether compound (1) used and / or the reaction scale, but is preferably 1 to 100 hours from the viewpoint of reactivity.

[0100] In the dealkoxymethylation reaction, the by-product alkoxymethoxymethane may be removed by distillation from the reaction system, if necessary. By removing the alkoxymethoxymethane from the reaction system, the equilibrium shifts to the product side, making it possible to shorten the reaction time.

[0101] Of the dialkoxy acetal, which is a protecting group for the carbonyl group, and the alkoxy methyl group, which is a protecting group for the hydroxyl group, present in the same molecule of the dialkoxy alkenyl alkoxy methyl ether compound (1), it is difficult to selectively hydrolyze only the alkoxy methyl group to effect dealkoxymethylation, and the dialkoxy acetal, which is more easily hydrolyzed, is hydrolyzed first. Therefore, from the viewpoint of yield, it is important to perform dealkoxymethylation under conditions that immediately re-acetalize the aldehyde generated by hydrolysis of the dialkoxy acetal. In addition, depending on the conditions, isomerization of the carbon-carbon double bond proceeds, decreasing the geometric selectivity, so it is important to select appropriate reaction conditions.

[0102] The dialkoxy-3-alkene-1-ol compound (2) will be described below. In the above general formula (2), R 4 and R 5 are each independently a monovalent hydrocarbon group having 1 to 15 carbon atoms, or R 4 and R 5 are combined together to form R 4 -R 5 represents a divalent hydrocarbon group having 2 to 10 carbon atoms, and a is as defined in the above general formula (1).

[0103] Specific examples of the dialkoxy-3-alkene-1-ol compound (2) include the following compounds: (3E)-6,6-dimethoxy-3-hexen-1-ol, (3E)-6,6-diethoxy-3-hexen-1-ol, (3E)-6,6-dipropoxy-3-hexen-1-ol, (3E)-6,6-dibutoxy-3-hexen-1-ol, (3E)-6,6-dipentyloxy-3-hexen-1-ol, (3E)-6,6-dihexyloxy-3-hexen-1-ol (3E)-6,6-dialkoxy-3-hexen-1-ol compounds such as (3E)-6,6-diheptyloxy-3-hexen-1-ol, (3E)-6,6-dioctyloxy-3-hexen-1-ol, (3E)-6,6-dinonyloxy-3-hexen-1-ol and (3E)-6,6-didecyloxy-3-hexen-1-ol; (3E)-7,7-dimethoxy-3-hepten-1-ol, (3E)-7,7-diethoxy-3-hepten-1-ol, (3E)-7,7-dipropoxy-3-hepten-1-ol, (3E)-7,7-dibutoxy-3-hepten-1-ol, (3E)-7,7-dipentyloxy-3-hepten-1-ol, (3E)-7,7-dihexyloxy-3-hepten-1-ol (3E)-7,7-dialkoxy-3-hepten-1-ol compounds such as (3E)-7,7-buten-1-ol, (3E)-7,7-diheptyloxy-3-hepten-1-ol, (3E)-7,7-dioctyloxy-3-hepten-1-ol, (3E)-7,7-dinonyloxy-3-hepten-1-ol and (3E)-7,7-didecyloxy-3-hepten-1-ol; (3E)-8,8-dimethoxy-3-octen-1-ol, (3E)-8,8-diethoxy-3-octen-1-ol, (3E)-8,8-dipropoxy-3-octen-1-ol, (3E)-8,8-dibutoxy-3-octen-1-ol, (3E)-8,8-dipentyloxy-3-octen-1-ol, (3E)-8,8-dihex ... (3E)-8,8-dialkoxy-3-octen-1-ol compounds such as (3E)-8,8-octen-1-ol, (3E)-8,8-diheptyloxy-3-octen-1-ol, (3E)-8,8-dioctyloxy-3-octen-1-ol, (3E)-8,8-dinonyloxy-3-octen-1-ol and (3E)-8,8-didecyloxy-3-octen-1-ol; (3E)-9,9-dimethoxy-3-nonen-1-ol, (3E)-9,9-diethoxy-3-nonen-1-ol, (3E)-9,9-dipropoxy-3-nonen-1-ol, (3E)-9,9-dibutoxy-3-nonen-1-ol, (3E)-9,9-dipentyloxy-3-nonen-1-ol, (3E)-9,9-dihexyloxy-3-nonen-1-ol, (3E)-9,9-dialkoxy-3-nonen-1-ol compounds such as (3E)-9,9-diheptyloxy-3-nonen-1-ol, (3E)-9,9-dioctyloxy-3-nonen-1-ol, (3E)-9,9-dinonyloxy-3-nonen-1-ol and (3E)-9,9-didecyloxy-3-nonen-1-ol; (3E)-10,10-dimethoxy-3-decen-1-ol, (3E)-10,10-diethoxy-3-decen-1-ol, (3E)-10,10-dipropoxy-3-decen-1-ol, (3E)-10,10-dibutoxy-3-decen-1-ol, (3E)-10,10-dipentyloxy-3-decen-1-ol, (3E)-10,10-dihexyloxy-3- (3E)-10,10-dialkoxy-3-decen-1-ol compounds such as decen-1-ol, (3E)-10,10-diheptyloxy-3-decen-1-ol, (3E)-10,10-dioctyloxy-3-decen-1-ol, (3E)-10,10-dinonyloxy-3-decen-1-ol and (3E)-10,10-didecyloxy-3-decen-1-ol; (3E)-11,11-dimethoxy-3-undecen-1-ol, (3E)-11,11-diethoxy-3-undecen-1-ol, (3E)-11,11-dipropoxy-3-undecen-1-ol, (3E)-11,11-dibutoxy-3-undecen-1-ol, (3E)-11,11-dipentyloxy-3-undecen-1-ol, (3E)-11,11-dihex ... (3E)-11,11-dialkoxy-3-undecen-1-ol compounds such as (3E)-11,11-diheptyloxy-3-undecen-1-ol, (3E)-11,11-dioctyloxy-3-undecen-1-ol, (3E)-11,11-dinonyloxy-3-undecen-1-ol and (3E)-11,11-didecyloxy-3-undecen-1-ol; (3E)-12,12-dimethoxy-3-dodecen-1-ol, (3E)-12,12-diethoxy-3-dodecen-1-ol, (3E)-12,12-dipropoxy-3-dodecen-1-ol, (3E)-12,12-dibutoxy-3-dodecen-1-ol, (3E)-12,12-dipentyloxy-3-dodecen-1-ol, (3E)-12,12-dihexyloxy-3- (3E)-12,12-dialkoxy-3-dodecen-1-ol compounds such as dodecen-1-ol, (3E)-12,12-diheptyloxy-3-dodecen-1-ol, (3E)-12,12-dioctyloxy-3-dodecen-1-ol, (3E)-12,12-dinonyloxy-3-dodecen-1-ol and (3E)-12,12-didecyloxy-3-dodecen-1-ol; (3E)-13,13-dimethoxy-3-tridecen-1-ol, (3E)-13,13-diethoxy-3-tridecen-1-ol, (3E)-13,13-dipropoxy-3-tridecen-1-ol, (3E)-13,13-dibutoxy-3-tridecen-1-ol, (3E)-13,13-dipentyloxy-3-tridecen-1-ol, (3E)-13,13-dihex ... (3E)-13,13-dialkoxy-3-tridecen-1-ol compounds such as liecen-1-ol, (3E)-13,13-diheptyloxy-3-tridecen-1-ol, (3E)-13,13-dioctyloxy-3-tridecen-1-ol, (3E)-13,13-dinonyloxy-3-tridecen-1-ol and (3E)-13,13-didecyloxy-3-tridecen-1-ol; (3E)-14,14-dimethoxy-3-tetradecen-1-ol, (3E)-14,14-diethoxy-3-tetradecen-1-ol, (3E)-14,14-dipropoxy-3-tetradecen-1-ol, (3E)-14,14-dibutoxy-3-tetradecen-1-ol, (3E)-14,14-dipentyloxy-3-tetradecen-1-ol, (3E)-14,14-dihexyloxy-3-tetradecen-1-ol, (3E)-14,14-dialkoxy-3-tetradecen-1-ol compounds such as toradesen-1-ol, (3E)-14,14-diheptyloxy-3-tetradecen-1-ol, (3E)-14,14-dioctyloxy-3-tetradecen-1-ol, (3E)-14,14-dinonyloxy-3-tetradecen-1-ol and (3E)-14,14-didecyloxy-3-tetradecen-1-ol; (3E)-15,15-dimethoxy-3-pentadecen-1-ol, (3E)-15,15-diethoxy-3-pentadecen-1-ol, (3E)-15,15-dipropoxy-3-pentadecen-1-ol, (3E)-15,15-dibutoxy-3-pentadecen-1-ol, (3E)-15,15-dipentyloxy-3-pentadecen-1-ol, (3E)-15,15-dihex ... (3E)-15,15-dialkoxy-3-pentadecen-1-ol compounds such as (3E)-15,15-diheptyloxy-3-pentadecen-1-ol, (3E)-15,15-dioctyloxy-3-pentadecen-1-ol, (3E)-15,15-dinonyloxy-3-pentadecen-1-ol and (3E)-15,15-didecyloxy-3-pentadecen-1-ol; (3E)-16,16-dimethoxy-3-hexadecen-1-ol, (3E)-16,16-diethoxy-3-hexadecen-1-ol, (3E)-16,16-dipropoxy-3-hexadecen-1-ol, (3E)-16,16-dibutoxy-3-hexadecen-1-ol, (3E)-16,16-dipentyloxy-3-hexadecen-1-ol, (3E)-16,16-dihexyloxy-3-hexadecen-1-ol (3E)-16,16-dialkoxy-3-hexadecen-1-ol compounds such as (3E)-16,16-diheptyloxy-3-hexadecen-1-ol, (3E)-16,16-dioctyloxy-3-hexadecen-1-ol, (3E)-16,16-dinonyloxy-3-hexadecen-1-ol and (3E)-16,16-didecyloxy-3-hexadecen-1-ol; (3E)-17,17-dimethoxy-3-heptadecen-1-ol, (3E)-17,17-diethoxy-3-heptadecen-1-ol, (3E)-17,17-dipropoxy-3-heptadecen-1-ol, (3E)-17,17-dibutoxy-3-heptadecen-1-ol, (3E)-17,17-dipentyloxy-3-heptadecen-1-ol, (3E)-17,17-dihexyloxy-3-heptadecen-1-ol, (3E)-17,17-dialkoxy-3-heptadecen-1-ol compounds such as putadecen-1-ol, (3E)-17,17-diheptyloxy-3-heptadecen-1-ol, (3E)-17,17-dioctyloxy-3-heptadecen-1-ol, (3E)-17,17-dinonyloxy-3-heptadecen-1-ol and (3E)-17,17-didecyloxy-3-heptadecen-1-ol; (3E)-18,18-dimethoxy-3-octadecen-1-ol, (3E)-18,18-diethoxy-3-octadecen-1-ol, (3E)-18,18-dipropoxy-3-octadecen-1-ol, (3E)-18,18-dibutoxy-3-octadecen-1-ol, (3E)-18,18-dipentyloxy-3-octadecen-1-ol, (3E)-18,18-dihex ... (3E)-18,18-dialkoxy-3-octadecen-1-ol compounds such as octadecen-1-ol, (3E)-18,18-diheptyloxy-3-octadecen-1-ol, (3E)-18,18-dioctyloxy-3-octadecen-1-ol, (3E)-18,18-dinonyloxy-3-octadecen-1-ol and (3E)-18,18-didecyloxy-3-octadecen-1-ol; (3Z)-6,6-dimethoxy-3-hexen-1-ol, (3Z)-6,6-diethoxy-3-hexen-1-ol, (3Z)-6,6-dipropoxy-3-hexen-1-ol, (3Z)-6,6-dibutoxy-3-hexen-1-ol, (3Z)-6,6-dipentyloxy-3-hexen-1-ol, (3Z)-6,6-dihexyloxy-3-hexen-1-ol, (3Z)-6,6-dialkoxy-3-hexen-1-ol compounds such as (3Z)-6,6-diheptyloxy-3-hexen-1-ol, (3Z)-6,6-dioctyloxy-3-hexen-1-ol, (3Z)-6,6-dinonyloxy-3-hexen-1-ol and (3Z)-6,6-didecyloxy-3-hexen-1-ol; (3Z)-7,7-dimethoxy-3-hepten-1-ol, (3Z)-7,7-diethoxy-3-hepten-1-ol, (3Z)-7,7-dipropoxy-3-hepten-1-ol, (3Z)-7,7-dibutoxy-3-hepten-1-ol, (3Z)-7,7-dipentyloxy-3-hepten-1-ol, (3Z)-7,7-dihexyloxy-3-hepten-1-ol (3Z)-7,7-dialkoxy-3-hepten-1-ol compounds such as (3Z)-7,7-buten-1-ol, (3Z)-7,7-diheptyloxy-3-hepten-1-ol, (3Z)-7,7-dioctyloxy-3-hepten-1-ol, (3Z)-7,7-dinonyloxy-3-hepten-1-ol and (3Z)-7,7-didecyloxy-3-hepten-1-ol; (3Z)-8,8-dimethoxy-3-octen-1-ol, (3Z)-8,8-diethoxy-3-octen-1-ol, (3Z)-8,8-dipropoxy-3-octen-1-ol, (3Z)-8,8-dibutoxy-3-octen-1-ol, (3Z)-8,8-dipentyloxy-3-octen-1-ol, (3Z)-8,8-dihex ... (3Z)-8,8-dialkoxy-3-octen-1-ol compounds such as (3Z)-8,8-octen-1-ol, (3Z)-8,8-diheptyloxy-3-octen-1-ol, (3Z)-8,8-dioctyloxy-3-octen-1-ol, (3Z)-8,8-dinonyloxy-3-octen-1-ol and (3Z)-8,8-didecyloxy-3-octen-1-ol; (3Z)-9,9-dimethoxy-3-nonen-1-ol, (3Z)-9,9-diethoxy-3-nonen-1-ol, (3Z)-9,9-dipropoxy-3-nonen-1-ol, (3Z)-9,9-dibutoxy-3-nonen-1-ol, (3Z)-9,9-dipentyloxy-3-nonen-1-ol, (3Z)-9,9-dihexyloxy-3-nonen-1-ol, (3Z)-9,9-dialkoxy-3-nonen-1-ol compounds such as (3Z)-9,9-diheptyloxy-3-nonen-1-ol, (3Z)-9,9-dioctyloxy-3-nonen-1-ol, (3Z)-9,9-dinonyloxy-3-nonen-1-ol and (3Z)-9,9-didecyloxy-3-nonen-1-ol; (3Z)-10,10-dimethoxy-3-decen-1-ol, (3Z)-10,10-diethoxy-3-decen-1-ol, (3Z)-10,10-dipropoxy-3-decen-1-ol, (3Z)-10,10-dibutoxy-3-decen-1-ol, (3Z)-10,10-dipentyloxy-3-decen-1-ol, (3Z)-10,10-dihexyloxy-3- (3Z)-10,10-dialkoxy-3-decen-1-ol compounds such as decene-1-ol, (3Z)-10,10-diheptyloxy-3-decen-1-ol, (3Z)-10,10-dioctyloxy-3-decen-1-ol, (3Z)-10,10-dinonyloxy-3-decen-1-ol and (3Z)-10,10-didecyloxy-3-decen-1-ol; (3Z)-11,11-dimethoxy-3-undecen-1-ol, (3Z)-11,11-diethoxy-3-undecen-1-ol, (3Z)-11,11-dipropoxy-3-undecen-1-ol, (3Z)-11,11-dibutoxy-3-undecen-1-ol, (3Z)-11,11-dipentyloxy-3-undecen-1-ol, (3Z)-11,11-dihex ... (3Z)-11,11-dialkoxy-3-undecen-1-ol compounds such as (3Z)-11,11-diheptyloxy-3-undecen-1-ol, (3Z)-11,11-dioctyloxy-3-undecen-1-ol, (3Z)-11,11-dinonyloxy-3-undecen-1-ol and (3Z)-11,11-didecyloxy-3-undecen-1-ol; (3Z)-12,12-dimethoxy-3-dodecen-1-ol, (3Z)-12,12-diethoxy-3-dodecen-1-ol, (3Z)-12,12-dipropoxy-3-dodecen-1-ol, (3Z)-12,12-dibutoxy-3-dodecen-1-ol, (3Z)-12,12-dipentyloxy-3-dodecen-1-ol, (3Z)-12,12-dihexyloxy-3- (3Z)-12,12-dialkoxy-3-dodecen-1-ol compounds such as dodecen-1-ol, (3Z)-12,12-diheptyloxy-3-dodecen-1-ol, (3Z)-12,12-dioctyloxy-3-dodecen-1-ol, (3Z)-12,12-dinonyloxy-3-dodecen-1-ol and (3Z)-12,12-didecyloxy-3-dodecen-1-ol; (3Z)-13,13-dimethoxy-3-tridecen-1-ol, (3Z)-13,13-diethoxy-3-tridecen-1-ol, (3Z)-13,13-dipropoxy-3-tridecen-1-ol, (3Z)-13,13-dibutoxy-3-tridecen-1-ol, (3Z)-13,13-dipentyloxy-3-tridecen-1-ol, (3Z)-13,13-dihex ... (3Z)-13,13-dialkoxy-3-tridecen-1-ol compounds such as liedecen-1-ol, (3Z)-13,13-diheptyloxy-3-tridecen-1-ol, (3Z)-13,13-dioctyloxy-3-tridecen-1-ol, (3Z)-13,13-dinonyloxy-3-tridecen-1-ol and (3Z)-13,13-didecyloxy-3-tridecen-1-ol; (3Z)-14,14-dimethoxy-3-tetradecen-1-ol, (3Z)-14,14-diethoxy-3-tetradecen-1-ol, (3Z)-14,14-dipropoxy-3-tetradecen-1-ol, (3Z)-14,14-dibutoxy-3-tetradecen-1-ol, (3Z)-14,14-dipentyloxy-3-tetradecen-1-ol, (3Z)-14,14-dihexyloxy-3-tetradecen-1-ol, (3Z)-14,14-dialkoxy-3-tetradecen-1-ol compounds such as toradesen-1-ol, (3Z)-14,14-diheptyloxy-3-tetradecen-1-ol, (3Z)-14,14-dioctyloxy-3-tetradecen-1-ol, (3Z)-14,14-dinonyloxy-3-tetradecen-1-ol and (3Z)-14,14-didecyloxy-3-tetradecen-1-ol; (3Z)-15,15-dimethoxy-3-pentadecen-1-ol, (3Z)-15,15-diethoxy-3-pentadecen-1-ol, (3Z)-15,15-dipropoxy-3-pentadecen-1-ol, (3Z)-15,15-dibutoxy-3-pentadecen-1-ol, (3Z)-15,15-dipentyloxy-3-pentadecen-1-ol, (3Z)-15,15-dihexyloxy-3-pentadecen-1-ol, (3Z)-15,15-dialkoxy-3-pentadecen-1-ol compounds such as (3Z)-15,15-diheptyloxy-3-pentadecen-1-ol, (3Z)-15,15-dioctyloxy-3-pentadecen-1-ol, (3Z)-15,15-dinonyloxy-3-pentadecen-1-ol and (3Z)-15,15-didecyloxy-3-pentadecen-1-ol; (3Z)-16,16-dimethoxy-3-hexadecen-1-ol, (3Z)-16,16-diethoxy-3-hexadecen-1-ol, (3Z)-16,16-dipropoxy-3-hexadecen-1-ol, (3Z)-16,16-dibutoxy-3-hexadecen-1-ol, (3Z)-16,16-dipentyloxy-3-hexadecen-1-ol, (3Z)-16,16-dihexyloxy-3-hexadecen-1-ol (3Z)-16,16-dialkoxy-3-hexadecen-1-ol compounds such as (3Z)-16,16-diheptyloxy-3-hexadecen-1-ol, (3Z)-16,16-dioctyloxy-3-hexadecen-1-ol, (3Z)-16,16-dinonyloxy-3-hexadecen-1-ol and (3Z)-16,16-didecyloxy-3-hexadecen-1-ol; (3Z)-17,17-dimethoxy-3-heptadecen-1-ol, (3Z)-17,17-diethoxy-3-heptadecen-1-ol, (3Z)-17,17-dipropoxy-3-heptadecen-1-ol, (3Z)-17,17-dibutoxy-3-heptadecen-1-ol, (3Z)-17,17-dipentyloxy-3-heptadecen-1-ol, (3Z)-17,17-dihexyloxy-3-heptadecen-1-ol (3Z)-17,17-dialkoxy-3-heptadecen-1-ol compounds such as decen-1-ol, (3Z)-17,17-diheptyloxy-3-heptadecen-1-ol, (3Z)-17,17-dioctyloxy-3-heptadecen-1-ol, (3Z)-17,17-dinonyloxy-3-heptadecen-1-ol and (3Z)-17,17-didecyloxy-3-heptadecen-1-ol; and (3Z)-18,18-dimethoxy-3-octadecen-1-ol, (3Z)-18,18-diethoxy-3-octadecen-1-ol, (3Z)-18,18-dipropoxy-3-octadecen-1-ol, (3Z)-18,18-dibutoxy-3-octadecen-1-ol, (3Z)-18,18-dipentyloxy-3-octadecen-1-ol, (3Z)-18,18-dihex ... (3Z)-18,18-dialkoxy-3-octadecen-1-ol compounds such as octadecen-1-ol, (3Z)-18,18-diheptyloxy-3-octadecen-1-ol, (3Z)-18,18-dioctyloxy-3-octadecen-1-ol, (3Z)-18,18-dinonyloxy-3-octadecen-1-ol and (3Z)-18,18-didecyloxy-3-octadecen-1-ol.

[0104] <Production of 1-halodialkoxy-3-alkene compound (3) by halogenation reaction> The 1-halodialkoxy-3-alkene compound (3) can be produced by halogenating the above-mentioned dialkoxy-3-alkene-1-ol compound (2), as shown in the following chemical reaction formula.

[0105] [ka]

[0106] In the above halogenation reaction, the dialkoxy-3-alkene-1-ol compound (2) may be used alone or in combination, if necessary. For example, by using a mixture of a (3E)-12,12-dialkoxy-3-dodecen-1-ol compound (2: a = 7) and a (3Z)-12,12-dialkoxy-3-dodecen-1-ol compound (2: a = 7), a mixture of a (3E)-1-halo-12,12-dialkoxy-3-dodecene compound (3: a = 7) and a (3Z)-1-halo-12,12-dialkoxy-3-dodecene compound (3: a = 7) can be obtained.

[0107] The halogenation reaction can be carried out, for example, by a method in which the hydroxyl group is tosylated using a p-toluenesulfonyl halide compound and then halogenated using a lithium halide compound, or by a method in which the hydroxyl group is directly halogenated using a halogenating agent. Examples of the halogenating agent include halogens such as chlorine, bromine, and iodine; hydrogen halide compounds such as hydrogen chloride, hydrogen bromide, and hydrogen iodide; methanesulfonyl halide compounds such as methanesulfonyl chloride, methanesulfonyl bromide, and methanesulfonyl iodide; benzenesulfonyl halide compounds such as benzenesulfonyl chloride, benzenesulfonyl bromide, and benzenesulfonyl iodide; p-toluenesulfonyl halide compounds such as p-toluenesulfonyl chloride, p-toluenesulfonyl bromide, and p-toluenesulfonyl iodide; phosphorus halide compounds such as phosphorus trichloride, phosphorus pentachloride, and phosphorus tribromide; carbon tetrahalide compounds such as carbon tetrachloride, carbon tetrabromide, and carbon tetraiodide; tetramethylsilyl chloride, tetramethylsilyl bromide, tetramethylsilyl iodide, triethylsilyl chloride, and the like. Examples of the alkylsilyl halide compounds include alkylsilyl halide compounds such as oxalyl chloride, oxalyl bromide, triethylsilyl iodide, triisopropylsilyl chloride, triisopropylsilyl bromide, triisopropylsilyl iodide, tert-butyldimethylsilyl chloride, tert-butyldimethylsilyl bromide, and tert-butyldimethylsilyl iodide; oxalyl halide compounds such as oxalyl chloride, oxalyl bromide, and oxalyl iodide; and N-halosuccinimide compounds such as N-chlorosuccinimide, N-bromosuccinimide, and N-iodosuccinimide. From the viewpoint of suppressing side reactions, however, preferred are methanesulfonyl halide compounds, benzenesulfonyl halide compounds, and p-toluenesulfonyl halide compounds, with methanesulfonyl halide compounds being particularly preferred. The halogenating agent may be used alone or in combination of two or more as required. The acid may be commercially available. The amount of the halogenating agent used is preferably 0.8 to 5.0 mol, more preferably 1.0 to 2.5 mol, per mol of the dialkoxy-3-alkene-1-ol compound (2).

[0108] In the halogenation reaction, a base may be used, if necessary. Examples of the base include hydroxides such as sodium hydroxide, potassium hydroxide, calcium hydroxide, and magnesium hydroxide; carbonates such as sodium carbonate, potassium carbonate, calcium carbonate, and magnesium carbonate; and amines such as triethylamine, N,N-diisopropylethylamine, piperidine, pyrrolidine, pyridine, lutidine, 4-dimethylaminopyridine, N,N-dimethylaniline, N,N-diethylaniline, and 1,8-diazabicyclo[5.4.0]-7-undecene (DBU). When a methanesulfonyl halide compound, a benzenesulfonyl halide compound, a p-toluenesulfonyl halide compound or the like is used as the halogenating agent, it is preferable to use an amine as the base, and it is more preferable to use a pyridine such as pyridine, lutidine or 4-dimethylaminopyridine. The base may be used alone or in combination with two or more kinds, if necessary. In addition, commercially available bases may be used. The amount of the base used is preferably 0 to 8.0 mol, more preferably 0 to 3.0 mol, per mol of the dialkoxy-3-alkene-1-ol compound (2), from the viewpoint of yield and / or economic efficiency.

[0109] In the halogenation reaction, a metal salt may be added, if necessary. Examples of the metal salt include lithium salts such as lithium chloride, lithium bromide, and lithium iodide; sodium salts such as sodium chloride, sodium bromide, and sodium iodide; potassium salts such as potassium chloride, potassium bromide, and potassium iodide; calcium salts such as calcium chloride, calcium bromide, and calcium iodide; and magnesium salts such as magnesium chloride, magnesium bromide, and magnesium iodide. The metal salt may be used alone or in combination with two or more kinds, if necessary. In addition, commercially available metal salts may be used. The amount of the metal salt used is preferably 0 to 30.0 mol, more preferably 0 to 5.0 mol, per mol of the dialkoxy-3-alkene-1-ol compound (2), from the viewpoint of reactivity. By adding the metal salt, the halide concentration in the reaction system can be increased, thereby increasing the reactivity. However, taking into account economic and / or environmental considerations, it is preferable to carry out the reaction without using a metal salt.

[0110] The halogenation reaction may be carried out in the presence of a solvent, if necessary. Examples of the solvent include general solvents, such as ethers such as diethyl ether, dibutyl ether, 4-methyltetrahydropyran, tetrahydrofuran, cyclopentyl methyl ether, and 1,4-dioxane; hydrocarbons such as hexane, heptane, benzene, toluene, xylene, and cumene; chlorine-based solvents such as trichloroethylene, dichloromethane, and chloroform; dimethyl sulfoxide, γ-butyrolactone, N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, and hexamethyl Examples of the solvent include aprotic polar solvents such as phosphoric triamide; nitriles such as acetonitrile and propionitrile; and esters such as methyl acetate, ethyl acetate, n-propyl acetate, and n-butyl acetate. From the viewpoint of reactivity, 4-methyltetrahydropyran, dichloromethane, chloroform, γ-butyrolactone, N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, and acetonitrile are preferred, and from the viewpoint of safety, γ-butyrolactone and acetonitrile are particularly preferred. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used in the halogenation reaction is preferably 0 to 2000 g, more preferably 0 to 600 g, based on 1 mol of the dialkoxy-3-alkene-1-ol compound (2). Since the use of such a solvent reduces the amount of the reaction mixture and decreases the productivity, the reaction may be carried out using a base as a solvent without using the above-mentioned solvent.

[0111] The reaction temperature in the halogenation reaction varies depending on the halogenating agent used, but is preferably 5 to 180° C. from the viewpoint of reactivity. The reaction time in the halogenation reaction varies depending on the halogenating agent used and / or the reaction scale, but is preferably 1 to 100 hours from the viewpoint of reactivity.

[0112] The 1-halodialkoxy-3-alkene compound (3) will be described below. In the above general formula (3), X represents a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom; R 4 and R 5 is as defined in general formula (2) above, and a is as defined in general formula (1) above.

[0113] Specific examples of the 1-halodialkoxy-3-alkene compound (3) include the following compounds: (3E)-1-halo-6,6-dimethoxy-3-hexene compounds such as (3E)-1-chloro-6,6-dimethoxy-3-hexene, (3E)-1-bromo-6,6-dimethoxy-3-hexene and (3E)-1-iodo-6,6-dimethoxy-3-hexene; (3E)-1-halo-6,6-diethoxy-3-hexene compounds such as (3E)-1-chloro-6,6-diethoxy-3-hexene, (3E)-1-bromo-6,6-diethoxy-3-hexene and (3E)-1-iodo-6,6-diethoxy-3-hexene; (3E)-1-halo-7,7-dimethoxy-3-heptene compounds such as (3E)-1-chloro-7,7-dimethoxy-3-heptene, (3E)-1-bromo-7,7-dimethoxy-3-heptene and (3E)-1-iodo-7,7-dimethoxy-3-heptene; (3E)-1-halo-7,7-diethoxy-3-heptene compounds such as (3E)-1-chloro-7,7-diethoxy-3-heptene, (3E)-1-bromo-7,7-diethoxy-3-heptene and (3E)-1-iodo-7,7-diethoxy-3-heptene; (3E)-1-halo-8,8-dimethoxy-3-octene compounds such as (3E)-1-chloro-8,8-dimethoxy-3-octene, (3E)-1-bromo-8,8-dimethoxy-3-octene and (3E)-1-iodo-8,8-dimethoxy-3-octene; (3E)-1-halo-8,8-diethoxy-3-octene compounds such as (3E)-1-chloro-8,8-diethoxy-3-octene, (3E)-1-bromo-8,8-diethoxy-3-octene and (3E)-1-iodo-8,8-diethoxy-3-octene; (3E)-1-halo-9,9-dimethoxy-3-nonene compounds such as (3E)-1-chloro-9,9-dimethoxy-3-nonene, (3E)-1-bromo-9,9-dimethoxy-3-nonene and (3E)-1-iodo-9,9-dimethoxy-3-nonene; (3E)-1-halo-9,9-diethoxy-3-nonene compounds such as (3E)-1-chloro-9,9-diethoxy-3-nonene, (3E)-1-bromo-9,9-diethoxy-3-nonene and (3E)-1-iodo-9,9-diethoxy-3-nonene; (3E)-1-halo-10,10-dimethoxy-3-decene compounds such as (3E)-1-chloro-10,10-dimethoxy-3-decene, (3E)-1-bromo-10,10-dimethoxy-3-decene and (3E)-1-iodo-10,10-dimethoxy-3-decene; (3E)-1-halo-10,10-diethoxy-3-decene compounds such as (3E)-1-chloro-10,10-diethoxy-3-decene, (3E)-1-bromo-10,10-diethoxy-3-decene and (3E)-1-iodo-10,10-diethoxy-3-decene; (3E)-1-halo-11,11-dimethoxy-3-undecene compounds such as (3E)-1-chloro-11,11-dimethoxy-3-undecene, (3E)-1-bromo-11,11-dimethoxy-3-undecene and (3E)-1-iodo-11,11-dimethoxy-3-undecene; (3E)-1-halo-11,11-diethoxy-3-undecene compounds such as (3E)-1-chloro-11,11-diethoxy-3-undecene, (3E)-1-bromo-11,11-diethoxy-3-undecene and (3E)-1-iodo-11,11-diethoxy-3-undecene; (3E)-1-halo-12,12-dimethoxy-3-dodecene compounds such as (3E)-1-chloro-12,12-dimethoxy-3-dodecene, (3E)-1-bromo-12,12-dimethoxy-3-dodecene and (3E)-1-iodo-12,12-dimethoxy-3-dodecene; (3E)-1-halo-12,12-diethoxy-3-dodecene compounds such as (3E)-1-chloro-12,12-diethoxy-3-dodecene, (3E)-1-bromo-12,12-diethoxy-3-dodecene, and (3E)-1-iodo-12,12-diethoxy-3-dodecene; (3E)-1-halo-12,12-dipropoxy-3-dodecene compounds such as (3E)-1-chloro-12,12-dipropoxy-3-dodecene, (3E)-1-bromo-12,12-dipropoxy-3-dodecene and (3E)-1-iodo-12,12-dipropoxy-3-dodecene; (3E)-1-halo-12,12-dibutoxy-3-dodecene compounds such as (3E)-1-chloro-12,12-dibutoxy-3-dodecene, (3E)-1-bromo-12,12-dibutoxy-3-dodecene, and (3E)-1-iodo-12,12-dibutoxy-3-dodecene; (3E)-1-halo-12,12-dipentoxy-3-dodecene compounds such as (3E)-1-chloro-12,12-dipentoxy-3-dodecene, (3E)-1-bromo-12,12-dipentoxy-3-dodecene, and (3E)-1-iodo-12,12-dipentoxy-3-dodecene; (3E)-1-halo-12,12-dihexyloxy-3-dodecene compounds such as (3E)-1-chloro-12,12-dihexyloxy-3-dodecene, (3E)-1-bromo-12,12-dihexyloxy-3-dodecene, and (3E)-1-iodo-12,12-dihexyloxy-3-dodecene; (3E)-1-halo-12,12-diheptyloxy-3-dodecene compounds such as (3E)-1-chloro-12,12-diheptyloxy-3-dodecene, (3E)-1-bromo-12,12-diheptyloxy-3-dodecene, and (3E)-1-iodo-12,12-diheptyloxy-3-dodecene; (3E)-1-halo-12,12-dioctyloxy-3-dodecene compounds such as (3E)-1-chloro-12,12-dioctyloxy-3-dodecene, (3E)-1-bromo-12,12-dioctyloxy-3-dodecene and (3E)-1-iodo-12,12-dioctyloxy-3-dodecene; (3E)-1-halo-12,12-dinonyloxy-3-dodecene compounds such as (3E)-1-chloro-12,12-dinonyloxy-3-dodecene, (3E)-1-bromo-12,12-dinonyloxy-3-dodecene, and (3E)-1-iodo-12,12-dinonyloxy-3-dodecene; (3E)-1-halo-12,12-didecyloxy-3-dodecene compounds such as (3E)-1-chloro-12,12-didecyloxy-3-dodecene, (3E)-1-bromo-12,12-didecyloxy-3-dodecene, and (3E)-1-iodo-12,12-didecyloxy-3-dodecene; (3E)-1-halo-13,13-dimethoxy-3-tridecene compounds such as (3E)-1-chloro-13,13-dimethoxy-3-tridecene, (3E)-1-bromo-13,13-dimethoxy-3-tridecene and (3E)-1-iodo-13,13-dimethoxy-3-tridecene; (3E)-1-halo-13,13-diethoxy-3-tridecene compounds such as (3E)-1-chloro-13,13-diethoxy-3-tridecene, (3E)-1-bromo-13,13-diethoxy-3-tridecene, and (3E)-1-iodo-13,13-diethoxy-3-tridecene; (3E)-1-halo-14,14-dimethoxy-3-tetradecene compounds such as (3E)-1-chloro-14,14-dimethoxy-3-tetradecene, (3E)-1-bromo-14,14-dimethoxy-3-tetradecene and (3E)-1-iodo-14,14-dimethoxy-3-tetradecene; (3E)-1-halo-14,14-diethoxy-3-tetradecene compounds such as (3E)-1-chloro-14,14-diethoxy-3-tetradecene, (3E)-1-bromo-14,14-diethoxy-3-tetradecene, and (3E)-1-iodo-14,14-diethoxy-3-tetradecene; (3E)-1-halo-14,14-dipropoxy-3-tetradecene compounds such as (3E)-1-chloro-14,14-dipropoxy-3-tetradecene, (3E)-1-bromo-14,14-dipropoxy-3-tetradecene, and (3E)-1-iodo-14,14-dipropoxy-3-tetradecene; (3E)-1-halo-14,14-dibutoxy-3-tetradecene compounds such as (3E)-1-chloro-14,14-dibutoxy-3-tetradecene, (3E)-1-bromo-14,14-dibutoxy-3-tetradecene, and (3E)-1-iodo-14,14-dibutoxy-3-tetradecene; (3E)-1-halo-14,14-dipentoxy-3-tetradecene compounds such as (3E)-1-chloro-14,14-dipentoxy-3-tetradecene, (3E)-1-bromo-14,14-dipentoxy-3-tetradecene, and (3E)-1-iodo-14,14-dipentoxy-3-tetradecene; (3E)-1-halo-14,14-dihexyloxy-3-tetradecene compounds such as (3E)-1-chloro-14,14-dihexyloxy-3-tetradecene, (3E)-1-bromo-14,14-dihexyloxy-3-tetradecene, and (3E)-1-iodo-14,14-dihexyloxy-3-tetradecene; (3E)-1-halo-14,14-diheptyloxy-3-tetradecene compounds such as (3E)-1-chloro-14,14-diheptyloxy-3-tetradecene, (3E)-1-bromo-14,14-diheptyloxy-3-tetradecene, and (3E)-1-iodo-14,14-diheptyloxy-3-tetradecene; (3E)-1-halo-14,14-dioctyloxy-3-tetradecene compounds such as (3E)-1-chloro-14,14-dioctyloxy-3-tetradecene, (3E)-1-bromo-14,14-dioctyloxy-3-tetradecene and (3E)-1-iodo-14,14-dioctyloxy-3-tetradecene; (3E)-1-halo-14,14-dinonyloxy-3-tetradecene compounds such as (3E)-1-chloro-14,14-dinonyloxy-3-tetradecene, (3E)-1-bromo-14,14-dinonyloxy-3-tetradecene, and (3E)-1-iodo-14,14-dinonyloxy-3-tetradecene; (3E)-1-halo-14,14-didecyloxy-3-tetradecene compounds such as (3E)-1-chloro-14,14-didecyloxy-3-tetradecene, (3E)-1-bromo-14,14-didecyloxy-3-tetradecene, and (3E)-1-iodo-14,14-didecyloxy-3-tetradecene; (3E)-1-halo-15,15-dimethoxy-3-pentadecene compounds such as (3E)-1-chloro-15,15-dimethoxy-3-pentadecene, (3E)-1-bromo-15,15-dimethoxy-3-pentadecene, and (3E)-1-iodo-15,15-dimethoxy-3-pentadecene; (3E)-1-halo-15,15-diethoxy-3-pentadecene compounds such as (3E)-1-chloro-15,15-diethoxy-3-pentadecene, (3E)-1-bromo-15,15-diethoxy-3-pentadecene, and (3E)-1-iodo-15,15-diethoxy-3-pentadecene; (3E)-1-halo-16,16-dimethoxy-3-hexadecene compounds such as (3E)-1-chloro-16,16-dimethoxy-3-hexadecene, (3E)-1-bromo-16,16-dimethoxy-3-hexadecene and (3E)-1-iodo-16,16-dimethoxy-3-hexadecene; (3E)-1-halo-16,16-diethoxy-3-hexadecene compounds such as (3E)-1-chloro-16,16-diethoxy-3-hexadecene, (3E)-1-bromo-16,16-diethoxy-3-hexadecene, and (3E)-1-iodo-16,16-diethoxy-3-hexadecene; (3E)-1-halo-17,17-dimethoxy-3-heptadecene compounds such as (3E)-1-chloro-17,17-dimethoxy-3-heptadecene, (3E)-1-bromo-17,17-dimethoxy-3-heptadecene, and (3E)-1-iodo-17,17-dimethoxy-3-heptadecene; (3E)-1-halo-17,17-diethoxy-3-heptadecene compounds such as (3E)-1-chloro-17,17-diethoxy-3-heptadecene, (3E)-1-bromo-17,17-diethoxy-3-heptadecene, and (3E)-1-iodo-17,17-diethoxy-3-heptadecene; (3E)-1-halo-18,18-dimethoxy-3-octadecene compounds such as (3E)-1-chloro-18,18-dimethoxy-3-octadecene, (3E)-1-bromo-18,18-dimethoxy-3-octadecene and (3E)-1-iodo-18,18-dimethoxy-3-octadecene; (3E)-1-halo-18,18-diethoxy-3-octadecene compounds such as (3E)-1-chloro-18,18-diethoxy-3-octadecene, (3E)-1-bromo-18,18-diethoxy-3-octadecene and (3E)-1-iodo-18,18-diethoxy-3-octadecene; (3Z)-1-halo-6,6-dimethoxy-3-hexene compounds such as (3Z)-1-chloro-6,6-dimethoxy-3-hexene, (3Z)-1-bromo-6,6-dimethoxy-3-hexene and (3Z)-1-iodo-6,6-dimethoxy-3-hexene; (3Z)-1-halo-6,6-diethoxy-3-hexene compounds such as (3Z)-1-chloro-6,6-diethoxy-3-hexene, (3Z)-1-bromo-6,6-diethoxy-3-hexene and (3Z)-1-iodo-6,6-diethoxy-3-hexene; (3Z)-1-halo-7,7-dimethoxy-3-heptene compounds such as (3Z)-1-chloro-7,7-dimethoxy-3-heptene, (3Z)-1-bromo-7,7-dimethoxy-3-heptene and (3Z)-1-iodo-7,7-dimethoxy-3-heptene; (3Z)-1-halo-7,7-diethoxy-3-heptene compounds such as (3Z)-1-chloro-7,7-diethoxy-3-heptene, (3Z)-1-bromo-7,7-diethoxy-3-heptene and (3Z)-1-iodo-7,7-diethoxy-3-heptene; (3Z)-1-halo-8,8-dimethoxy-3-octene compounds such as (3Z)-1-chloro-8,8-dimethoxy-3-octene, (3Z)-1-bromo-8,8-dimethoxy-3-octene and (3Z)-1-iodo-8,8-dimethoxy-3-octene; (3Z)-1-halo-8,8-diethoxy-3-octene compounds such as (3Z)-1-chloro-8,8-diethoxy-3-octene, (3Z)-1-bromo-8,8-diethoxy-3-octene and (3Z)-1-iodo-8,8-diethoxy-3-octene; (3Z)-1-halo-9,9-dimethoxy-3-nonene compounds such as (3Z)-1-chloro-9,9-dimethoxy-3-nonene, (3Z)-1-bromo-9,9-dimethoxy-3-nonene and (3Z)-1-iodo-9,9-dimethoxy-3-nonene; (3Z)-1-halo-9,9-diethoxy-3-nonene compounds such as (3Z)-1-chloro-9,9-diethoxy-3-nonene, (3Z)-1-bromo-9,9-diethoxy-3-nonene and (3Z)-1-iodo-9,9-diethoxy-3-nonene; (3Z)-1-halo-10,10-dimethoxy-3-decene compounds such as (3Z)-1-chloro-10,10-dimethoxy-3-decene, (3Z)-1-bromo-10,10-dimethoxy-3-decene and (3Z)-1-iodo-10,10-dimethoxy-3-decene; (3Z)-1-halo-10,10-diethoxy-3-decene compounds such as (3Z)-1-chloro-10,10-diethoxy-3-decene, (3Z)-1-bromo-10,10-diethoxy-3-decene and (3Z)-1-iodo-10,10-diethoxy-3-decene; (3Z)-1-halo-11,11-dimethoxy-3-undecene compounds such as (3Z)-1-chloro-11,11-dimethoxy-3-undecene, (3Z)-1-bromo-11,11-dimethoxy-3-undecene and (3Z)-1-iodo-11,11-dimethoxy-3-undecene; (3Z)-1-halo-11,11-diethoxy-3-undecene compounds such as (3Z)-1-chloro-11,11-diethoxy-3-undecene, (3Z)-1-bromo-11,11-diethoxy-3-undecene and (3Z)-1-iodo-11,11-diethoxy-3-undecene; (3Z)-1-halo-12,12-dimethoxy-3-dodecene compounds such as (3Z)-1-chloro-12,12-dimethoxy-3-dodecene, (3Z)-1-bromo-12,12-dimethoxy-3-dodecene and (3Z)-1-iodo-12,12-dimethoxy-3-dodecene; (3Z)-1-halo-12,12-diethoxy-3-dodecene compounds such as (3Z)-1-chloro-12,12-diethoxy-3-dodecene, (3Z)-1-bromo-12,12-diethoxy-3-dodecene and (3Z)-1-iodo-12,12-diethoxy-3-dodecene; (3Z)-1-halo-12,12-dipropoxy-3-dodecene compounds such as (3Z)-1-chloro-12,12-dipropoxy-3-dodecene, (3Z)-1-bromo-12,12-dipropoxy-3-dodecene and (3Z)-1-iodo-12,12-dipropoxy-3-dodecene; (3Z)-1-halo-12,12-dibutoxy-3-dodecene compounds such as (3Z)-1-chloro-12,12-dibutoxy-3-dodecene, (3Z)-1-bromo-12,12-dibutoxy-3-dodecene, and (3Z)-1-iodo-12,12-dibutoxy-3-dodecene; (3Z)-1-halo-12,12-dipentoxy-3-dodecene compounds such as (3Z)-1-chloro-12,12-dipentoxy-3-dodecene, (3Z)-1-bromo-12,12-dipentoxy-3-dodecene, and (3Z)-1-iodo-12,12-dipentoxy-3-dodecene; (3Z)-1-halo-12,12-dihexyloxy-3-dodecene compounds such as (3Z)-1-chloro-12,12-dihexyloxy-3-dodecene, (3Z)-1-bromo-12,12-dihexyloxy-3-dodecene, and (3Z)-1-iodo-12,12-dihexyloxy-3-dodecene; (3Z)-1-halo-12,12-diheptyloxy-3-dodecene compounds such as (3Z)-1-chloro-12,12-diheptyloxy-3-dodecene, (3Z)-1-bromo-12,12-diheptyloxy-3-dodecene, and (3Z)-1-iodo-12,12-diheptyloxy-3-dodecene; (3Z)-1-halo-12,12-dioctyloxy-3-dodecene compounds such as (3Z)-1-chloro-12,12-dioctyloxy-3-dodecene, (3Z)-1-bromo-12,12-dioctyloxy-3-dodecene and (3Z)-1-iodo-12,12-dioctyloxy-3-dodecene; (3Z)-1-halo-12,12-dinonyloxy-3-dodecene compounds such as (3Z)-1-chloro-12,12-dinonyloxy-3-dodecene, (3Z)-1-bromo-12,12-dinonyloxy-3-dodecene, and (3Z)-1-iodo-12,12-dinonyloxy-3-dodecene; (3Z)-1-halo-12,12-didecyloxy-3-dodecene compounds such as (3Z)-1-chloro-12,12-didecyloxy-3-dodecene, (3Z)-1-bromo-12,12-didecyloxy-3-dodecene, and (3Z)-1-iodo-12,12-didecyloxy-3-dodecene; (3Z)-1-halo-13,13-dimethoxy-3-tridecene compounds such as (3Z)-1-chloro-13,13-dimethoxy-3-tridecene, (3Z)-1-bromo-13,13-dimethoxy-3-tridecene and (3Z)-1-iodo-13,13-dimethoxy-3-tridecene; (3Z)-1-halo-13,13-diethoxy-3-tridecene compounds such as (3Z)-1-chloro-13,13-diethoxy-3-tridecene, (3Z)-1-bromo-13,13-diethoxy-3-tridecene and (3Z)-1-iodo-13,13-diethoxy-3-tridecene; (3Z)-1-halo-14,14-dimethoxy-3-tetradecene compounds such as (3Z)-1-chloro-14,14-dimethoxy-3-tetradecene, (3Z)-1-bromo-14,14-dimethoxy-3-tetradecene and (3Z)-1-iodo-14,14-dimethoxy-3-tetradecene; (3Z)-1-halo-14,14-diethoxy-3-tetradecene compounds such as (3Z)-1-chloro-14,14-diethoxy-3-tetradecene, (3Z)-1-bromo-14,14-diethoxy-3-tetradecene and (3Z)-1-iodo-14,14-diethoxy-3-tetradecene; (3Z)-1-halo-14,14-dipropoxy-3-tetradecene compounds such as (3Z)-1-chloro-14,14-dipropoxy-3-tetradecene, (3Z)-1-bromo-14,14-dipropoxy-3-tetradecene and (3Z)-1-iodo-14,14-dipropoxy-3-tetradecene; (3Z)-1-halo-14,14-dibutoxy-3-tetradecene compounds such as (3Z)-1-chloro-14,14-dibutoxy-3-tetradecene, (3Z)-1-bromo-14,14-dibutoxy-3-tetradecene and (3Z)-1-iodo-14,14-dibutoxy-3-tetradecene; (3Z)-1-halo-14,14-dipentoxy-3-tetradecene compounds such as (3Z)-1-chloro-14,14-dipentoxy-3-tetradecene, (3Z)-1-bromo-14,14-dipentoxy-3-tetradecene and (3Z)-1-iodo-14,14-dipentoxy-3-tetradecene; (3Z)-1-halo-14,14-dihexyloxy-3-tetradecene compounds such as (3Z)-1-chloro-14,14-dihexyloxy-3-tetradecene, (3Z)-1-bromo-14,14-dihexyloxy-3-tetradecene, and (3Z)-1-iodo-14,14-dihexyloxy-3-tetradecene; (3Z)-1-halo-14,14-diheptyloxy-3-tetradecene compounds such as (3Z)-1-chloro-14,14-diheptyloxy-3-tetradecene, (3Z)-1-bromo-14,14-diheptyloxy-3-tetradecene, and (3Z)-1-iodo-14,14-diheptyloxy-3-tetradecene; (3Z)-1-halo-14,14-dioctyloxy-3-tetradecene compounds such as (3Z)-1-chloro-14,14-dioctyloxy-3-tetradecene, (3Z)-1-bromo-14,14-dioctyloxy-3-tetradecene and (3Z)-1-iodo-14,14-dioctyloxy-3-tetradecene; (3Z)-1-halo-14,14-dinonyloxy-3-tetradecene compounds such as (3Z)-1-chloro-14,14-dinonyloxy-3-tetradecene, (3Z)-1-bromo-14,14-dinonyloxy-3-tetradecene, and (3Z)-1-iodo-14,14-dinoroxy-3-tetradecene; (3Z)-1-halo-14,14-didecyloxy-3-tetradecene compounds such as (3Z)-1-chloro-14,14-didecyloxy-3-tetradecene, (3Z)-1-bromo-14,14-didecyloxy-3-tetradecene, and (3Z)-1-iodo-14,14-didecyloxy-3-tetradecene; (3Z)-1-halo-15,15-dimethoxy-3-pentadecene compounds such as (3Z)-1-chloro-15,15-dimethoxy-3-pentadecene, (3Z)-1-bromo-15,15-dimethoxy-3-pentadecene, and (3Z)-1-iodo-15,15-dimethoxy-3-pentadecene; (3Z)-1-halo-15,15-diethoxy-3-pentadecene compounds such as (3Z)-1-chloro-15,15-diethoxy-3-pentadecene, (3Z)-1-bromo-15,15-diethoxy-3-pentadecene, and (3Z)-1-iodo-15,15-diethoxy-3-pentadecene; (3Z)-1-halo-16,16-dimethoxy-3-hexadecene compounds such as (3Z)-1-chloro-16,16-dimethoxy-3-hexadecene, (3Z)-1-bromo-16,16-dimethoxy-3-hexadecene and (3Z)-1-iodo-16,16-dimethoxy-3-hexadecene; (3Z)-1-halo-16,16-diethoxy-3-hexadecene compounds such as (3Z)-1-chloro-16,16-diethoxy-3-hexadecene, (3Z)-1-bromo-16,16-diethoxy-3-hexadecene, and (3Z)-1-iodo-16,16-diethoxy-3-hexadecene; (3Z)-1-halo-17,17-dimethoxy-3-heptadecene compounds such as (3Z)-1-chloro-17,17-dimethoxy-3-heptadecene, (3Z)-1-bromo-17,17-dimethoxy-3-heptadecene, and (3Z)-1-iodo-17,17-dimethoxy-3-heptadecene; (3Z)-1-halo-17,17-diethoxy-3-heptadecene compounds such as (3Z)-1-chloro-17,17-diethoxy-3-heptadecene, (3Z)-1-bromo-17,17-diethoxy-3-heptadecene, and (3Z)-1-iodo-17,17-diethoxy-3-heptadecene; (3Z)-1-halo-18,18-dimethoxy-3-octadecene compounds such as (3Z)-1-chloro-18,18-dimethoxy-3-octadecene, (3Z)-1-bromo-18,18-dimethoxy-3-octadecene and (3Z)-1-iodo-18,18-dimethoxy-3-octadecene; and (3Z)-1-halo-18,18-diethoxy-3-octadecene compounds such as (3Z)-1-chloro-18,18-diethoxy-3-octadecene, (3Z)-1-bromo-18,18-diethoxy-3-octadecene, and (3Z)-1-iodo-18,18-diethoxy-3-octadecene.

[0114] <Production of dialkoxy-1,3-alkadiene compound (4) by elimination reaction> As shown in the following chemical reaction formula, the dialkoxy-1,3-alkadiene compound (4) can be produced by eliminating the hydrogen halide HX from the above-mentioned 1-halodialkoxy-3-alkene compound (3) in the presence of a base.

[0115] [ka]

[0116] In the above elimination reaction, the 1-halodialkoxy-3-alkene compound (3) may be used alone or in combination with two or more kinds, if necessary. Examples of the base used in the elimination reaction of the leaving group X include hydroxides such as sodium hydroxide, potassium hydroxide, calcium hydroxide, and magnesium hydroxide; metal alkoxides such as sodium methoxide, sodium ethoxide, sodium t-butoxide, sodium t-amyloxide, lithium methoxide, lithium ethoxide, lithium t-butoxide, lithium t-amyloxide, potassium methoxide, potassium ethoxide, potassium t-butoxide, and potassium t-amyloxide; methyllithium, ethyllithium, n-butyllithium, methylmagnesium chloride, dimsyl sodium, sodium acetylide, and potassium acetylide. metal amides such as sodium amide, lithium amide, lithium diisopropylamide, lithium hexamethyldisilazide, sodium hexamethyldisilazide, potassium hexamethyldisilazide, and lithium dicyclohexylamide; metal hydride reagents such as sodium hydride, potassium hydride, and calcium hydride; and amines such as triethylamine, N,N-diisopropylethylamine, piperidine, pyrrolidine, pyridine, lutidine, 4-dimethylaminopyridine, N,N-dimethylaniline, N,N-diethylaniline, and 1,8-diazabicyclo[5.4.0]-7-undecene (DBU). As the base, from the viewpoint of suppressing the by-production of impurities and obtaining the dialkoxy-1,3-alkadiene compound (4) in good yield, amines such as DBU, and metal alkoxides such as sodium methoxide, sodium ethoxide, and potassium t-butoxide are preferred. The base may be used alone or in combination with two or more kinds, if necessary. In addition, commercially available bases may be used. The amount of the base used is preferably 0.8 to 10.0 mol, more preferably 1.0 to 5.0 mol, per mol of the 1-halodialkoxy-3-alkene compound (3), from the viewpoints of yield and economic efficiency.

[0117] In the above elimination reaction, a solvent may be used, if necessary. Examples of the solvent include general solvents, such as ethers such as diethyl ether, dibutyl ether, 4-methyltetrahydropyran, tetrahydrofuran, cyclopentyl methyl ether, and 1,4-dioxane; hydrocarbons such as hexane, heptane, benzene, toluene, xylene, and cumene; chlorine-based solvents such as trichloroethylene, dichloromethane, and chloroform; aprotic polar solvents such as dimethyl sulfoxide, γ-butyrolactone, N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, and hexamethylphosphoric triamide; and acetonitrile. and propionitrile; and esters such as methyl acetate, ethyl acetate, n-propyl acetate, and n-butyl acetate. From the viewpoint of reactivity, however, preferred are ethers such as 4-methyltetrahydropyran and tetrahydrofuran; aprotic polar solvents such as γ-butyrolactone, N-methylpyrrolidone, N,N-dimethylformamide, and N,N-dimethylacetamide; and nitriles such as acetonitrile, with tetrahydrofuran, γ-butyrolactone, N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, and acetonitrile being more preferred. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used is preferably 0 to 6000 g, more preferably 0 to 2000 g, based on 1 mol of the 1-halodialkoxy-3-alkene compound (3).

[0118] The reaction temperature in the elimination reaction varies depending on the base used, but is preferably −40 to 140° C., more preferably −20 to 100° C., from the viewpoint of reactivity. The reaction time in the elimination reaction varies depending on the base used and / or the reaction scale, but is preferably 1 to 100 hours from the viewpoint of reactivity.

[0119] The dialkoxy-1,3-alkadiene compound (4) will be described below. In the dialkoxy-1,3-alkadiene compound (4), R4 and R 5 is as defined in general formula (2) above, and a is as defined in general formula (1) above. R in dialkoxy-1,3-alkadiene compound (4) 4 and R 5 Specific examples of the monovalent hydrocarbon group and the divalent hydrocarbon group are R in the dialkoxyalkenyl alkoxymethyl ether compound (1), 2 and R 3 is the same as the specific examples when is a monovalent hydrocarbon group and a divalent hydrocarbon group.

[0120] Specific examples of the dialkoxy-1,3-alkadiene compound (4) include the following compounds: (3E)-6,6-dimethoxy-1,3-hexadiene, (3E)-6,6-diethoxy-1,3-hexadiene, (3E)-6,6-dipropoxy-1,3-hexadiene, (3E)-6,6-dibutoxy-1,3-hexadiene, (3E)-6,6-dipentyloxy-1,3-hexadiene, (3E)-6,6-dihexyloxy-1, (3E)-6,6-dialkoxy-1,3-hexadiene compounds such as 3-hexadiene, (3E)-6,6-diheptyloxy-1,3-hexadiene, (3E)-6,6-dioctyloxy-1,3-hexadiene, (3E)-6,6-dinonyloxy-1,3-hexadiene and (3E)-6,6-didecyloxy-1,3-hexadiene; (3E)-7,7-dimethoxy-1,3-heptadiene, (3E)-7,7-diethoxy-1,3-heptadiene, (3E)-7,7-dipropoxy-1,3-heptadiene, (3E)-7,7-dibutoxy-1,3-heptadiene, (3E)-7,7-dipentyloxy-1,3-heptadiene, (3E)-7,7-dihexyloxy-1, (3E)-7,7-dialkoxy-1,3-heptadiene compounds such as 3-heptadiene, (3E)-7,7-diheptyloxy-1,3-heptadiene, (3E)-7,7-dioctyloxy-1,3-heptadiene, (3E)-7,7-dinonyloxy-1,3-heptadiene and (3E)-7,7-didecyloxy-1,3-heptadiene; (3E)-8,8-dialkoxy-1,3-octadiene compounds such as (3E)-8,8-dimethoxy-1,3-octadiene and (3E)-8,8-diethoxy-1,3-octadiene; (3E)-9,9-dialkoxy-1,3-nonadiene compounds such as (3E)-9,9-dimethoxy-1,3-nonadiene and (3E)-9,9-diethoxy-1,3-nonadiene; (3E)-10,10-dialkoxy-1,3-decadiene compounds such as (3E)-10,10-dimethoxy-1,3-decadiene and (3E)-10,10-diethoxy-1,3-decadiene; (3E)-11,11-dialkoxy-1,3-undecadiene compounds such as (3E)-11,11-dimethoxy-1,3-undecadiene and (3E)-11,11-diethoxy-1,3-undecadiene; (3E)-12,12-dimethoxy-1,3-dodecadiene, (3E)-12,12-diethoxy-1,3-dodecadiene, (3E)-12,12-dipropoxy-1,3-dodecadiene, (3E)-12,12-dibutoxy-1,3-dodecadiene, (3E)-12,12-dipentyloxy-1,3-dodecadiene, (3E)-12,12-dihexyloxy-1 (3E)-12,12-dialkoxy-1,3-dodecadiene compounds such as (3E)-12,12-diheptyloxy-1,3-dodecadiene, (3E)-12,12-dioctyloxy-1,3-dodecadiene, (3E)-12,12-dinonyloxy-1,3-dodecadiene and (3E)-12,12-didecyloxy-1,3-dodecadiene; (3E)-13,13-dialkoxy-1,3-tridecadiene compounds such as (3E)-13,13-dimethoxy-1,3-tridecadiene and (3E)-13,13-diethoxy-1,3-tridecadiene; (3E)-14,14-dimethoxy-1,3-tetradecadiene, (3E)-14,14-diethoxy-1,3-tetradecadiene, (3E)-14,14-dipropoxy-1,3-tetradecadiene, (3E)-14,14-dibutoxy-1,3-tetradecadiene, (3E)-14,14-dipentyloxy-1,3-tetradecadiene, (3E)-14,14-dihexyloxy-1, (3E)-14,14-dialkoxy-1,3-tetradecadiene compounds such as 3-tetradecadiene, (3E)-14,14-diheptyloxy-1,3-tetradecadiene, (3E)-14,14-dioctyloxy-1,3-tetradecadiene, (3E)-14,14-dinonyloxy-1,3-tetradecadiene and (3E)-14,14-didecyloxy-1,3-tetradecadiene; (3E)-15,15-dialkoxy-1,3-pentadecadiene compounds such as (3E)-15,15-dimethoxy-1,3-pentadecadiene and (3E)-15,15-diethoxy-1,3-pentadecadiene; (3E)-16,16-dialkoxy-1,3-hexadecadiene compounds such as (3E)-16,16-dimethoxy-1,3-hexadecadiene and (3E)-16,16-diethoxy-1,3-hexadecadiene; (3E)-17,17-dialkoxy-1,3-heptadecadiene compounds such as (3E)-17,17-dimethoxy-1,3-heptadecadiene and (3E)-17,17-diethoxy-1,3-heptadecadiene; (3E)-18,18-dialkoxy-1,3-octadecadiene compounds such as (3E)-18,18-dimethoxy-1,3-octadecadiene and (3E)-18,18-diethoxy-1,3-octadecadiene; (3Z)-6,6-dimethoxy-1,3-hexadiene, (3Z)-6,6-diethoxy-1,3-hexadiene, (3Z)-6,6-dipropoxy-1,3-hexadiene, (3Z)-6,6-dibutoxy-1,3-hexadiene, (3Z)-6,6-dipentyloxy-1,3-hexadiene, (3Z)-6,6-dihexyloxy-1, (3Z)-6,6-dialkoxy-1,3-hexadiene compounds such as 3-hexadiene, (3Z)-6,6-diheptyloxy-1,3-hexadiene, (3Z)-6,6-dioctyloxy-1,3-hexadiene, (3Z)-6,6-dinonyloxy-1,3-hexadiene and (3Z)-6,6-didecyloxy-1,3-hexadiene; (3Z)-7,7-dimethoxy-1,3-heptadiene, (3Z)-7,7-diethoxy-1,3-heptadiene, (3Z)-7,7-dipropoxy-1,3-heptadiene, (3Z)-7,7-dibutoxy-1,3-heptadiene, (3Z)-7,7-dipentyloxy-1,3-heptadiene, (3Z)-7,7-dihexyloxy-1, (3Z)-7,7-dialkoxy-1,3-heptadiene compounds such as 3-heptadiene, (3Z)-7,7-diheptyloxy-1,3-heptadiene, (3Z)-7,7-dioctyloxy-1,3-heptadiene, (3Z)-7,7-dinonyloxy-1,3-heptadiene and (3Z)-7,7-didecyloxy-1,3-heptadiene; (3Z)-8,8-dialkoxy-1,3-octadiene compounds such as (3Z)-8,8-dimethoxy-1,3-octadiene and (3Z)-8,8-diethoxy-1,3-octadiene; (3Z)-9,9-dialkoxy-1,3-nonadiene compounds such as (3Z)-9,9-dimethoxy-1,3-nonadiene and (3Z)-9,9-diethoxy-1,3-nonadiene; (3Z)-10,10-dialkoxy-1,3-decadiene compounds such as (3Z)-10,10-dimethoxy-1,3-decadiene and (3Z)-10,10-diethoxy-1,3-decadiene; (3Z)-11,11-dialkoxy-1,3-undecadiene compounds such as (3Z)-11,11-dimethoxy-1,3-undecadiene and (3Z)-11,11-diethoxy-1,3-undecadiene; (3Z)-12,12-dimethoxy-1,3-dodecadiene, (3Z)-12,12-diethoxy-1,3-dodecadiene, (3Z)-12,12-dipropoxy-1,3-dodecadiene, (3Z)-12,12-dibutoxy-1,3-dodecadiene, (3Z)-12,12-dipentyloxy-1,3-dodecadiene, (3Z)-12,12-dihexyloxy-1 (3Z)-12,12-dialkoxy-1,3-dodecadiene compounds such as (3Z)-12,12-diheptyloxy-1,3-dodecadiene, (3Z)-12,12-dioctyloxy-1,3-dodecadiene, (3Z)-12,12-dinonyloxy-1,3-dodecadiene and (3Z)-12,12-didecyloxy-1,3-dodecadiene; (3Z)-13,13-dialkoxy-1,3-tridecadiene compounds such as (3Z)-13,13-dimethoxy-1,3-tridecadiene and (3Z)-13,13-diethoxy-1,3-tridecadiene; (3Z)-14,14-dimethoxy-1,3-tetradecadiene, (3Z)-14,14-diethoxy-1,3-tetradecadiene, (3Z)-14,14-dipropoxy-1,3-tetradecadiene, (3Z)-14,14-dibutoxy-1,3-tetradecadiene, (3Z)-14,14-dipentyloxy-1,3-tetradecadiene, (3Z)-14,14-dihexyloxy-1, (3Z)-14,14-dialkoxy-1,3-tetradecadiene compounds such as 3-tetradecadiene, (3Z)-14,14-diheptyloxy-1,3-tetradecadiene, (3Z)-14,14-dioctyloxy-1,3-tetradecadiene, (3Z)-14,14-dinonyloxy-1,3-tetradecadiene and (3Z)-14,14-didecyloxy-1,3-tetradecadiene; (3Z)-15,15-dialkoxy-1,3-pentadecadiene compounds such as (3Z)-15,15-dimethoxy-1,3-pentadecadiene and (3Z)-15,15-diethoxy-1,3-pentadecadiene; (3Z)-16,16-dialkoxy-1,3-hexadecadiene compounds such as (3Z)-16,16-dimethoxy-1,3-hexadecadiene and (3Z)-16,16-diethoxy-1,3-hexadecadiene; (3Z)-17,17-dialkoxy-1,3-heptadecadiene compounds such as (3Z)-17,17-dimethoxy-1,3-heptadecadiene and (3Z)-17,17-diethoxy-1,3-heptadecadiene; and (3Z)-18,18-dialkoxy-1,3-octadecadiene compounds such as (3Z)-18,18-dimethoxy-1,3-octadecadiene and (3Z)-18,18-diethoxy-1,3-octadecadiene.

[0121] <Production of terminally conjugated alkadienal compound (5) by hydrolysis reaction> The terminally conjugated alkadienal compound (5) can be produced by hydrolyzing the above-mentioned dialkoxy-1,3-alkadiene compound (4), as shown in the following chemical reaction formula.

[0122] [ka]

[0123] In the above hydrolysis reaction, the dialkoxy-1,3-alkadiene compound (4) may be used alone or in combination with two or more kinds, if necessary. For example, by using a mixture of a (3E)-12,12-dialkoxy-1,3-dodecadiene compound (4: a = 7) and a (3Z)-12,12-dialkoxy-1,3-dodecadiene compound (4: a = 7), Setothosea asigna (9E)-9,11-dodecadienal (5:a=7), which is the sex pheromone of Setora Nitens A mixture of (9Z)-9,11-dodecadienal (5:a=7), which is the sex pheromone of In this way, the E and Z forms can be synthesized individually or alternatively as a mixture. Setothosea asigna and Setora Nitens When manufacturing active ingredients for a composite mating disruptant that controls both species simultaneously, the E and Z isomers can be manufactured separately and then mixed after manufacturing, or they can be manufactured as a mixture of the E and Z isomers from the beginning.

[0124] The hydrolysis is usually carried out under acidic conditions. Examples of the acid used under the above-mentioned acidic conditions include inorganic acids such as hydrochloric acid and hydrobromic acid, p-toluenesulfonic acid, benzenesulfonic acid, trifluoroacetic acid, acetic acid, formic acid, oxalic acid, iodotrimethylsilane, and titanium tetrachloride. From the viewpoint of reactivity, acetic acid, formic acid, and oxalic acid are preferred. The acid may be used alone or in combination with two or more acids as required. In addition, commercially available acids may be used. The amount of the acid used is preferably 0.01 to 10.0 mol per 1 mol of the dialkoxy-1,3-alkadiene compound (4). The amount of water used is preferably 18 to 3000 g per 1 mol of the dialkoxy-1,3-alkadiene compound (4) from the viewpoint of reactivity.

[0125] In the hydrolysis reaction, a solvent may be further used, if necessary, in addition to the above-mentioned acid or water. Examples of the solvent include hydrocarbons such as hexane, heptane, toluene, xylene, benzene, and cumene; ethers such as diethyl ether, dibutyl ether, 4-methyltetrahydropyran, tetrahydrofuran, cyclopentyl methyl ether, and 1,4-dioxane; polar solvents such as dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, acetonitrile, acetone, γ-butyrolactone, dichloromethane, and chloroform; and alcohols such as methanol and ethanol. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The optimum solvent varies depending on the acid used. For example, when oxalic acid is used as the acid, tetrahydrofuran, acetone and γ-butyrolactone are preferred from the viewpoint of reactivity. The amount of the solvent used is preferably 0 to 3000 g per 1 mol of the dialkoxy-1,3-alkadiene compound (4) from the viewpoint of reactivity.

[0126] The reaction temperature in the hydrolysis reaction varies depending on the acid and / or solvent used, but is preferably 5 to 180° C. from the viewpoint of reactivity. The reaction time in the hydrolysis reaction varies depending on the acid, solvent and / or reaction scale used, but is preferably 1 to 100 hours from the viewpoint of reactivity.

[0127] Usually, 1-halodialkoxy-3-alkene compound (3) is subjected to an elimination reaction in the presence of a base, and then water is added to separate the mixture, followed by concentration and purification, but the hydrolysis reaction can also be carried out in the washing step of the elimination reaction without carrying out the concentration and purification. By carrying out the hydrolysis reaction in the washing step of the elimination reaction in this way, the solvent used in the elimination reaction can be used as it is in the hydrolysis reaction, which is industrially advantageous since it reduces waste and / or reduces the energy and / or time required for concentration and purification.

[0128] The terminally conjugated alkadienal compound (5) will be described below. In the above general formula (5), a is as defined in the above general formula (1).

[0129] Specific examples of the terminally conjugated alkadienal compound (5) include 4,6-hexadienal compounds such as (4E)-4,6-hexadienal and (4Z)-4,6-hexadienal; 5,8-octadienal compounds such as (5E)-5,8-octadienal and (5Z)-5,8-octadienal; 6,8-nonadienal compounds such as (6E)-6,8-nonadienal and (6Z)-6,8-nonadienal; (7E)-7, 7,9-decadienal compounds such as (7Z)-7,9-decadienal; 8,10-undecadienal compounds such as (8E)-8,10-undecadienal and (8Z)-8,10-undecadienal; 9,11-dodecadienal compounds such as (9E)-9,11-dodecadienal and (9Z)-9,11-dodecadienal; (10E)-10,12-tridecadienal and (10Z)-1 10,12-tridecadienal compounds such as 0,12-tridecadienal; 11,13-tetradecadienal compounds such as (11E)-11,13-tetradecadienal and (11Z)-11,13-tetradecadienal; 12,14-pentadecadienal compounds such as (12E)-12,14-pentadecadienal and (12Z)-12,14-pentadecadienal; (13E)-13,15-hexadecadienal and (13Z)-13,15-hexadecadienal compounds; (14E)-14,16-heptadecadienal and (14Z)-14,16-heptadecadienal compounds; and (15E)-15,17-octadecadienal and (15Z)-15,17-octadecadienal compounds. EXAMPLES

[0130] The present invention will be described in detail below with reference to examples, but the present invention is not limited to the following examples. In the following, unless otherwise specified, "purity" refers to the area percentage obtained by gas chromatography (GC) analysis, "production ratio" refers to the relative ratio of the area percentage obtained by GC analysis, and "yield" refers to the yield calculated based on the area percentage obtained by GC analysis. In each example, reaction monitoring and yield calculation were performed according to the following GC conditions. GC conditions: GC: Shimadzu Corporation capillary gas chromatograph GC-2014, column: DB-WAX (sp-2331), 0.25 μm x 0.25 mm φ x 30 m, carrier gas: He (1.55 mL / min), detector: FID, column temperature: 150 °C, 5 °C / min heating to 230 °C. The yield was calculated according to the following formula, taking into account the purity (%GC) of the raw materials and the product. Yield (%) = {[(weight of product obtained by reaction × %GC) / molecular weight of product] ÷[(weight of starting material in reaction × %GC) / molecular weight of starting material]} × 100 GBL stands for γ-butyrolactone, THF for tetrahydrofuran, and Ph for phenyl and t Bu represents a tert-butyl group.

[0131] Example 1 <(3E)-12,12-diethoxy-3-dodecenyl methoxymethyl ether (1:R 1 =H,R 2 =R 3 =CH 2 CH 3 ;a=7) Production>

[0132] [ka]

[0133] Magnesium (77.34 g, 3.18 mol) and tetrahydrofuran (909.30 g) were added to a reactor at room temperature, and the mixture was stirred for 21 minutes at 60 to 65° C. After the stirring was completed, (3E)-11-chloro-3-undecenyl methoxymethyl ether (782.04 g, 3.031 mol, purity 96.41%; 3Z:3E=92.7:7.3) was added dropwise to the reactor at 60 to 75° C., and after the dropping was completed, the mixture was stirred at 75 to 80° C. for 2 hours. Subsequently, toluene (1409.42 g) and ethyl orthoformate (583.95 g, 3.94 mol) were added dropwise to the reactor at 75 to 85°C, and after completion of the dropwise addition, the mixture was stirred at 90 to 100°C for 16 hours. Thereafter, the mixture was cooled to 30 to 45°C, and an aqueous solution of acetic acid (acetic acid (378.88 g) and water (1136.63 g)) was added to the reaction liquid to separate the liquid, and the aqueous layer was removed to obtain an organic layer. The obtained organic layer was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain (3E)-12,12-diethoxy-3-dodecenyl methoxymethyl ether (1:R 1 =H,R 2 =R 3 =CH 2 CH 3 ;a=7) (887.38 g, 2.67 mol, purity 95.21%; 3Z:3E=92.6:7.4, bp=159.2-167.8 °C / 0.40 kPa (3.0 mmHg)) was obtained in a yield of 88.10%.

[0134] The (3E)-12,12-diethoxy-3-dodecenyl methoxymethyl ether (1:R 1 =H,R 2 =R 3 =CH 2 CH 3 ;a=7) spectral data is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3):δ=1.19(6H,t,J=6.9Hz),1.23-1.38(10H,m),1.59(2H,dt,J=9.2Hz,6.1Hz),1.97(2H ,q-like,J=6.6Hz),2.28(2H,ddt,J=1.1Hz,6.7Hz,6.7Hz),3.35(3H,s),3.47(1H,q,J= 7.3Hz,),3.49(1H,q,J=7.3Hz),3.53(2H,t,J=6.9Hz),3.61(1H,q,J=7.3Hz),3.63(1H, q,J=7.3Hz),4.46(1H,t,J=5.7Hz),4.61(2H,s),5.35-5.43(1H,m),5.46-5.54(1H,m); 13 C-NMR (500 MHz, CDCl 3 ):δ=15.33,24.72,29.04,29.38,29.41,32.59,33.03,33.56,55.09,60.78,67.65,96.32,102.93,126.10,132.72 [Mass spectrum] EI-mass spectrum (70 eV): m / z 315 (M + -1), 271, 239, 208, 181, 103, 75, 45, 29 [Infrared absorption spectrum] (D-ATR): νmax = 2926, 2855, 1443, 1374, 1150, 1112, 1062, 968, 919

[0135] Example 2 <(3Z)-12,12-diethoxy-3-dodecenyl methoxymethyl ether (1:R 1 =H,R 2 =R 3 =CH 2 CH 3 ;a=7) Production>

[0136] [ka]

[0137] Magnesium (81.65 g, 3.36 mol) and tetrahydrofuran (960.00 g) were added to a reactor at room temperature, and the mixture was stirred for 11 minutes at 60 to 65° C. After the stirring was completed, (3Z)-11-chloro-3-undecenyl methoxymethyl ether (840.24 g, 3.20 mol, purity 94.75%; 3Z:3E=96.2:3.8) was added dropwise to the reactor at 60 to 75° C., and after the dropping was completed, the mixture was stirred at 75 to 80° C. for 3 hours. Subsequently, toluene (1488.00 g) and ethyl orthoformate (616.51 g, 4.16 mol) were added dropwise to the reactor at 75 to 85°C, and after completion of the dropwise addition, the mixture was stirred at 90 to 100°C for 15.5 hours. Thereafter, the mixture was cooled to 30 to 45°C, and an aqueous acetic acid solution (acetic acid (400.00 g) and water (1200.00 g)) was added to the reaction liquid to separate the liquid, and the aqueous layer was removed to obtain an organic layer. The obtained organic layer was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain (3Z)-12,12-diethoxy-3-dodecenyl methoxymethyl ether (1:R 1 =H,R 2 =R 3 =CH 2 CH 3 ;a=7) (907.41 g, 2.71 mol, purity 92.59%; 3Z:3E=95.7:4.3, bp=160.0-167.1°C / 0.40 kPa (3.0 mmHg)) was obtained in a yield of 84.56%.

[0138] The (3Z)-12,12-diethoxy-3-dodecenyl methoxymethyl ether (1:R 1 =H,R 2 =R 3 =CH 2 CH 3 ;a=7) spectral data is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3):δ=1.19(6H,t,J=6.9Hz),1.24-1.38(12H,m),1.55-1.62(2H,m),2.03(2H,dt,J= 6.9Hz,6.9Hz),2.33(2H,dt,J=6.9Hz,6.9Hz),3.35(3H,s),3.46(1H,q,J=6.9Hz), 3.48(1H,q,J=6.9Hz),3.52(2H,t,J=6.9Hz),3.61(1H,q,J=6.9Hz),3.63(1H,q,J= 6.9Hz),4.46(1H,t,J=5.7Hz),4.61(2H,s),5.33-5.40(1H,m),5.42-5.50(1H,m); 13 C-NMR (500 MHz, CDCl 3 ):δ=15.32,24.70,27.29,27.86,29.16,29.40,29.54,33.55,55.07,60.76,67.38,96.30,102.91,125.36,132.11 [Mass spectrum] EI-mass spectrum (70 eV): m / z 315 (M + -1), 271, 175, 103, 75, 45 [Infrared absorption spectrum] (D-ATR): νmax = 2927, 2856, 1443, 1375, 1150, 1111, 1062, 1037, 920, 724

[0139] Example 3 <(3Z)-12,12-dimethoxy-3-dodecenyl butoxymethyl ether (1:R 1 =CH 3 (CH 2 ) 2 ,R 2 =R 3 =CH 3 ;a=7) Production>

[0140] [ka]

[0141] Zinc chloride (0.042 g, 0.31 mmol) and dibutoxymethane (8.32 g, 0.052 mol) were added to a reactor at room temperature and stirred for 7 minutes at 15 to 25° C. After stirring was completed, acetyl chloride (3.63 g, 0.046 mol) was added dropwise to the reactor at 20 to 35° C., and after addition, the mixture was stirred at 35 to 40° C. for 2 hours to prepare chloromethyl butyl ether. The reactor was then charged with (3Z)-12,12-dimethoxy-3-dodecen-1-ol (2:R 4 =R 5 =CH 3 A mixed solution of (3Z)-12,12-dimethoxy-3-dodecenyl butoxymethyl ether (1:R) (8.00 g, 0.031 mol, purity 94.15%; 3Z:3E=96.1:3.9) and N,N-diethylaniline (6.91 g, 0.046 mol) was added dropwise at 20-30°C, and after completion of the dropwise addition, the mixture was stirred at 20-30°C for 25 hours. Next, a 25% by mass aqueous sodium hydroxide solution (15.00 g, 0.094 mol as sodium hydroxide) and then water (15.00 g) were added to the reaction solution, and the mixture was separated. The aqueous layer was removed to obtain an organic layer. The obtained organic layer was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain (3Z)-12,12-dimethoxy-3-dodecenyl butoxymethyl ether (1:R 1 =CH 3 (CH 2 ) 2 ,R 2 =R 3 =CH 3 ;a=7 (11.55 g, 0.031 mol, purity 88.68%; 3Z:3E=96.0:4.0) was obtained in 100% yield.

[0142] The (3Z)-12,12-dimethoxy-3-dodecenyl butoxymethyl ether (1:R 1 =CH 3 (CH 2 ) 2 ,R 2 =R 3 =CH 3 ;a=7) spectral data is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3):δ=0.92(3H,t,J=7.3Hz),1.23-1.42(12H,m),1.52-1.60(4H,m),2.03(2H,q-like,J=6.9Hz),2.32(2H,q-like,J=6.9Hz),3.30(6H,s),3 .52(4H,t,J=6.7Hz),4.34(1H,t,J=5.7Hz),4.66(2H,s),5.36(1H,dtt,J=11.1Hz,6.9Hz,1.5Hz),5.45(1H,dtt,J=10.7Hz,7.3Hz,1.5Hz); 13 C-NMR (500 MHz, CDCl 3 ):δ=13.84,19.34,24.56,27.29,27.87,29.16,29.40,29.56,31.78,32.45,52.52,67.33,67.52,95.15,104.51,125.43,132.06 [Mass spectrum] EI-mass spectrum (70 eV): m / z 329 (M + -1), 299, 267, 241, 225, 194, 175, 149, 121, 95, 75, 57 [Infrared absorption spectrum] (D-ATR): νmax = 2928, 2857, 1465, 1383, 1118, 1075, 1041, 954, 827, 724

[0143] Example 4 <(3Z)-12,12-dimethoxy-3-dodecenyl benzyloxymethyl ether (1:R 1 =Ph,R 2 =R 3 =CH 3 ;a=7) Production>

[0144] [ka]

[0145] Sodium hydride (1.48 g, 0.034 mmol, purity 55%), potassium iodide (0.051 g, 0.31 mmol) and tetrahydrofuran (40.00 g) were added to a reactor at room temperature and stirred for 25 minutes at 0 to 5° C. After stirring was completed, (3Z)-12,12-dimethoxy-3-dodecen-1-ol (2:R 4 =R 5 =CH 3 3Z:3E=96.1:3.9) was added dropwise at 0-10°C, and the mixture was stirred at 0-10°C for 1 hour. Benzyl chloromethyl ether (5.36g, 0.034mol) was then added at 0-10°C, and the mixture was stirred at 45-55°C for 4 hours. Next, an aqueous ammonium chloride solution (ammonium chloride (0.21g), salt (0.94g) and water (29.52g)) was added to the reaction solution, and the mixture was separated. The aqueous layer was removed to obtain an organic layer. The obtained organic layer was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain (3Z)-12,12-dimethoxy-3-dodecenyl benzyloxymethyl ether (1:R 1 =Ph,R 2 =R 3 =CH 3 ;a=7 (3.21 g, 0.0073 mol, purity 82.80%) was obtained in a yield of 23.66%.

[0146] The (3Z)-12,12-dimethoxy-3-dodecenyl benzyloxymethyl ether (1:R 1 =Ph,R 2 =R 3 =CH 3 ;a=7) spectral data is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3):δ=1.24-1.40(10H,m),1.59(2H,q-like,J=7.0Hz),2.04(2H,dt,J=6.9Hz ,6.9Hz),2.35(2H,dt,J=7.3Hz,7.3Hz),3.31(6H,s),3.60(2H,t,J=7.1Hz) ,4.35(1H,t,J=5.7Hz),4.61(2H,s),4.76(2H,s),5.39(1H,dtt,J=10.7Hz, 7.3Hz,1.5Hz),5.48(1H,dtt,J=10.7Hz,7.3Hz,1.5Hz),7.27-7.37(5H,m); 13 C-NMR (500 MHz, CDCl 3 ):δ=24.56,27.31,27.85,29.17,29.41,29.56,32.46,52.54,67.59,69.25,94.50,104.53,125.40,127.62,127.86,128.36,132.15,137.93 [Mass spectrum] EI-mass spectrum (70 eV): m / z 287 (M + -77), 243, 225, 194, 175, 149, 121, 91, 75, 41 [Infrared absorption spectrum] (D-ATR): νmax = 2927, 2855, 1455, 1383, 1121, 1052, 955, 735, 698

[0147] Example 5 <(3Z)-7,7-diethoxy-3-heptenyl methoxymethyl ether (1:R 1 =H,R 2 =R 3 =CH 2 CH 3 ;a=2) Production>

[0148] [ka]

[0149] Magnesium (9.83 g, 0.42 mol) and tetrahydrofuran (120.00 g) were added to a reactor at room temperature, and the mixture was stirred for 23 minutes at 60 to 65° C. After the stirring was completed, (3Z)-6-chloro-3-hexenyl methoxymethyl ether (73.66 g, 0.40 mol, purity 97.02%) was added dropwise to the reactor at 60 to 75° C., and after the dropping was completed, the mixture was stirred at 75 to 80° C. for 3 hours. Subsequently, toluene (186.00 g) and ethyl orthoformate (77.06 g, 0.52 mol) were added dropwise to the reactor at 75 to 85°C, and the mixture was stirred at 90 to 100°C for 11 hours. Thereafter, the mixture was cooled to 30 to 45°C, and an aqueous solution of acetic acid (acetic acid (400 g), water (1200.00 g)) was added to the reaction liquid to separate the liquid, and the aqueous layer was removed to obtain an organic layer. The obtained organic layer was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain (3Z)-7,7-diethoxy-3-heptenyl methoxymethyl ether (1:R 1 =H,R 2 =R 3 =CH 2 CH 3 ;a=2) (83.39 g, 0.29 mol, purity 85.52%; 3Z:3E=90.6:9.4, bp=112.0-126.9°C / 0.40 kPa (3.0 mmHg)) was obtained in a yield of 72.37%.

[0150] The (3Z)-7,7-diethoxy-3-heptenyl methoxymethyl ether (1:R 1 =H,R 2 =R 3 =CH 2 CH 3 The spectral data for ;a=2) is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3):δ=1.19(6H,t,J=7.0Hz),1.63-1.68(2H,m),2.11(2H,dt,J=7.4Hz,7.4Hz),2.34(2H,dt,J=6.9Hz,6.9Hz),3.34(3H,s),3.46(1H,q,J=7.0Hz), 3.48(1H,q,J=7.0Hz),3.52(2H,t,J=6.9Hz),3.61(1H,q,J=7.0Hz),3.63 (1H,q,J=7.0Hz),4.47(1H,t,J=5.7Hz),4.60(2H,s),5.36-5.50(2H,m); 13 C-NMR (500 MHz, CDCl 3 ):δ=15.31,22.67,27.79,33.33,55.06,60.92,67.26,96.29,102.28,126.14,130.94 [Mass spectrum] EI-mass spectrum (70 eV): m / z 245 (M + -1), 231, 217, 201, 185, 169, 155, 103, 75, 45 [Infrared absorption spectrum] (D-ATR): νmax = 2975, 2930, 2881, 1444, 1374, 1111, 1062, 1038, 969, 920, 731

[0151] Example 6 <(3E)-12,12-dimethoxy-3-dodecen-1-ol (2:R 4 =R 5 =CH 3 ;a=7) Production>

[0152] [ka]

[0153] (3E)-12,12-diethoxy-3-dodecenyl methoxymethyl ether (1:R 1 =H, R 2 =R 3 =CH 2 CH 3;a=7) (81.66g, 0.24mol, purity 84.11%; 3Z:3E=0:100), methanol (238.20g, 7.43mol) and p-toluenesulfonic acid monohydrate (0.46g, 0.0024mol) were charged into a reactor equipped with a distillation column, and the reaction liquid was heated to 60°C and stirred for 4.5 hours. After stirring was completed, the internal temperature was raised to 65-70°C, and a mixture of by-produced dimethoxymethane and methanol was distilled and removed from the distillation column. The reaction liquid during the reaction was sampled, and when the reaction rate reached 100%, a 25% by mass aqueous sodium hydroxide solution (3.82g, 0.024mol as sodium hydroxide) was added, and methanol was removed until no distillation occurred. Thereafter, water (80g) was added and the liquid was separated, and the aqueous layer was removed to obtain an organic layer. The resulting organic layer was concentrated under reduced pressure, and the residue was distilled under reduced pressure to give (3E)-12,12-dimethoxy-3-dodecen-1-ol (2:R 4 =R 5 =CH 3 ;a=7) (53.21 g, 0.21 mol, purity 95.02%; 3Z:3E=0:100, bp=140.6-145.8 °C / 0.40 kPa (3.0 mmHg)) was obtained in a yield of 86.86%.

[0154] The (3E)-12,12-dimethoxy-3-dodecen-1-ol (2:R 4 =R 5 =CH 3 ;a=7) spectral data is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3 ):δ=1.22-1.37(10H,m),1.53-1.60(2H,m),1.63(1H,br.s),1.98(2H,q-like,J=7.3Hz),2.24(2H,dt,J=6.1Hz,6.1Hz) ,3.29(6H,s),3.59(2H,t,J=6.3Hz),4.33(1H,t,J=5.7Hz),5.37(1H,dtt,J=15.3Hz,7.2Hz,1.3Hz),5.48-5.56(1H,m); 13 C-NMR (500 MHz, CDCl 3):δ=24.49,28.97,29.29,29.33,32.39,32.56,35.92,52.52,61.98,104.50,125.72,134.10 [Mass spectrum] EI-mass spectrum (70 eV): m / z 243 (M + -1), 213, 182, 163, 150, 135, 121, 107, 95, 75, 55, 41, 29 [Infrared absorption spectrum] (D-ATR): νmax = 3417, 2926, 2854, 1464, 1386, 1128, 1053, 968

[0155] Example 7 <(3E)-1-chloro-12,12-dimethoxy-3-dodecene (3:X=Cl,R 4 =R 5 =CH 3 ;a=7) Production>

[0156] [ka]

[0157] At room temperature, the reactor was charged with (3E)-12,12-dimethoxy-3-dodecen-1-ol (2:R 4 =R 5 =CH 3 ;a=7) (31.79 g, 0.12 mol, purity 95.02%; 3Z:3E=0:100), pyridine (19.82 g, 0.17 mol) and γ-butyrolactone (37.07 g) were added and stirred at 0 to 10° C. for 32 minutes. Subsequently, methanesulfonyl chloride (17.59 g, 0.22 mol) was added dropwise at 0 to 10°C. After completion of the dropwise addition, the temperature was raised to 60 to 65°C and the mixture was stirred for 12.5 hours. After completion of the stirring, water (61.80 g) and hexane (61.80 g) were added and the mixture was separated, and the aqueous layer was removed to obtain an organic layer. The obtained organic layer was washed with an aqueous acetic acid solution (acetic acid (6.18 g) and water (61.80 g)), and then with an aqueous sodium hydrogen carbonate solution (sodium hydrogen carbonate (3.09 g) and water (61.80 g)). The organic layer obtained by concentrating the organic layer under reduced pressure, and the residue was distilled under reduced pressure to obtain (3E)-1-chloro-12,12-dimethoxy-3-dodecene (3:X=Cl, R 4 =R 5 =CH 3 ;a=7) (25.04 g, 0.089 mol, purity 93.81%, 3Z:3E=0:100, bp=136.2-147.2 °C / 0.40 kPa (3.0 mmHg)) was obtained in a yield of 72.30%.

[0158] The (3E)-1-chloro-12,12-dimethoxy-3-dodecene (3:X=Cl, R 4 =R 5 =CH 3 ;a=7) spectral data is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3 ):δ=1.23-1.38(10H,m),1.54-1.61(2H,m),1.99(2H,q-like,J=6.9Hz),2.43(2H,ddt,J=1.1Hz,7.1Hz,7.1Hz),3.30(6H,s), 3.49(2H,t,J=6.9Hz),4.34(1H,t,J=5.7Hz),5.38(1H,dtt,J=15.3Hz,6.9Hz,1.5Hz),5.52(1H,dtt,J=15.3Hz,6.9Hz,1.2Hz); 13 C-NMR (500 MHz, CDCl 3 ):δ=24.54,28.95,29.21,29.33,29.38,32.45,32.47,35.87,44.46,52.54,104.52,125.47,133.98 [Mass spectrum] EI-mass spectrum (70 eV): m / z 261 (M + -1), 231, 194, 172, 157, 143, 95, 75, 55, 41, 27 [Infrared absorption spectrum] (D-ATR): νmax = 2927, 2855, 1463, 1127, 1055, 968, 722, 658

[0159] Example 8 <(3E)-12,12-dimethoxy-1,3-dodecadiene (4:R 4 =R 5 =CH 3 ;a=7) Production>

[0160] [ka]

[0161] Potassium tert-butoxide (18.26 g, 0.16 mol) and tetrahydrofuran (71.49 g) were added to a reactor at room temperature, and the mixture was stirred at -5 to 5°C for 17 minutes. Next, at 0 to 10° C., (3E)-1-chloro-12,12-dimethoxy-3-dodecene (3:X=Cl, R 4 =R 5 =CH 3 3E)-12,12-dimethoxy-1,3-dodecadiene (4:R;a=7) (25.04 g, 0.089 mol, purity 93.81%, 3Z:3E=0:100) was added dropwise. After completion of the dropwise addition, the temperature was raised to 20-25°C and the mixture was stirred for 7.5 hours. After completion of the stirring, water (26.81 g) was added and the mixture was separated, and the aqueous layer was removed to obtain an organic layer. The obtained organic layer was concentrated under reduced pressure to obtain (3E)-12,12-dimethoxy-1,3-dodecadiene (4:R 4 =R 5 =CH 3 The crude product of 3Z:3E=0:100 (25.29 g, 0.094 mol, purity 84.79%; a=7) was quantitatively obtained.

[0162] The (3E)-12,12-dimethoxy-1,3-dodecadiene (4:R 4 =R 5=CH 3 ;a=7) spectral data is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3 ):δ=1.25-1.43(10H,m),1.54-1.61(2H,m),2.06(2H,dt,J=6.9Hz,6.9Hz),3.30(6H,s),4.35(1H,t,J=5.7Hz),4.93(1H,dd,J=9.8Hz,1.1Hz) ,5.07(1H,dd,J=17.4Hz,1.1Hz),5.69(1H,dt,J=6.9Hz,6.9Hz),6.03(1H,dd,J=15.1Hz,10.3Hz),6.29(1H,ddd,J=16.8Hz,10.3Hz,10.3Hz); 13 C-NMR (500 MHz, CDCl 3 ):δ=24.54,29.04,29.11,29.35,29.37,32.44,32.48,52.53,104.51,114.54,130.84,135.49,137.31 [Mass spectrum] EI-mass spectrum (70 eV): m / z 225 (M + -1), 195, 163, 121, 107, 95, 75, 55, 41 [Infrared absorption spectrum] (D-ATR): νmax = 2927, 2855, 1464, 1126, 1056, 1003, 951, 897

[0163] Example 9 <Production of (9E)-9,11-dodecadienal (5:a=7)>

[0164] [ka]

[0165] At room temperature, the (3E)-12,12-dimethoxy-1,3-dodecadiene (4:R 4 =R 5 =CH 3A crude product of (a=7) (25.29 g, 0.094 mol, purity 84.79%; 3Z:3E=0:100), oxalic acid dihydrate (35.58 g, 0.28 mol), tetrahydrofuran (94.07 g) and pure water (94.07 g) were added and stirred at 60-65°C for 2 hours. The reaction solution was then cooled to 50°C, hexane (27.67 g) was added, and the mixture was stirred for 45 minutes. After stirring, the reaction solution was left to stand and separated, and the aqueous layer was removed to obtain an organic layer. The organic layer obtained was concentrated under reduced pressure, and the residue was distilled under reduced pressure to give (9E)-9,11-dodecadienal (5:a=7) (16.22 g, 0.085 mol, purity 94.76%, 3Z:3E=0:100, bp=112.1-118.3°C / 0.40 kPa (3.0 mmHg)) in a yield of 95.40% as the yield for the two steps of Examples 8 and 9. (3E)-12,12-diethoxy-3-dodecenyl methoxymethyl ether (1:R 1 =H,R 2 =R 3 =CH 2 CH 3 The geometry of the 3-position of (9E)-9,11-dodecadienal (5: a = 7) was maintained in the geometry of the 9-position of (9E)-9,11-dodecadienal (5: a = 7), and no isomerization was observed.

[0166] The spectral data of the (9E)-9,11-dodecadienal (5: a = 7) obtained above is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3 ):δ=1.26-1.34(6H,m),1.31-1.41(2H,m),1.61(2H,quin-like,J=7.3Hz),2. 06(2H,tt,J=6.9Hz,6.9Hz),2.41(2H,dt,J=7.5Hz,1.9Hz),4.94(1H,d,J=9.9H z),5.07(1H,d,J=17.6Hz),5.68(1H,ddd,J=15.3Hz,7.3Hz,7.3Hz),6.03(1H,d d,J=15.3Hz,10.3Hz),6.29(1H,dt,J=17.2Hz,10.3Hz),9.75(1H,t,J=1.9Hz); 13 C-NMR (500 MHz, CDCl3 ):δ=21.98,28.88,29.02,29.13,32.42,43.84,114.60,130.90,135.33,137.25,202.79 [Mass spectrum] EI-mass spectrum (70 eV): m / z 180 (M + ), 151, 137, 123, 112, 98, 81, 67, 54, 41, 29 [Infrared absorption spectrum] (D-ATR): νmax = 2928, 2855, 1726, 1464, 1004, 951, 897

[0167] Example 10 <Production of (9E)-9,11-dodecadienal (5:a=7)> [ka]

[0168] Potassium tert-butoxide (184.15 g, 1.64 mol) and tetrahydrofuran (573.84 g) were added to a reactor at room temperature, and the mixture was stirred at -5 to 5°C for 12 minutes. Subsequently, at 0 to 10° C., (3E)-1-chloro-12,12-dimethoxy-3-dodecene (3:X=Cl, R 4 =R 5 =CH 3;a=7) (216.02g, 0.72mol, purity 87.27%) was added dropwise. After the dropwise addition, the temperature was raised to 20-25°C and stirred for 5 hours. After the stirring was completed, water (458.65g) was added and separated, and the aqueous layer was removed to obtain an organic layer. To the obtained organic layer, oxalic acid dihydrate (135.65g, 1.08mol), tetrahydrofuran (143.46g) and pure water (717.30g) were added and stirred at 60-65°C for 2 hours (washing step). Then, the reaction solution was cooled to 50°C, hexane (210.96g) was added, and the mixture was stirred for 63 minutes. After the stirring was completed, the reaction solution was left to stand and separated, and the aqueous layer was removed to obtain an organic layer. The obtained organic layer was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain (9E)-9,11-dodecadienal (5:a=7) (137.32 g, 0.65 mol, purity 85.77%, bp=100.6-112.1°C / 0.40 kPa (3.0 mmHg)) in a yield of 91.07%. The spectrum of the obtained (9E)-9,11-dodecadienal (5:a=7) was the same as that obtained in Example 9.

[0169] Example 11 <(3Z)-12,12-dimethoxy-3-dodecen-1-ol (2:R 4 =R 5 =CH 3 ;a=7) Production>

[0170] [ka]

[0171] (3Z)-12,12-diethoxy-3-dodecenyl methoxymethyl ether (1:R 1 =H,R 2 =R 3 =CH 2 CH 3;a=7) (907.41g, 2.71mol, purity 92.59%; 3Z:3E=95.7:4.3), methanol (2655.00g, 82.87mol) and p-toluenesulfonic acid monohydrate (15.15g, 0.080mol) were charged into a reactor equipped with a distillation column, and the reaction liquid was heated to 60°C and stirred for 10 hours. After stirring was completed, the internal temperature was raised to 65-70°C, and a mixture of by-produced dimethoxymethane and methanol was distilled and removed from the distillation column. The reaction liquid was sampled during the reaction, and when the reaction rate reached 100%, a 25% by mass aqueous sodium hydroxide solution (25.49g, 0.16mol as sodium hydroxide) was added, and methanol was removed until no distillation occurred. Thereafter, water (200g) and hexane (324.92g) were added and the liquid was separated, and the aqueous layer was removed to obtain an organic layer. The obtained organic layer was concentrated under reduced pressure to give (3Z)-12,12-dimethoxy-3-dodecen-1-ol (2:R 4 =R 5 =CH 3 ;a=7) (689.37 g, 2.59 mol, purity 91.89%; 3Z:3E=95.4:4.6) was obtained in a crude yield of 95.71%.

[0172] The (3Z)-12,12-dimethoxy-3-dodecen-1-ol (2:R 4 =R 5 =CH 3 ;a=7) spectral data is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3 ):δ=1.23-1.37(10H,m),1.53-1.60(2H,m),1.63(1H,br.s),2.04(2H,q-like,J=6.9Hz),2.31(2H,q-like,J=6.9Hz), 3.29(6H,s),3.61(2H,t,J=6.7Hz),4.34(1H,t,J=5.7Hz),5.34(1H,dtt,J=11.1Hz,7.3Hz,1.5Hz),5.49-5.57(1H,m); 13 C-NMR (500 MHz, CDCl 3):δ=24.51,27.27,29.09,29.35,29.58,30.76,32.40,52.53,62.25,104.50,124.98,133.30 [Mass spectrum] EI-mass spectrum (70 eV): m / z 243 (M + -1), 213, 182, 163, 150, 135, 121, 107, 75, 55, 41, 29 [Infrared absorption spectrum] (D-ATR): νmax = 3429, 2926, 1464, 1386, 1128, 1053, 723

[0173] Example 12 <(3Z)-1-chloro-12,12-dimethoxy-3-dodecene (3:X=Cl,R 4 =R 5 =CH 3 ;a=7) Production>

[0174] [ka]

[0175] At room temperature, the reactor was charged with (3Z)-12,12-dimethoxy-3-dodecen-1-ol (2:R 4 =R 5 =CH 3 ;a=7) (689.37 g, 2.59 mol, purity 91.89%; 3Z:3E=95.4:4.6), pyridine (369.06 g, 4.67 mol) and γ-butyrolactone (777.63 g) were added and stirred at 0 to 10° C. for 23 minutes. Subsequently, methanesulfonyl chloride (415.69 g, 3.63 mol) was added dropwise at 0 to 10°C. After completion of the dropwise addition, the temperature was raised to 60 to 65°C and the mixture was stirred for 8 hours. After completion of the stirring, water (777.63 g) and hexane (777.63 g) were added and the mixture was separated, and the aqueous layer was removed to obtain an organic layer. The obtained organic layer was washed with an aqueous acetic acid solution (acetic acid (7.78 g) and water (777.63 g)), and then washed with an aqueous sodium hydrogen carbonate solution (sodium hydrogen carbonate (7.78 g) and water (777.63 g)), and the obtained organic layer was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain (3Z)-1-chloro-12,12-dimethoxy-3-dodecene (3:X=Cl, R 4 =R 5 =CH 3 ;a=7) (478.35 g, 1.66 mol, purity 91.37%; 3Z:3E=95.5:4.5, bp=130.1-145.9° C. / 0.40 kPa (3.0 mmHg)) was obtained in a yield of 61.46% for the two steps of Examples 11 and 12.

[0176] The (3Z)-1-chloro-12,12-dimethoxy-3-dodecene (3:X=Cl, R 4 =R 5 =CH 3 ;a=7) spectral data is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3 ):δ=1.25-1.38(10H,m),1.54-1.61(2H,m),2.03(2H,q-like,J=6.9Hz),2.50(2H,dt,J=7.1Hz,7.1Hz),3.30(6H,s),3.49 (2H,t,J=7.3Hz),4.34(1H,t,J=5.8Hz),5.36(1H,dtt,J=10.7Hz,7.2Hz,1.9Hz),5.51(1H,dtt,J=10.7Hz,7.3Hz,1.5Hz); 13 C-NMR (500 MHz, CDCl 3 ):δ=24.54,27.33,29.11,29.37,29.44,30.66,32.45,44.21,52.54,104.51,124.81,133.20 [Mass spectrum] EI-mass spectrum (70 eV): m / z 261 (M + -1), 231, 172, 157, 143, 95, 75, 55, 41, 27 [Infrared absorption spectrum] (D-ATR): νmax = 2927, 2855, 1463, 1127, 1055, 725, 662

[0177] Example 13 <(3Z)-12,12-dimethoxy-1,3-dodecadiene (4:R 4 =R 5 =CH 3 ;a=7) Production>

[0178] [ka]

[0179] Potassium tert-butoxide (373.21 g, 3.33 mol) and tetrahydrofuran (1380.40 g) were added to a reactor at room temperature, and the mixture was stirred at -5 to 5°C for 40 minutes. Subsequently, at 0 to 10° C., (3Z)-1-chloro-12,12-dimethoxy-3-dodecene (3:X=Cl, R 4 =R 5 =CH 3 3Z)-12,12-dimethoxy-1,3-dodecadiene (4:R;a=7) (478.35 g, 1.66 mol, purity 91.37%; 3Z:3E=95.5:4.5) was added dropwise. After completion of the dropwise addition, the temperature was raised to 20-25°C and the mixture was stirred for 5 hours. After completion of the stirring, water (798.90 g) was added and the mixture was separated, and the aqueous layer was removed to obtain an organic layer. The obtained organic layer was concentrated under reduced pressure to obtain (3Z)-12,12-dimethoxy-1,3-dodecadiene (4:R 4 =R 5 =CH 3 The crude product of (a=7) (416.26 g, 1.56 mol, purity 84.89%) was obtained in a crude yield of 93.87%.

[0180] The (3Z)-12,12-dimethoxy-1,3-dodecadiene (4:R 4 =R5 =CH 3 ;a=7) spectral data is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3 ):δ=1.24-1.41(10H,m),1.54-1.61(2H,m),2.17(2H,ddt,J=1.2Hz,7.5Hz,7.5Hz),3.30(6H,s),4.35(1H,t,J=5.7Hz),5.07(1H,d,J=10.3Hz),5 .16(1H,dd,J=17.0Hz,1.9Hz),5.44(1H,q-like,J=7.7Hz),5.98(1H,dd,J=10.7Hz,10.7Hz),6.62(1H,dddd,J=16.8Hz,10.5Hz,10.5Hz,1.1Hz); 13 C-NMR (500 MHz, CDCl 3 ):δ=24.54,27.66,29.07,29.36,29.38,29.53,32.44,52.53,104.51,116.65,129.10,132.28,132.95 [Mass spectrum] EI-mass spectrum (70 eV): m / z 226 (M + ), 195, 163, 121, 95, 75, 41 [Infrared absorption spectrum] (D-ATR): νmax = 2927, 2855, 1464, 1385, 1126, 1056, 997, 902

[0181] Example 14 <Production of (9Z)-9,11-dodecadienal (5:a=7)>

[0182] [ka]

[0183] At room temperature, the reactor was charged with (3Z)-12,12-dimethoxy-1,3-dodecadiene (4:R 4 =R 5 =CH 3A crude product (416.26 g, 1.56 mol, purity 84.89%) of (a=7), oxalic acid dihydrate (628.96 g, 4.99 mol), tetrahydrofuran (1663.00 g) and pure water (1663.00 g) were added and stirred at 60 to 65°C for 4 hours. The reaction solution was then cooled to 50°C, hexane (498.09 g) was added and stirred for 47 minutes. After stirring, the reaction solution was left to stand and separated, and the aqueous layer was removed to obtain an organic layer. The organic layer obtained was concentrated under reduced pressure, and the residue was distilled under reduced pressure to give (9Z)-9,11-dodecadienal (5:a=7) (20.75 g, 1.53 mol, purity 97.71%, 3Z:3E=95.7:4.3, bp=108.0-113.9°C / 0.40 kPa (3.0 mmHg)) in a yield of 91.73% as the yield for the two steps of Examples 13 and 14. 1 =H,R 2 =R 3 =CH 2 CH 3 The geometry of the 3-position of (9Z)-9,11-dodecadienal (5: a = 7) was maintained at the 9-position of (9Z)-9,11-dodecadienal (5: a = 7), and no isomerization was observed.

[0184] The spectral data of the (9Z)-9,11-dodecadienal (5: a = 7) obtained above is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3 ):δ=1.25-1.33(6H,m),1.33-1.41(2H,m),1.61(2H,quin-like,J=7.3Hz),2.17(2H, ddt,J=1.5Hz,7.6Hz,7.6Hz),2.41(2H,dt,J=1.9Hz,7.3Hz),5.07(1H,d,J=9.9Hz),5 .17(1H,dd,J=16.8Hz,1.9Hz),5.43(1H,dd,J=16.8Hz,1.9Hz),5.98(1H,dd,J=10.7H z,10.7Hz),6.62(1H,dddd,J=16.8Hz,10.5Hz,10.5Hz,1.1Hz),9.75(1H,t,J=1.9Hz); 13 C-NMR (500 MHz, CDCl3 ):δ=21.99,27.60,28.90,29.04,29.13,29.43,43.84,116.72,129.17,132.24,132.79,202.78 [Mass spectrum] EI-mass spectrum (70 eV): m / z 180 (M + ), 151, 137, 123, 112, 98, 81, 67, 54, 41, 29 [Infrared absorption spectrum] (D-ATR): νmax = 2928, 2855, 1726, 1464, 999, 903, 657, 613

[0185] Example 15 <(3Z)-7,7-dimethoxy-3-hepten-1-ol (2:R 4 =R 5 =CH 3 ;a=2) Production>

[0186] [ka]

[0187] (3Z)-7,7-diethoxy-3-heptenyl methoxymethyl ether (1:R 1 =H,R 2 =R 3 =CH 2 CH 3;a=2) (69.52g, 0.27mol, purity 94.37%; 3Z:3E=90.6:9.4), methanol (853.23g, 26.63mol) and p-toluenesulfonic acid monohydrate (2.53g, 0.01mol) were charged into a reactor equipped with a distillation column, and the reaction liquid was heated to 60°C and stirred for 5.5 hours. After stirring was completed, the internal temperature was raised to 65-70°C, and a mixture of by-produced dimethoxymethane and methanol was distilled and removed from the distillation column. The reaction liquid during the reaction was sampled, and when the reaction rate reached 100%, a 25% by mass aqueous sodium hydroxide solution (4.26g, 0.027mol as sodium hydroxide) was added, and methanol was removed until no distillation occurred. Thereafter, water (30g) was added and the liquid was separated, and the aqueous layer was removed to obtain an organic layer. The resulting organic layer was concentrated under reduced pressure, and the residue was distilled under reduced pressure to give (3Z)-7,7-dimethoxy-3-hepten-1-ol (2:R 4 =R 5 =CH 3 ;a=2) (43.20 g, 0.24 mol, purity 95.76%; 3Z:3E=90.4:9.6, bp=110.0-116.0 °C / 3.0 mmHg) was obtained in a yield of 89.16%.

[0188] The (3Z)-7,7-dimethoxy-3-hepten-1-ol (2:R 4 =R 5 =CH 3 The spectral data for ;a=2) is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3 ):δ=1.65(2H,dt,J=6.9Hz,6.9Hz),1.95(1H,br.s),2.11(2H,dt,J=7.5Hz,7.5Hz),2.31(2H,dt,J=6.8Hz ,6.8Hz),3.29(6H,s),3.61(2H,t,J=6.5Hz),4.36(1H,t,J=5.9Hz),5.36-5.43(1H,m),5.47-5.54(1H,m); 13 C-NMR (500 MHz, CDCl 3):δ=22.45,30.67,31.90,52.47,62.10,103.64,126.18,131.67 [Infrared absorption spectrum] (D-ATR): νmax = 3415, 2946, 1448, 1385, 1128, 1055, 918, 729

[0189] Example 16 <(3Z)-1-chloro-7,7-dimethoxy-3-heptene (3:X=Cl,R 4 =R 5 =CH 3 ;a=2) Production>

[0190] [ka]

[0191] At room temperature, a reactor was charged with (3Z)-7,7-dimethoxy-3-hepten-1-ol (2:R 4 =R 5 =CH 3 ;a=2) (178.00 g, 0.68 mol, purity 94.77%; 3Z:3E=89.6:10.4), pyridine (70.85 g, 0.90 mol), potassium carbonate (13.75 g, 0.10 mol) and γ-butyrolactone (GBL) (149.28 g) were added and stirred at 0 to 10° C. for 18 minutes. Subsequently, methanesulfonyl chloride (79.80 g, 0.70 mol) was added dropwise at 0 to 10°C. After completion of the dropwise addition, the temperature was raised to 60 to 65°C and the mixture was stirred for 5.5 hours. After completion of the stirring, water (199.04 g) and hexane (199.04 g) were added and the mixture was separated, and the aqueous layer was removed to obtain an organic layer. The obtained organic layer was washed with an aqueous acetic acid solution (acetic acid (24.88 g) and water (199.04 g)), and then washed with an aqueous sodium hydrogen carbonate solution (sodium hydrogen carbonate (12.56 g), water (199.04 g)), and the obtained organic layer was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain (3Z)-1-chloro-7,7-dimethoxy-3-heptene (3:X=Cl, R 4 =R 5 =CH 3;a=2) (62.54 g, 0.30 mol, purity 91.97%; 3Z:3E=89.5:10.5, bp=73.2-74.0°C / 3.0 mmHg) was obtained in a yield of 60.00%.

[0192] The (3Z)-1-chloro-7,7-dimethoxy-3-heptene (3:X=Cl, R 4 =R 5 =CH 3 The spectral data for ;a=2) is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3 ):δ=1.62‐1.69(2H,m),2.10(2H,dt,J=7.9Hz,7.9Hz),2.52(2H,dt,J=6.9Hz,6.9Hz),3.31 (6H,s),3.50(2H,t,J=6.9Hz),4.35(1H,t,J=5.7Hz)5.37-5.44(1H,m),5.48-5.55(1H,m); 13 C-NMR (500 MHz, CDCl 3 ):δ=22.55,30.51,32.10,44.12,52.78,103.79,125.67,131.88 [Mass spectrum] EI-mass spectrum (70 eV): m / z 191 (M + -1), 161, 143, 129, 97, 75, 58, 41 [Infrared absorption spectrum] (D-ATR): νmax = 2952, 2830, 1447, 1385, 1295, 1127, 1066, 918, 737, 660

[0193] Example 17 <(3Z)-7,7-dimethoxy-1,3-heptadiene (4:R 4 =R 5 =CH 3 ;a=2) Production>

[0194] [ka]

[0195] Potassium tert-butoxide (47.33 g, 0.42 mol) and tetrahydrofuran (198.48 g) were added to a reactor at room temperature, and the mixture was stirred at -5 to 5°C for 17 minutes. Subsequently, at 0 to 10° C., (3Z)-1-chloro-7,7-dimethoxy-3-heptene (3:X=Cl, R 4 =R 5 =CH 3 3Z)-7,7-dimethoxy-1,3-heptadiene (4:R=2) (51.98 g, 0.25 mol, purity 91.97%; 3Z:3E=89.5:10.5) was added dropwise. After completion of the dropwise addition, the temperature was raised to 20-25°C and the mixture was stirred for 1.5 hours. After completion of the stirring, water (125.43 g) was added and the mixture was separated, and the aqueous layer was removed to obtain an organic layer. The obtained organic layer was concentrated under reduced pressure to obtain (3Z)-7,7-dimethoxy-1,3-heptadiene (4:R=2) (51.98 g, 0.25 mol, purity 91.97%; 3Z:3E=89.5:10.5). 4 =R 5 =CH 3 The crude product of ;a=2) (74.28 g, 0.26 mol, purity 55.13%; 3Z:3E=89.5:10.5) was obtained in a crude yield of 100%.

[0196] The (3Z)-7,7-dimethoxy-1,3-heptadiene (4:R 4 =R 5 =CH 3 The spectral data for ;a=2) is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3 ):δ=1.68(2H,dt,J=5.7Hz,7.6Hz),2.24(2H,ddt,J=1.5Hz,7.7Hz,7.7Hz),3.31(6H,s),4.35(1H,t,J=5.7Hz),5.09(1H,d,J=9.9Hz),5.18(1 H,dd,J=16.8Hz,1.9Hz),5.43(1H,dt,J=7.7Hz,7.7Hz),6.01(1H,dd,J=10.7Hz,10.7Hz),6.64(1H,dddd,J=16.9Hz,10.6Hz,10.6Hz,1.1Hz); 13 C-NMR (500 MHz, CDCl 3):δ=22.90,32.20,52.76,103.82,117.21,129.82,131.35,132.00 [Mass spectrum] EI-mass spectrum (70 eV): m / z 155 (M + -1), 124, 93, 75, 58, 41 [Infrared absorption spectrum] (D-ATR): νmax = 2950, ​​2830, 1436, 1385, 1365, 1126, 1080, 1065, 903, 788, 667

[0197] Example 18 <Production of (4Z)-4,6-heptadienal (5:a=2)>

[0198] [ka]

[0199] At room temperature, the reactor was charged with (3Z)-7,7-dimethoxy-1,3-heptadiene (4:R 4 =R 5 =CH 3 A crude product of (a=2) (74.28g, 0.26mol, purity 55.13%; 3Z:3E=89.5:10.5), oxalic acid dihydrate (93.83g, 0.74mol), tetrahydrofuran (248.10g) and pure water (248.10g) were added and stirred at 60-65°C for 2 hours. Then, the reaction solution was cooled to 50°C, hexane (726.70g) was added and stirred for 48 minutes. After the stirring was completed, the reaction solution was left to stand and separated, and the aqueous layer was removed to obtain an organic layer. The obtained organic layer was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain (4Z)-4,6-heptadienal (5:a=2) (20.75 g, 0.18 mol, purity 97.71%, 3Z:3E=89.8:10.2, bp=58.9-59.0°C / 8.00 kPa (60.0 mmHg)) in a yield of 74.20% as the yield of the two steps of Examples 17 and 18. (3Z)-7,7-dimethoxy-3-hepten-1-ol (2:R 4 =R 5 =CH 3The geometry of the 3-position of (4Z)-4,6-heptadienal (5: a = 2) was maintained at the 4-position of (4Z)-4,6-heptadienal (5: a = 2), and no isomerization was observed.

[0200] The spectral data of the (4Z)-4,6-heptadienal (5: a=2) obtained above is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl 3 ):δ=2.47-2.56(4H,m),5.13(1H,d,J=10.4Hz),5.21(1H,dd,J=16.8Hz,1.9Hz),5.36-5.43(1H,m),6.0 2(1H,dd,J=10.7Hz,10.7Hz),6.62(1H,dddd,J=18.7Hz,10.7Hz,10.7Hz,1.1Hz),9.76(1H,d,J=1.6Hz); 13 C-NMR (500 MHz, CDCl 3 ):δ=20.38,43.50,118.00,129.61,130.42,131.53,201.57 [Mass spectrum] EI-mass spectrum (70 eV): m / z 110 (M + ), 95, 82, 67, 54, 41, 27 [Infrared absorption spectrum] (D-ATR): νmax = 2825, 2726, 1725, 1437, 1409, 1000, 908, 786, 648

Claims

1. The following general formula (1): R 1 CH 2 OCH 2 OCH 2 CH 2 EH=EH(EH 2 ) a HH(OR) 2 )(OR 3 ) (1) (In the formula, R 1 represents a hydrogen atom, an n-alkyl group having 1 to 9 carbon atoms, or a phenyl group; R 2 and R 3 each independently represents a monovalent hydrocarbon group having 1 to 15 carbon atoms, or R 2 and R 3 are bonded together to form R 2 -R 3 represents a divalent hydrocarbon group having 2 to 10 carbon atoms, and a represents an integer of 1 to 15. The dialkoxyalkenyl alkoxymethyl ether compound represented by the following general formula (2): HOCH 2 CH 2 CH=CH(CH 2 ) a CH(OR 4 )(OR 5 ) (2) (In the formula, R 4 and R 5 each independently represents a monovalent hydrocarbon group having 1 to 15 carbon atoms, or R 4 and R 5 are bonded together to form R 4 -R 5 represents a divalent hydrocarbon group having 2 to 10 carbon atoms, and a is as defined above. obtaining a dialkoxy-3-alkene-1-ol compound represented by The dialkoxy-3-alkene-1-ol compound (2) is halogenated to obtain a compound represented by the following general formula (3): XCH 2 CH 2 CH=CH(CH 2 ) a CH(OR 4 )(OR 5 ) (3) (wherein X represents a halogen atom, and R 4 , R 5 and a is as defined above. obtaining a 1-halodialkoxy-3-alkene compound represented by the formula: The 1-halodialkoxy-3-alkene compound (3) is subjected to an elimination reaction in the presence of a base to obtain a compound represented by the following general formula (4): CH 2 =CHCH=CH(CH 2 ) a CH(OR 4 )(OR 5 ) (4) (In the formula, R 4 , R 5 and a is as defined above. obtaining a dialkoxy-1,3-alkadiene compound represented by the formula: The dialkoxy-1,3-alkadiene compound (4) is hydrolyzed to obtain a compound represented by the following general formula (5): CH 2 =CHCH=CH(CH 2 ) a CHO (5) (In the formula, a is as defined above.) obtaining a terminally conjugated alkadienal compound represented by A method for producing a terminally conjugated alkadienal compound (5), comprising at least

2. The method for producing a terminally conjugated alkadienal compound (5) according to claim 1, wherein the hydrolysis is carried out in a washing step of the elimination reaction.

3. The following general formula (1): R 1 CH 2 OCH 2 OCH 2 CH 2 EH=EH(EH 2 ) a HH(OR) 2 )(OR 3 ) (1) (In the formula, R 1 represents a hydrogen atom, an n-alkyl group having 1 to 9 carbon atoms, or a phenyl group; R 2 and R 3 each independently represents a monovalent hydrocarbon group having 1 to 15 carbon atoms, or R 2 and R 3 are bonded together to form R 2 -R 3 represents a divalent hydrocarbon group having 2 to 10 carbon atoms, and a represents an integer of 1 to 15. A dialkoxyalkenyl alkoxymethyl ether compound represented by the formula:

4. The dialkoxyalkenyl alkoxymethyl ether compound (1) according to claim 3, wherein a is 7.

Citation Information

Patent Citations

  • Process for producing aliphatic aldehyde compound having terminal conjugated diene structure

    JP2017193493A